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ABSTRACT 
 
The purpose of this research was to explore a convenient method for bulk separations 
of volatile fatty acid (VFA) mixtures in dilute aqueous solution, and to develop new chiral 
stationary phases (CSPs) for enantiomeric separations by high-performance liquid 
chromatography (HPLC). 
Direct separations of acetic, propionic, and butyric acids in dilute water solution by 
azeotropic distillation were demonstrated.  Despite of its highest boiling point among these 
three acids, the butyric acid is the first acid to distill, followed by propionic acid.  Over half 
of acetic acid still remains in the pot even when the other two acids are gone.  Quantitative 
carbon-13 nuclear magnetic resonance (NMR) was employed as an effective and accurate 
detecting method for the acid mixtures.  A comparison of short (1 second) vs. long (30 
seconds) delay (D1) between successive scans was made.  The effects of a paramagnetic 
reagent, disodium (diethylenetriaminepentaacetato)iron(III) (Na2[Fe(DTPA)]), and its 
concentration on the quantitative carbon-13 analysis was also discussed. 
The basis for most chiral high performance liquid chromatographic separations is the 
chiral stationary phases.  The design, synthesis and evaluation of new chiral stationary phases 
are the other important part of this research.   
We first evaluated the chromatographic performance of the polymeric (R,R) and (S,S) 
poly (trans-1,2-cyclohexanediyl-bis acrylamide) based CSPs, which are known as (R,R) and 
(S,S) poly-cyclic amine polymer (P-CAP) HPLC columns.  These two columns are effective 
in separating enantiomers under normal phase and polar organic conditions, and with mobile 
phases containing halogenated solvents.  The retention behavior, effects of mobile phase 
vii 
additives, normal-phase organic modifier, flow rate, column efficiency under different 
mobile phase conditions, sample loading capacity, and reversal of analyte elution order are 
discussed in detail.  Hydrogen bonding interactions between these CSPs and analytes are the 
dominant interactions for chiral recognition by P-CAP columns.  Dipole-dipole interactions 
and steric repulsion may also contribute to enantiomeric separations.   
For the first time, we prepared stable β-cyclodextrin (β-CD) derivatives which contain 
π-electron deficient substituents (i.e., π-acidic moieties) for enantiomeric separations by 
HPLC.  A variety of different dinitro-substituted aryl groups are investigated and compared 
in terms of their enantioselectivity.  These CSPs are highly stable and robust under three 
mobile phase modes, including the reversed-phase, normal phase, and polar organic modes 
and exhibit very broad selectivity for a wide variety of compounds, including heterocyclic 
compounds, chiral acids, chiral amines, chiral alcohols, chiral sulfoxides and sulfilimines, 
amino acid derivatives, and other chiral compounds.  The effects of the mobile phase pH, 
buffer composition, number and position of the dinitro groups on the phenyl ring substituent, 
degree of substitution, and the bonding strategy on the chromatographic performance of the 
CSPs are investigated.  The 2,6-dinitro-4-trifluoromethylphenyl (DNP-TFM) substituted β-
cyclodextrin-based CSPs have the best column performance overall.  For each mobile phase 
mode, no degradation in column performance was observed even after more than 1000 
injections.   
Finally, we optimized the 2,6-dinitro-4-trifluoromethylphenyl derivatized β-
cyclodextrin-based CSPs for enhanced enantiomeric separations.  Five different CSPs, which 
differ from each other in the linkage chain, the position of DNP-TFM groups on β-CD ring, 
or the sequence of synthetic procedure, were prepared and evaluated with 14 pairs of 
viii 
enantiomeric analytes in the reversed-phase mode.  The spacer effect is much more 
pronounced for the β-cyclodextrin derivatives with the DNP-TFM substituted only on the 
secondary hydroxyl groups.  The synthetic sequence of derivatization and bonding chemistry 
also affects the chiral recognition capability of the CSPs.  The optimized CSP based on DNP-
TFM derivatized β-CD exhibits broad enantioselectivity and high separation efficiency 
which makes it one of the most useful derivatized cyclodextrin CSPs. 
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CHAPTER 1.  GENERAL INTRODUCTION 
 
Chemical separations are widely utilized in process industries.  In manufacturing, 
separation processes are used to remove impurities from raw materials, purifying products, 
recycling chemical streams, and protecting environments, etc [1].  Due to the fact that 
separation processes can cost from 40% to 70% of both capital and operating expenditures, 
significant savings can be achieved by application of the proper separation technology [1].  
The common chemical separation technologies include distillation, extraction, crystallization, 
adsorption, chromatography, ion exchange, membranes, electrical and other field-induced 
separations, etc.  This research focuses on the separation of organic molecules by distillation 
and chiral high performance liquid chromatography. 
1.1 Distillation 
Distillation is a chemical separation method which utilizes different boiling points to 
separate and purify a liquid component from a mixture.  So, it is suitable for the separation of 
the components, in the liquid mixture, which have different vapor pressures, or boiling points.  
Due to the fact that distillation has a simple process flowsheet, and is a low-risk and low-
capital-investment process, about 90% to 95% of all the chemical process industry 
separations are achieved by distillation [1].  In a distillation column, the countercurrent flow 
of vapor and liquid mix together.  Trays or packings are usually used inside the column to 
improve interfacial contact of the two phases.  Despite its low energy efficiency and the 
requirement of thermal stability of analytes at their boiling points, distillation is still favored 
for volatile analytes against other separation methods. 
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An azeotrope is a liquid mixture of two or more components which has the same 
composition for both vapor and liquid states when it is distilled at a certain pressure [2,3].  
Therefore, it is impossible to completely separate the azeotropic components into individual 
compound by simple distillation.  However, it is still possible to separate several azeotropes 
from each other by distillation, provided they have different boiling points. 
In view of the limited supply of petroleum and fossil fuels, it is of great interest to 
obtain valuable organic compounds, such as volatile fatty acids (VFA), from biorenewable 
resources [4-7].  These volatile fatty acids, including acetic, propionic, and butyric acids, 
exist as a dilute mixture in the anaerobic fermentation sludge [8].  Distillation may provide a 
convenient way to separate these acids out of the mixture, furthermore, possibly from each 
other.  Azeotropic data of these three acids with water are shown in Table 1 [3,9]. 
1.2 Quantitative 13C NMR Analysis 
The nuclear magnetic resonance (NMR) was discovered by Bloch [10,11] and Purcell 
[12,13] independently in 1945.  It is a sophisticated technique which measures the absorption 
and emission of electromagnetic radiofrequency radiation by the nuclei of certain atoms that 
are placed in a strong magnetic field [14,15].  Because abundant information on the atomic 
interactions within or between organic compounds and/or macromolecules can be revealed 
by NMR, it is of major importance not only in molecular structure determination [16], but 
also in molecular binding studies [17].  Among hundreds of atoms and their isotopes, the 
most commonly measured atomic species in NMR are 1H, 13C, 15N, 19F and 31P. 
Due to the low natural abundance of 13C (only 1.1%), either 13C-enriched and/or highly 
concentrated samples, or long acquisition times are required for a 13C spectra with sufficient 
signal-to-noise ratio (S/N).  Moreover, different type of carbons may have significantly 
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different relaxation times, which could range from hundreds of milliseconds to over 100 
seconds [18].  The wide spread of 13C relaxation times leads to preferential saturation of the 
more slowly relaxing 13C nuclei.  Consequently, the signal intensities acquired by the NMR 
spectrometer for the same amount but different types of 13C nuclei may vary [16].  This 
makes 13C NMR difficult for quantitative analysis. 
The difficulty can be overcome in different ways.  First, the pulse delay between 
repetitions of scans can be set long enough to ensure that every carbon relaxes back to 
Boltzmann equilibrium before the next radiofrequency pulse is applied [19].  This method 
may suffer from long analysis time.  Second, adding a paramagnetic reagent, such as Fe3+, 
Cr3+, Gd3+, Mn2+,Eu3+, etc. can significantly suppress the nuclear Overhauser effect (NOE) 
and shorten the 13C spin-lattice relaxation times (T1) of all carbons so that differences in T1 
become insignificant [16,20-22].  The NOE is unfavorable for quantitative 13C analysis 
because it perturbs signal intensities of different carbons.  The NOE can be further 
suppressed by a gated decoupler [16].  The decoupler is turned on during data acquisition and 
off during the pulse delay. 
1.3 Chromatography 
Analytical separations largely relied on precipitation, crystallization, distillation, and 
extraction before the middle of twentieth century.  However, since then, chromatography has 
become a powerful and widely used analytical method which finds widespread applications 
in research and industry [23,24].   
The Russian botanist Micaël S. Tswett demonstrated the separation of plant pigments 
by liquid column chromatography in 1903 [25].  Because of his innovative work, Tswett is 
regarded as the father of chromatography [26].  In 1952, the Nobel Prize in chemistry was 
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awarded to Archer J. P. Martin and Richard L. M. Synge for their invention of partition 
chromatography and the related plate theory [27].  A total of twelve Nobel Prizes between 
1937 and 1972 were awarded to the scientists whose work were largely based on 
chromatography [28].  This fact clearly shows the extensive applications of chromatography 
in almost all branches of science.  Numerous varieties of chromatography, from paper 
chromatography, thin-layer chromatography (TLC), gas chromatography (GC), high-
performance liquid chromatography (HPLC), supercritical fluid chromatography (SFC), to 
capillary electrochromatography (CEC), have been developed.  The successful development 
of chromatography directly or indirectly triggered the development of many detection 
methods, such as flame ionization detector (FID), electron-capture detector (ECD), mass 
spectrometry (MS), etc.  This revolution successfully led analytical chemistry from 
gravimetric and titration-based wet chemistry to modern instrumental analysis.  The first 
century of chromatography (from 1903 to 2003) has tremendous fascinating stories [29,30].  
Chemists, as well as scientists in other areas, have been benefiting, and will continue to 
benefit from this powerful and versatile analytical method.  New technologies based on 
chromatography continue to be developed. 
1.4 Chirality 
Louis Pasteur first proposed molecular asymmetry in 1848 to explain the crystal 
morphological principles introduced by René J. Haüy in 1809 [31,32].  The four valences of 
a carbon atom form a tetrahedron structure with the carbon atom as its center was first 
proposed by Jacobus H. van't Hoff and Achille Le Bel in 1874, independently [32].  These 
hypotheses are considered to be the origin of stereochemistry and they gave rise to the 
concept of chirality in chemistry, i.e. the asymmetric geometry of molecules.  The term 
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chiral was proposed by Lord Kelvin (William Thomson) in 1884 in his Baltimore Lectures 
on Molecular Dynamics and the Wave Theory of Light [33]:  
“I call any geometrical figure, or group of points, chiral, and say it 
has chirality, if its image in a plane mirror, ideally realized, cannot be 
brought to coincide with itself.” 
--- Lord Kelvin 
In simple words, chirality means handedness, which refers to the existence of left/right 
opposition.  So, any object, which cannot be superimposed with its mirror image, is chiral.  
These two non-superimposable mirror images are called enantiomers.  A pair of enantiomers 
behaves in exactly the same way in an achiral environment, but they may have quite different 
properties when they are subjected to a chiral influence.  In stereochemistry, a carbon with 
four different substituents is said to be a chiral or stereogenic center.  Other atoms, such as 
sulfur, nitrogen, phosphorus and silicon, may also produce stable chiral centers.  Besides 
chiral centers, molecules with chiral axes and chiral planes also can exist as enantiomers. 
Chirality has become more and more important in research and many industries, such 
as the pharmaceutical industry, agrochemical industry, food and beverage industry, and 
petrochemical industry, etc.  Any life in nature is a biological system, which consists of L-
amino acids and D-type of sugars.  A pair of enantiomers may have different effects on the 
biological systems.  The most striking example is the thalidomide tragedy in the middle of 
the last century [34].  Some examples of enantiomers which show the effect of chirality are 
listed in Table 2 [31,32,35-37].  The fact that two enantiomers can produce different 
pharmacological effects in biological systems makes chirality especially important for the 
drug industry.   
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In 1992, the Food and Drug Administration (FDA) issued new guidelines for the 
development of new stereoisomeric drugs [38].  The FDA requires companies to evaluate the 
racemates and enantiomers of stereoisomeric drugs.  Now, the FDA may approve single 
enantiomers as new drugs, as opposed to racemic drugs.  This policy results in a so-called 
“chiral extension”.  Many pharmaceutical companies benefit from “chiral extension” by 
extending their racemic drugs for which patents are about to expire [31].  Today, a large 
number of pharmaceuticals are chiral molecules.  In 2004, nine out of the top-ten best-selling 
drugs had chiral active ingredients and the top-four drugs (Lipitor, Zocor, Plavix, and 
Nexium) are all sold in the form of single enantiomers [39]. 
In order to get single enantiomers, many methods, including asymmetric synthesis, 
crystallization of diastereomeric salts, chromatographic separation, biologic digestion, and 
enzymatic resolution, etc. can be used.  Despite its relatively high cost, chiral 
chromatography is still favored for rapid producing high-purity enantiomers from racemic 
mixtures, especially when other choices are limited.  Chiral high-performance liquid 
chromatography is widely used in industry for preparative separations.  In recent years, 
interest has expanded to chiral separations by supercritical fluid chromatography, which is 
usually considered as an ideal substitute for normal-phase HPLC because of its low organic 
solvent consumption [40,41]. 
1.5 Chiral Liquid Chromatography 
Louis Pasteur’s pioneering work on crystallization and hand-picking the individual 
minuscule crystals of ammonium sodium tartrate demonstrated the first enantiomeric 
separation [42].  However, until the early 1980s, enantiomeric separations were still thought 
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to be difficult and often intractable, with only a few sporadic reports [43].  Since then, 
advances in this field have made the separation of enantiomers practical and even routine. 
Chiral selectors are needed in order to achieve enantiomeric separations.  In chiral 
liquid chromatography, a chiral selector can be used either as a mobile phase additive if it is 
soluble in the mobile phases and compatible with the detection method, or as a chiral 
stationary phase (CSP).  Immobilizing chiral selectors by either coating or chemical bonding 
them on a solid support is the most widely accepted approach today, because in this way, 
much less chiral selector is needed and thus favorable for preparative separations.  Also, 
immobilized chiral selectors will not interfere with the detection of analytes.  According to 
their structures, chiral selectors can be categorized as (1) macrocyclic chiral selectors; (2) 
polymeric chiral selectors; (3) π-π association chiral selectors; (4) ligand exchange chiral 
selectors; and (5) miscellaneous and hybrid chiral selectors [44]. In order to achieve chiral 
recognition, there should be at least three-points of interaction between a chiral selector and 
the enantiomer to be separated [45,46].  Due to the wide variety of chiral analyte structures 
and solubilities, the structure of chiral selectors may also vary.  Although over one hundred 
chiral selectors have been commercialized, researchers all over the world are still devoting 
great efforts to the development of new chiral selectors for making more efficient and 
versatile chiral stationary phases or solving challenging enantiomeric separation problems.  
The list of commercialized chiral selectors is still growing. 
1.5.1 Macrocyclic chiral selectors 
The macrocyclic chiral selectors include (1) cyclodextrins (CDs) and their derivatives; 
(2) glycopeptide antibiotics; and (3) chiral crown ethers.  This class of chiral selectors has 
dominated enantiomeric separations by gas chromatography and capillary electrophoresis, 
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and has also been very important in chiral liquid chromatography, especially in the reversed-
phase and polar organic modes [43].  Cyclodextrins and their derivatives will be discussed in 
more detail in next section. 
Macrocyclic glycopeptides were first introduced by Armstrong and co-workers in 1994 
and have been the newest and fastest growing class of chiral stationary phases since then 
[41,47-66].  There are literally hundreds of macrocyclic antibiotics.  However, currently, 
teicoplanin, teicoplanin aglycone, vancomycin, and ristocetin A are the four major types that 
are available as chiral stationary phases [43].  The teicoplanin aglycone is the teicoplanin 
glycopeptide without sugar moieties.  The structures of these chiral selectors are shown in 
Fig. 1 [65].  The total syntheses of these naturally occurred products were also explored [67-
72]. 
The macrocyclic glycopeptide CSPs can be used in all three mobile phase modes, 
namely, reversed-phase, polar organic and normal phase modes.  The teicoplanin CSP 
(Chirobiotic T) effectively resolves all native amino acids and many peptides in the reversed-
phase mode with only an unbuffered alcohol-water mobile phase [43,53].  The carbohydrate 
moieties on the macrocyclic glycopeptides also affect the enantioselectivity of the 
corresponding CSPs.  The teicoplanin aglycone CSP (Chirobiotic TAG) usually produces 
better enantioselectivities for many amino acids and chiral carboxylic acids, but its 
enantioselectivity for many other neutral or cationic chiral compounds is not as good as that 
of the native teicoplanin CSP [64].  These four closely related glycopeptide CSPs exhibit 
complementary enantioselectivities for many chiral analytes [66].  This feature is beneficial 
in methods development because if a partial separation is observed on one CSP, then a 
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baseline separation can usually be achieved on another related CSP with the same or very 
similar mobile phase. 
Chiral crown ether CSPs are another type of macrocyclic chiral selectors, which were 
first introduced by Cram and coworkers [73-76].  The cavity of the macrocyclic polyether 
18-crown-6 has a perfect size for cations like K+ and NH4+ to form inclusion complexes.  
When coupled with chiral moieties, such as enantiomerically pure 1,1’-binaphthyl moieties, 
the modified chiral crown ether CSPs are able to separate some chiral compounds mostly 
with primary amine moieties [43].  The first chiral resolution of secondary amines on this 
type of CSP was also reported [77].  It is important to keep the amino group of the analytes 
protonated for this type of CSP, so usually, aqueous and acidic mobile phases are used.  The 
commonly used acids are perchloric acid, sulfuric acid and trifluoroacetic acid.  No 
preparative scale chiral separation on this type of CSP has been reported probably due to the 
difficulties in recovery of analytes from the mobile phases with strong, non-volatile and/or 
possibly explosive acids [78].   
1.5.2 Polymeric chiral selectors 
The polymeric chiral selectors include naturally occurring polymers (such as 
polysaccharides and proteins) and synthetic polymers.  The application of this type of chiral 
selectors is important in chiral HPLC, but very limited in chiral GC and CE.  The protein-
based CSPs were significant in the early development of chiral separations [79-82].  
However, its importance has declined continuously since the mid-1990s with the discovery 
of new CSPs.  The reasons for this decline include: (1) the protein-based chiral selectors are 
the most labile class of CSPs; (2) they have the least sample loading capacity; (3) they often 
10 
are the most expensive CSPs; (4) the same enantiomeric separations usually can be achieved 
on other new CSPs.  Thus, research interests have turned to other types of CSPs. 
The polysaccharide-based CSPs mainly include cellulose and amylose derivatives.  
Cellulose and starch are the most abundant naturally occurring chiral polymers in the world.  
Cellulose is composed of unbranched chains of D-glucose units joined by β-1,4’-glycosidic 
linkages.  Amylose differs from cellulose only in that it has an α-1,4’-glycosidic linkage.  
The first resolution of racemic amino acids using polysaccharide-based CSPs was done by 
Kotake et al. on paper chromatograms [83], which, obviously, was made of cellulose.  
However, there have been difficulties repeating these results, and in general, native cellulose 
and amylose are considered very poor chiral selectors without derivatization.  Derivatized 
cellulose for enantiomeric separations was first attempted by Mintas et al. in the late 1970s 
[43,84,85].  Okamoto et al. subsequently prepared a series of triester and tricarbamate 
derivatives of cellulose and amylose, which showed highly effective enantioselectivities for a 
wide variety of racemates [86-93].   
The triester and tricarbamate derivatives of cellulose and amylose were physically 
coated onto macroporous γ-aminopropyl functionalized silica gel [88,89].  This actually 
severely limits the choice of mobile phases.  Some common organic solvents, such as 
tetrahydrofuran (THF), chloroform, and ethyl acetate, cannot be used as mobile phase 
because the polysaccharide derivatives will be dissolved or swollen in these solvents [94].  It 
was recommended that these columns be used in the normal phase mode with n-
hexane/alcohol mixtures and stored with n-hexane at ~ 4 ˚C when not being used.  To reduce 
tailing, small amount (up to 1%) of organic acids or bases can be added into the mobile 
phases [88,89].  After the polar organic mode was introduced by Armstrong [95,96], it was 
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found that this mobile phase mode also worked well for many polysaccharide-based CSPs 
[97,98].  Some of these polysaccharide-based CSPs were also conditioned for reversed-phase 
mode.  However, these CSPs are not to be used in a multimodal mobile phase manner.  The 
separation mechanism heavily relies on the three-dimensional structure of polysaccharides 
[99].  Changing the mobile phase mode changes the configuration of polysaccharides, and 
these changes of configuration are often irreversible thus harmful to enantioselectivity.  The 
chemically bonded-type polysaccharide-based CSPs were also prepared in order to expand 
the choice of solvents as mobile phases.  However, poor chiral recognition was observed, 
compared to the corresponding coated forms [94].  This is probably because the higher-order 
structure regularity may be reduced in the bonded forms. 
Synthetic polymers used as chiral stationary phases can be divided into two categories.  
The first type is made from achiral monomers in the presence of chiral catalyst [100,101].  
The formation of either right-hand or left-hand helical coils, depending on the chiral catalyst, 
gives the whole polymer chirality.  These CSPs are very interesting from an academic point 
of view, although their enantioselectivities seem to be very limited [43].  The other type is 
made from enantiomeric monomers.  In this way, two opposite enantiomeric versions of the 
CSPs can be prepared and thus the elution order of the analytes can be easily inverted.  It is 
relatively easy to increase the loading of the polymeric chiral selectors on the solid support.  
This may be beneficial to preparative separations.  However, a common problem for this kind 
of CSPs may be the slow analyte mass transfer kinetics [102].  Therefore, in order to improve 
the separation efficiency, the degree of polymerization, grafting density and polymer 
architecture should be carefully controlled so that the polymeric materials form a uniform, 
thin, and ordered layer on the porous solid support without changing the pore morphology.   
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1.5.3 π-π Association chiral selectors 
As the name suggests, the major associative interaction between these types of CSPs 
and analytes is the π-π interaction [103-121].  The chiral selectors usually contain a π-
electron donor (π-basic), or π-electron acceptor (π-acidic) moiety, or both.  The common π-
basic moieties include phenyl, alkyl-substituted phenyl, and naphthyl groups.  And the 
commonly used π-acidic moiety is the dinitro-, trifluoromethyl-, and pentafluoro-substituted 
phenyl groups.  To be separated on this type of CSPs, analytes usually should have a π-
electron system complementary to the CSPs.  An achiral aromatic group, such as 3,5-
dinitrobenzoyl or dansyl groups in most cases, is usually needed for derivatization of the 
compounds which do not have aromatic moieties.  Most of the applications of π-π 
association chiral selectors are in the normal phase mode.  Moreover, this type of CSPs 
usually can have good coverage on solid supports.  Therefore, they are useful for many 
preparative separations. 
1.5.4 Ligand exchange chiral selectors 
In 1961, Helfferich first reported that compounds which can form complexes with 
metal ions can be separated by a ligand exchange chromatographic technique [122].  
Subsequently, ligand exchange chiral selectors were developed by Davankov et al. [123-128].  
The chiral selector (ligand) is bonded to a solid support to form a CSP.  The best ligands 
usually contain electron-donating atoms, such as nitrogen, oxygen, and sulfur, which can 
coordinate with metal ions.  Proline, hydroxyproline, histidine, phenylalanine, aspartic acid, 
glutamic acid, methionine, thereonine, leucine, and valine are commonly used as chiral 
ligands.  Several transition metal ions, including Cu (II), Ni (II) and Zn (II), were tested.  The 
tetra-coordinate Cu (II) is the best for bifunctional analytes and bidentate chiral ligands, and 
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hexa-coordinate Ni (II) is preferable with tridentate ligands.  The metal ions provide the site 
for the exchange process between the ligands and analytes.  Ligand exchange chiral 
separations are usually carried out with buffered aqueous mobile phases containing a suitable 
concentration of metal ions.  For the CSPs containing a metal ion complex as the chiral 
ligand, no metal ions are needed in the mobile phases.  An organic modifier, such as 
acetonitrile, methanol, ethanol and THF, can be added in order to optimize a separation [129-
132].  Applications in normal phase mode were also reported [133,134]. 
1.5.5 Miscellaneous and hybrid chiral selectors 
The chiral selectors mentioned above are the most popular and commonly used CSPs in 
research and industries.  Due to the diversity of the development of chiral selectors, 
miscellaneous types of CSPs were also reported [43,135], although they have not been the 
current mainstream CSPs yet.  These CSPs may have some specific applications.  For 
example, the derivatized cinchona alkaloids were reported as effective CSPs for many chiral 
molecules [136-139].   
The hybrid chiral selectors are a combination of aforementioned types of CSPs.  For 
example, the naphthylethyl carbamate [140], 3,5-dimethylphenyl carbamate [140], and the 
new 2,6-dinitro-4-trifluoromethylphenyl ether [141] of β-cyclodextrin derivatives, are all 
macrocyclic chiral selectors.  However, they all may rely on π-π association interactions for 
enantiomeric separations. 
1.6 Cyclodextrins and Their Derivatives 
Cyclodextrins are cyclic oligosaccharides consisting of six to thirteen D-(+)-
glucopyranose units through α-(1,4) linkages [142].  These naturally occurring products can 
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be obtained from enzymatic reactions of starch.  The smallest cyclodextrin molecule is the α-
CD which has six glucopyranose units, followed by β-CD (seven units), γ-CD (eight units), 
δ-CD (nine units), and so on till θ-CD which consists of thirteen repeating glucose units 
[143].  The structures of α-, β-, and γ-CDs are shown in Fig. 2.  These three cyclodextrin 
molecules form a toroidal and hollow truncated cone structure (Fig. 3) [144].  However, the 
larger δ- through θ-cyclodextrins no longer have a regular truncated cone structure but a 
collapsed cylinder structure, so their real internal cavities are even smaller than γ-
cyclodextrin [143].  The α-, β-, and γ-cyclodextrins are the most commonly used CDs in 
research and industry, and β-cyclodextrin represents 95% of all produced and consumed CDs 
because of (1) its suitable cavity dimension for the formation of inclusion complexes with 
most common solute molecules [145], (2) the ease of isolation and production, and (3) its 
lowest price among all cyclodextrins.  The physical and chemical characteristics of native 
cyclodextrin molecules are listed in Table 3 [142,145,146].   
The discovery of α- and β-cyclodextrins can date back to Villiers and Schardinger’s 
work over one hundred years ago and the γ-cyclodextrin was discovered by Freudenburg and 
Cramer almost 50 years later [143].  In 1959, the first application of cyclodextrins for chiral 
separations was tried by Cramer and Dietsche as a selective precipitation/crystallization 
agent for enantiomers [146].  The first use of cyclodextrin in chromatography was reported 
by Armstrong et al. as a mobile phase additive in thin layer chromatography (TLC) [147-
149].  A short time later, cyclodextrins were first immobilized on silica gel through an ether 
linkage [144,150] or ethylenediamine linkage [151,152] as chiral stationary phases for 
column liquid chromatography.  The ether linkage bonded β-cyclodextrin is highly effective 
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and stable under chromatographic conditions [118,144,153-158] and was successfully 
commercialized [140].  It was also the first commercially successful reversed-phase chiral 
stationary phase [43,146].  Besides the CD bonded phases, the β-CD polymer coated phases 
were also prepared [159-161], although the enantioseparation efficiency seems not as good as 
that of the bonded stationary phases. 
In the cyclodextrin molecules, each glucopyranose unit has three hydroxyl groups.  
Two of the hydroxyl groups, which reside on C-2 and C-3 positions, are secondary and the 
other on C-6 position, is a primary hydroxyl group (see Fig. 2 and 3).  The hydroxyl group on 
the C-2 position of one glucopyranose unit can form a hydrogen bond with the C-3 hydroxyl 
group of the neighboring glucopyranose unit.  Because of its cavity size, the β-cyclodextrin 
has a complete belt of such hydrogen bonding [142].  This makes the β-cyclodextrin 
structure very rigid.  However, this kind of internal hydrogen bonding belt is incomplete for 
α- and γ-CDs due to angular strain and flexibility of the cyclodextrin framework.  That 
explains why β-cyclodextrin has the lowest solubility in water, compared to α-CD and γ-CD 
(see Table 3) [142].  Because all hydrophilic hydroxyl groups are on the rim of cyclodextrin 
torus, the interior cavity of cyclodextrins is relatively hydrophobic in nature (see Fig. 3).  
This characteristic structure, in addition to the hollow truncated cone shape, allows 
cyclodextrins to form inclusion complexes with a wide variety of organic and inorganic 
molecules [144,154-156,162-165].  Generally speaking, α-cyclodextrin can form an 
inclusion complex with a small molecule with a phenyl or naphthyl ring.  The cavity of β-
cyclodextrin can accommodate a molecule with naphthyl or heavily substituted phenyl 
16 
groups.  And the cavity of γ-cyclodextrin is big enough for three-ring-size compounds like 
anthracene or bulky steroid-type molecules [146,166].   
The cyclodextrin’s secondary hydroxyl groups are located at the larger diameter 
opening of the truncated cone, and the primary hydroxyl groups are at the smaller opening 
(see Fig. 3).  These hydroxyl groups provide the starting point for structural modification.  
The derivatization of cyclodextrins may improve the solubility of cyclodextrins and enhance 
their enantioselectivities.  Numerous derivatives of cyclodextrins have been made and some 
of them have been found to be useful in separation science [140,145,146].  The most useful 
derivatized cyclodextrin chiral selectors for liquid chromatography are listed in Table 4 [140].  
The different moieties used to derivatize cyclodextrins can greatly affect the chiral 
recognition of these CSPs.  The hydroxypropyl derivatized β-cyclodextrins (Cyclobond I 
2000 SP or RSP, see Table 4) exhibit great enantioselectivity for a wide variety of racemates 
[140,157] and may be the most broadly applicable of all cyclodextrin-based CSPs in the 
reversed-phase mode [43,146].  The aromatic substituted β-cyclodextrin (Cyclobond I 2000 
RN, SN and DMP, see Table 4) are useful not only in the reversed-phased mode, but also in 
the normal phase and polar organic phase modes [118,119,167,168].   
Before 1992, the mobile phases available for chromatographers were water-containing 
polar reversed-phase and water-free hydrocarbon-containing non-polar normal phase.  
Armstrong and coworkers [95,96] introduced a new mobile phase, which contains polar 
organic solvents, mostly acetonitrile with 0 to 10% methanol, initially for the chiral 
recognition of β-adrenergic blocking agents on β-cyclodextrin based CSPs.  This mobile 
phase mode quickly gave rise to applications on other types of CSPs like glycopeptide 
antibiotics-based CSPs [65,66] and polysaccharide-based CSPs [97,98], and proved to be a 
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useful addition to the reversed-phase and normal phase modes [95,96,140,169-172].  The 
acetonitrile molecule, which is the major component of the polar organic mobile phases, 
tends to occupy the cyclodextrin cavity.  A hydrogen-bonding solvent, such as methanol, can 
be added to compete with hydrogen-bonding analytes in the interaction with cyclodextrin 
molecules.  In this mode, the analyte associates with the cyclodextrin molecule mainly via 
hydrogen bonding interactions (Fig. 4A).  However, in the reversed-phase mode, the 
inclusion complexation is formed and contributes to chiral recognition, in addition to 
hydrogen bonding and steric interactions at the mouth of the cyclodextrin cavity (Fig. 4B) 
[172].   
Since the stable and high-coverage cyclodextrin-based bonded phase for enantiomeric 
separations by liquid column chromatography was introduced by Armstrong in 1983, the 
applications of cyclodextrins and their derivatives have increased exponentially due to the 
broad enantioselectivities of these CSPs for a wide variety of racemic compounds in all three 
mobile phase modes.  The applications are even more pervasive in gas chromatography and 
capillary electrophoresis enantiomeric separations [43].  New derivatives of cyclodextrins 
and their applications in chemistry and separation science are reported each year.  
Cyclodextrins and their derivatives are truly the most versatile chiral selectors, not only 
because they can be used in all three LC mobile phases, but also because they are widespread 
in other separation techniques, especially GC and CE. 
1.7 Chiral Recognition Mechanism 
Understanding the chiral recognition mechanism is beneficial to the method 
development of enantioselective HPLC.  A minimum of three simultaneous interactions 
between one or both enantiomers and the chiral stationary phase is required for chiral 
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recognition to occur.  Interactions that contribute to chiral recognition include hydrogen 
bonding, π-π association, inclusion complexation, dipole stacking, steric effects, ionic 
attraction/repulsion, etc.  It should be noted that not all interactions between chiral selectors 
and analytes are enantioselective [173].  These non-enantioselective interactions contribute to 
the retention of both enantiomers but not their enantioseparation.  The non-enantioselective 
interactions may come from non-enantioselective sites on chiral selectors and/or the linkage 
chain, and silanol groups on silica gel [146].  The chiral recognition mechanism is mostly 
dependent on the chiral selector, the analyte and the mobile phase.  The example in Fig. 4 
clearly shows that with the same chiral selector and analyte, different mobile phase modes 
may result in different chiral recognition mechanisms [172].  It is the difference of 
interactions between CSPs and analyte enantiomers that contributes to chiral separations.  
Increasing the retention time of analytes in CSPs may or may not enhance chiral recognition. 
When chiral selectors preferentially interact with one of the enantiomers and form two 
somewhat different diastereomeric complexes, chiral recognition is achieved.  In every 
enantiomeric separation by chromatography, there must be a sufficient difference in free 
energy for the transfer of two enantiomers between the chiral stationary phase and mobile 
phase [146].  The difference of free energy of binding ( ) can be calculated through 
the separation factor α by the following equation [65,174]: 
, (R S GΔ Δ )
, ( ) lnR S G RT αΔ Δ = −  
For chiral chromatographic separation, only a small free energy difference is needed to 
achieve a baseline separation.  The diastereomeric binding study by nuclear magnetic 
resonance usually needs larger free energy differences than chromatographic methods in 
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order to observe different chemical shift or coupling.  In addition to chromatographic 
[43,65,146,174-179] and NMR methods [174,176,180-184], X-ray diffraction [156,174,185], 
molecular modeling [156,157,174,176,182,184-186], and computer-aided chemistry 
[174,179,184,187,188] can also be used to study the chiral recognition mechanism. 
1.8 Dissertation Organization 
This dissertation begins with a general introduction of the background information for 
this research.  The following chapters are presented as four complete scientific manuscripts 
with accompanying cited literature, figures, and tables.  General conclusions summarize the 
work.  Appendices provide supporting materials for the chapter papers.   
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(A) (B) 
  
(C) (D) 
Fig. 1 Chemical structures of four major macrocyclic glycopeptides: (A) teicoplanin; (B) 
teicoplanin aglycone; (C) vancomycin; (D) ristocetin A. (from Ref. [65]). 
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Fig. 3 Schematic representation of naturally occurring α-, β-, and γ-cyclodextrins. (from Ref. 
[189]) 
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(A) (B) 
Fig. 4 Schematic illustration of interaction between β-cyclodextrin and propranolol in (A) 
polar organic mode; and (B) reversed-phase mode.  (from Ref. [172]). 
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Table 1 
Azeotropic data for acetic, propionic and butyric acids with water (from Ref. [3,9]) 
 Acetic acid Propionic acid Butyric acid 
Formula CH3COOH CH3CH2COOH CH3CH2CH2COOH 
Formula Weight 60.05 74.08 88.11 
Boiling Point (˚C) 117 141 162 
Azeotrope Temperature (˚C) N/A 99.9 99.8 
Azeotrope Weight Percentage N/A 17.7% 18.4% 
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Table 2 
Examples of enantiomers which show the effect of chirality (from Ref. [31,32,35-37]) 
Compound Structure Isomer Effect 
(R)- Anti-nausea 
Thalidomide N
O
O
HN
O
O
H
 (S)- Teratogenic 
(R)- Highly toxic 
Penicillamine SH
HOOC
NH2
 (S)- Anti-arthritic 
(R)- Odor of orange 
Limonene 
 (S)- Odor of lemon 
(R)- Active contraceptive 
Propranolol 
O N
H
OH
 
(S)- β-Adrenergic blocker 
(R)- Odor of spearmint 
Carvone 
O
 (S)- Odor of caraway 
(R,R)- Sweetener, 200 times stronger than table sugar. 
Aspartame 
OH
N
H
O
H3C
O
NH2O
O
(R,S)-, (S,R)-, 
(S,S)- 
The other three isomers are 
tasteless or even bitter. 
(R)- Little effect, if any, compared to the (S)-isomer. Amphetamine 
NH2 (S)- Potent central nervous system stimulant. 
L-Threoascorbic 
acid Vitamin C, antiscorbutic 
Ascorbic acid 
OO
OH
OHHO
OHH  
D-Threoascorbic 
acid No antiscorbutic properties. 
(R)- Ten times less effective than (S)-enantiomer. 
Epinephrine 
H
NHO
HO
OH
 (S)- Active vasoconstrictor 
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Table 3 
The physical and chemical characteristics of native cyclodextrin molecules. (from Ref. 
[142,145,146]) 
 α-CD β-CD γ-CD 
Number of glucose units 6 7 8 
Molecular mass (g/mol) 972 1135 1297 
Internal diameter (nm) 0.47 – 0.53 0.60 – 0.65 0.75 – 0.83 
External diameter (nm) 1.37 1.53 1.69 
Depth of cavity (nm) 0.79 0.79 0.79 
Number of stereogenic centers 30 35 40 
Water solubility (g/L, 25 ˚C) 145.0 18.5 232.0 
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Table 4 
The commercialized β-cyclodextrin-based Cyclobond I 2000 HPLC columns. (from Ref. 
[140]) 
CSP R Cyclobond I 2000 suffix 
 
DM 
(dimethylated) OCH3
O C
O
CH3 
AC 
(acetylated) 
CH CH2
OH
CH3O  
SP or RSP 
(hydroxypropyl ether) 
NH CH
CH3
CO
O
 
RN or SN 
(naphthylethyl carbamate) 
R
R
R
Silica Gel
R
 
O C
O
NH
CH3
CH3 
DMP 
(3,5-dimethylphenyl carbamate) 
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CHAPTER 2.  UNUSUAL DISTILLATION BEHAVIOR OF A 
MIXTURE OF VOLATILE FATTY ACIDS IN DILUTE 
AQUEOUS SOLUTION.  ANALYSIS BY QUANTITATIVE 13C 
NMR. 
 
A paper submitted to Bioresource Technology 
 
Qiqing Zhong1,2, Ronald C. Holtan2, Walter S. Trahanovsky2,3
 
Abstract 
A convenient distillation procedure was developed to separate and to concentrate the 
volatile fatty acids (VFAs) acetic, propionic, and butyric acids from a mixture of the three 
acids in dilute aqueous solution.  Surprisingly, butyric acid is the first acid to distill in spite 
of having the highest boiling point of these three acids.  Acetic acid is the last to distill and 
propionic acid is in between.  This phenomenon is directly related to the azeotropic 
distillation of dilute aqueous solutions of the acids.  A quantitative 13C NMR analytical 
procedure was developed which was used to determine the composition of mixtures of these 
three acids. 
2.1 Introduction 
Volatile fatty acids are valuable building blocks in organic synthesis and are 
important materials in many industries (Höhn, 2002; Torrence, 2002; Yoneda et al., 2001; 
Zigová and Šturdík, 2000).  At the present time, the source of these acids is primarily 
petroleum (Höhn, 2002; Torrence, 2002; Yoneda et al., 2001; Zigová and Šturdík, 2000).  In 
view of the limited supply of petroleum and fossil fuels, there is much interest in finding 
                                                 
1 Graduate student, primary researcher and author. 
2 Department of Chemistry, Iowa State University, Ames, IA 50011 USA 
3 Author for correspondence. 
39 
other sources of chemicals such as these acids.  These acids can also be obtained from the 
anaerobic fermentation of animal manure (Nielsen et al., 2004) and carbohydrates 
(Thanakoses et al., 2003), which are abundant and biorenewable resources, but they are 
produced in the fermentation sludge as a mixture and in low concentrations (approximately 
1% for each acid) (Coates et al., 2005; Pind et al., 2003).  Distillation of the sludge solution 
provides a method for separating the volatile fatty acids from non-volatile materials and also 
provides the possibility of separating the acids from each other. 
It has been demonstrated that volatile fatty acids can be separated from some 
combinations of acids by the partition method (Gray, 1947; Ramsey and Patterson, 1945; 
Trofimov et al., 1969), or distillation (Preiss, 1940; Schicktanz et al., 1940).  For the 
quantitative analysis of volatile fatty acids, gas chromatography (GC) (Ceccon, 1990; Chen 
and Lifschitz, 1989; Fussell and McCalley, 1987; Innocente et al., 2000; Yan and Jen, 1992), 
high performance liquid chromatography (HPLC) (Chen and Lifschitz, 1989), and capillary 
electrophoresis (CE) (Desauziers et al., 2000) are widely used methods.  However, most of 
these methods require at least baseline separation of the analytes.  Quantitative 13C NMR 
spectroscopic analysis of aqueous solutions of the acids is an attractive alternative method 
which provides accurate and precise analysis of mixtures (Cookson and Smith, 1984).  
Moreover, it is a non-destructive measuring method, which may be especially useful when 
dealing with valuable samples.  The NMR spin-lattice relaxation time T1 varies for different 
types of carbons (Field, 1989).  The delay between repetitions of scans for quantitative 13C 
analysis should be long enough (4T1 to 5T1 is needed for the relaxation of 98% of the 
carbons) to ensure that every carbon relaxes back to equilibrium before the next 
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radiofrequency pulse is applied (Mooney, 1989).  Usually, a quaternary or carbonyl carbon 
has the longest T1 and this establishes the rate of acquisition (Mooney, 1989).   
The time for complete relaxation of quaternary or carbonyl carbons can be shortened 
by adding a paramagnetic relaxation reagent, such as oxygen or a transition metal ion such as 
Fe3+, Cr3+, Gd3+, Mn2+,Eu3+, etc.  The paramagnetic relaxation reagent also removes the 
nuclear Overhauser effect (NOE) in the proton decoupled 13C acquisition and this further 
helps to obtain quantitative 13C NMR analysis (Gansow et al., 1977; Levy and Komoroski, 
1974; Wenzel et al., 1982).   
The goal of this work is to explore the use of distillation as a means of separating and 
concentrating volatile fatty acids.  A quantitative 13C NMR method of analysis was 
developed to determine the amounts of each fatty acid.  The distillation behavior and the 
development of a quantitative 13C NMR method of analysis are discussed in detail. 
2.2 Experimental 
2.2.1 Chemicals and instruments 
Glacial acetic acid was from Allied Chemical, Allied Corporation, Morristown, NJ, 
USA.  Propionic acid (analytical reagent grade) was from Mallinckrodt Chemical Works, St. 
Louis, MO, USA.  Butyric acid (99+%) and disodium (diethylenetriaminepentaacetato) 
iron(III) dihydrate (Na2[Fe(DTPA)]•2H2O or Na2[Fe(C14H18N3O10)]•2H2O, 98%) were from 
Aldrich Chemical Company, Inc., Milwaukee, WI, USA.  Ethylene glycol (certified) was 
from Fisher Scientific, Fair Lawn, NJ, USA.  Deuterium oxide (99.9 atom %D) was from 
Sigma-Aldrich, Inc., St. Louis, MO, USA.  All chemicals were used as received without 
further purification. 
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The 13C proton-decoupled NMR spectra of the acid distillation portions (1 ml) with 
internal standard (ethylene glycol) were recorded using a 10 mm (o.d.) NMR tube on a 
Bruker DRX-400 spectrometer tuned at 100MHz.  The 13C chemical shifts were referenced to 
the carbon of the internal standard, ethylene glycol (62.45 ppm).  All experiments were done 
at room temperature (~23°C). 
2.2.2 Fractional distillation of dilute aqueous solutions of three acids 
The fractional distillation apparatus consisted of a 100-mL round bottom flask with a 
thermometer well fitted with a distillation column (30 cm-long, 1.5 cm i.d., filled with glass 
beads) to which is attached a distillation head (see Appendix A of this chapter).  The flask 
was heated by a temperature-controlled oil bath.  The distillation of 50 g of a solution 
containing 2% of each acid represents a typical distillation:  A solution of acetic acid (1.0 g), 
propionic acid (1.0 g), and butyric acid (1.0 g) in deionized water (47 mL) was gently heated 
and seven distillation portions together with the remaining liquid in the pot were collected for 
13C NMR analysis.  The heating rate was controlled so that each distillation portion was 
collected over a period of about one hour.  The internal standard, ethylene glycol, was added 
before the 13C NMR spectra were taken.  Calculation of the acid concentrations is based on 
the ratio of the integrations of the α-carbon signals of each acid to the internal standard 
signal. 
2.3 Results and Discussion 
2.3.1 Quantitative 13C NMR analysis method development 
Generally, quaternary or carbonyl carbons have longer T1 relaxation times for a 
nuclear spin than carbons bearing hydrogen atoms.  In our case, the carbonyl carbons of each 
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volatile fatty acid have the longest T1 relaxation times and thus determine the acquisition rate.  
For quantitative 13C NMR analysis, it is important to give enough delay (D1) to allow over 
99% of the radiofrequency-pulse-excited spins to relax back to equilibrium between 
successive scans so that each scan gives the maximum signal for each carbon. 
Because the concentration of volatile fatty acids in the real fermentation sample is 
about 1%, we used a solution of 1% butyric acid in water as a test solution.  Ethylene glycol 
was used as the internal standard.  Figure 1 shows the comparison of the 13C spectra of the 
test solution under four different conditions.  For all runs, the same number of scans (1024 
scans) was taken.  The four samples were taken from the same stock solution of butyric acid 
and ethylene glycol.  The spectra are shown in Fig. 1 and the integration and relative error of 
the signals for each carbon based on the signal for the internal standard ethylene glycol are 
presented in Table 1. 
Spectrum A was taken under normal 13C NMR conditions (D1 = 1 sec) and the 
integration of the carbonyl signal is much lower than those for the methyl and methylene 
carbons.  A delay of 30 seconds with no added paramagnetic relaxation reagent was used for 
Spectrum B.  Due to this long delay, the signals for all carbons show similar integration 
which makes the spectrum quantitative.  On the basis of Wenzel et al’s work (1982), 
disodium (diethylenetriaminepentaacetato)iron(III) dihydrate (Na2[Fe(DTPA)]•2H2O) was 
selected as the paramagnetic relaxation reagent.  When 100 μmol/mL of Na2[Fe(DTPA)] (the 
concentration used by Wenzel et al. (1982)) was added, the signals of butyric acid were 
barely seen after 1024 scans, so the concentration of Na2[Fe(DTPA)] was reduced to 10 
μmol/mL.  When D1 was kept at 1 second, the signal of the carbonyl carbon was a little bit 
weaker than those of the other carbons (Spectrum C) and the integrations of the signals for all 
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four carbons were significantly lower than the true value.  When D1 was increased to 3 
seconds, a quantitative 13C spectrum was obtained (Spectrum D).  The acquisition time of 
Spectrum D was one tenth that for Spectrum B.  Table 1 shows that the measurement errors 
were around ±5% for both Spectra B and D, reasonable errors for quantitative NMR analysis. 
If the nuclei relax very rapidly, then the time available for measurement is very short 
and this results in broad poorly defined signals (Field, 1989).  This is what we observed when 
100 μmol/mL of Na2[Fe(DTPA)] was used. 
2.3.2 Distillation of three acids 
The three volatile fatty acids (C2 – C4) have similar chemical and physical properties.  
At one atmosphere pressure, butyric acid has the highest boiling point (162 °C), compared to 
acetic acid (117 °C) and propionic acid (142 °C).  Based on these data, one would expect 
acetic acid to be the first acid to distill from a mixture of the three acids.  We confirmed this 
by studying the distillation of a mixture of 33% of each of the three acids.  The first 1.5 mL 
of distillate from 50 mL of the mixture was 86.4% acetic acid and 13.6% propionic acid (see 
Table B-1 in Appendix B of this chapter). 
However, we found that distillation of an aqueous solution of the three acids gave 
butyric acid as the first to distill.  Moreover, a significant amount of acetic acid remains in 
the pot even when the other two acids are gone.  Table 2 shows the data for the distillation 
experiment of a solution containing 1% of each acid.  Portion F is the liquid left in the pot.  
For the calculation of the acid concentrations in all six portions, integration of the signal of 
the α-carbon was used for all three acids.  Note that the total weight recovery was only 94% 
due to mass loss during the distillation process.  The recoveries for these acids are: acetic 
acid (83%), propionic acid (97%) and butyric acid (99%). 
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By taking smaller cuts initially and using a slower distillation rate (over 1 hour 
collection time for each portion), better separations have been achieved for the distillation of 
these three acids even at higher concentration (2% w/w for each acid, see Table 3 and 
Appendix C).  Fig. 2 shows the change of the amount of three acids in the pot during the 
distillation process.  The distribution of the three acids in these eight portions is shown in Fig. 
3.  The initial concentration of each of the three acids in water was 2% by weight and 50 g of 
solution was used for distillation.  Butyric acid (94%) is concentrated in the first 10 g of 
distillate (Portion A, B, C and D) and is completely absent in the last three portions (Portion 
F, G and H).  In contrast to this, acetic acid was the slowest to distill and about 70% of it 
remained in the pot (Portion H, weight 8 g).  Propionic acid distilled out slightly slower than 
butyric acid and is found in all seven distillate portions but not in the pot (Portion H). 
It is expected that the separation of the three acids will become worse as the initial 
concentrations of the acids increase.  The distillation of a solution containing 4% of each of 
the three acids shows that the same distillation sequence and trend of these three acids were 
observed (Table 4), compared to the 2% run (Table 3).  However, the acid distributions 
spread out wider among distillate portions.  For first 10 mL distillates out of 50 mL 
distillation solution, for the 1%, 2%, and 4% mixtures, one half of the butyric acid distilled 
over, about half as much propionic acid distilled over, and roughly no acetic acid distilled 
over.  One advantage of this azeotropic distillation is that it can concentrate dilute butyric 
acid (1% or less) to about 18%.  In order to determine the distillation behavior of a 
significantly more concentrated solution, 50 g of a solution containing 25% of each of the 
three acids and 25% water was distilled.  For this solution, even the first few mLs of distillate 
showed no separation of the acids.  The first 1.63 g cut showed 7.7% acetic, 9.3% propionic, 
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and 7.4% butyric acids (see Table B-2 in Appendix B of this chapter).  It is obvious that, in 
this more concentrated solution, various factors lead to comparable vapor pressures for the 
three acids. 
Apparently, butyric acid and propionic acid distill from the aqueous solution before 
acetic acid due to the formation of minimum-boiling azeotropes of the first two acids with 
water.  A binary minimum-boiling azeotrope is a mixture of two components which has an 
extremum vapor pressure at a constant boiling point and the same composition for both vapor 
and the remaining liquid (Gmehling et al., 1995; 2006).  The boiling points for the azeotropes 
of butyric acid-water (99.8 °C), and propionic acid-water (99.9 °C), are slightly lower than 
the boiling point of pure water (Gmehling et al., 2006), but acetic acid does not form such an 
azeotrope.  Thus, our results with the mixture of the three acids in water reflect the 
distillation behavior of the binary mixtures of each acid in water.  The concentrations of 
butyric acid in the first three portions in Fig. 2 are about 16% (molar fraction 0.0375), which 
is close to the value (0.0441) reported in the literature (Gmehling et al., 2006). 
Separation of butyric acid from propionic acid was also observed in the experiment 
above.  In a distillation experiment with these two acids (1% for each, the mole ratio of 
butyric to propionic acid is 0.84:1) in a 50 g aqueous solution, 16.0% butyric acid and 1.7% 
propionic acid were found in the first portion (1.5 g).  The mole ratio of butyric to propionic 
acid was 8:1 (see Table B-3 in Appendix B of this chapter).  So, even though the difference 
between the azeotropic distillation temperatures of these two acids is only 0.1 °C, relatively 
significant separation was still possible with careful and slow distillation.   
In Fig. 2, it is shown that acetic acid can be accumulated in the pot to about 8% while 
the other two acids are distilled.  Another distillation experiment of 50 g of 8% acetic acid in 
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aqueous solution showed that over 60% of the acetic acid was distilled out and the remaining 
acetic acid in the pot was concentrated to 25% (Fig. 4 and Table B-4 in Appendix B of this 
chapter). 
2.4 Conclusions 
The quantitative 13C NMR analysis of volatile fatty acids in dilute water solution (1% 
or 2%, w/w) can be achieved by either elongating the delay D1 between successive scans to 
30 seconds without a paramagnetic relaxation reagent, or by adding 10 μmol/mL of 
Na2[Fe(DTPA)] with a delay D1 of 3 seconds.  A high concentration of a relaxation reagent 
can severely broaden the NMR peaks and worsen the signal-to-noise ratio.  Distillation of a 
mixture of three volatile fatty acids in a dilute aqueous solution gives separation of the three 
volatile fatty acids.  Because of a minimum-boiling azeotropic effect for butyric and 
propionic acids, butyric acid is the first acid to distill out and acetic acid is the last.  This 
results in acetic acid being concentrated in the pot after the removal of the butyric and 
propionic acids.  Quantitative 13C NMR spectroscopy was a successful method for 
determining the acid composition of the distillation samples. 
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Fig. 1 Proton-decoupled 13C NMR spectrum of 1% butyric acid in water solution with 
ethylene glycol as internal standard.  (A) No relaxation reagent, D1 = 1 sec. (B) No 
relaxation reagent, D1 = 30 sec. (C) 10 μmol/mL Na2[Fe(DTPA)], D1 = 1 sec. (D) 10 
μmol/mL Na2[Fe(DTPA)], D1 = 3 sec.  The number of scans is 1024 for all 
experiments. 
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Fig. 2 The change of the amount of acetic, propionic and butyric acid remaining in pot 
during the distillation process.  The initial concentration was 2% for each acid.  The 
collecting time for each distillate was controlled by slow distillation and was over one 
hour.  The butyric acid was the fastest acid to be distilled out, followed by propionic 
acid.  About 70% acetic acid still remained in the pot even when propionic acid and 
butyric acid were gone. 
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(A) 
 
(B) 
 
(C) 
Fig. 3 Distribution of the three acids in eight portions of the distillation of the solution of (A) 
acetic, (B) propionic and (C) butyric acid (2% for each acid). 
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Fig. 4 The changes in the acetic acid concentration in each portion during distillation 
process of an 8% acetic acid aqueous solution.  Portion A to E were distillates and 
Portion F was the leftover in the pot.  The concentration of acetic acid increased 
gradually and all the distillates have lower concentration than the initial solution (8%).  
This clearly suggests that no azeotrope was formed for the acetic acid/water system. 
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Table 1 
The integration and relative error of the 13C NMR signals for the four carbons of butyric acid 
shown in Fig. 1.a
Spectrum C-1 C-2 C-3 C-4 
A 71.3 (-63.4%) 205.4 (5.6%) 202.8 (4.2%) 183.6 (-5.6%) 
B 198.5 (2.0%) 204.8 (5.3%) 196.8 (1.2%) 207.7 (6.8%) 
C 154.1 (-20.8%) 182.6 (-6.1%) 166.1 (-14.6%) 193.3 (-0.6%) 
D 195.0 (0.2%) 190.2 (-2.2%) 193.1 (-0.7%) 194.2 (-0.2%) 
a Integration of the carbon of the internal standard ethylene glycol was set to be 200.0.  These four samples were 
taken from the same stock solution of butyric acid (0.3206g) and ethylene glycol (0.1161g).  Numbers in 
parentheses are relative errors of the measured values to the “true” values. 
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Table 2 
The weight and concentration of acetic, propionic and butyric acids in the distillates and 
leftover in the pot during the distillation of an aqueous solution containing 1% of each acid.a
Acetic Acid Propionic Acid Butyric Acid 
Portion Weight /g 
Weight /g [acid] /% Weight /g [acid] /% Weight /g [acid] /% 
A 4.9435 0.015 0.30% 0.091 1.84% 0.191 3.86% 
B 5.2201 0.021 0.40% 0.067 1.28% 0.122 2.34% 
C 5.3808 0.025 0.46% 0.075 1.40% 0.080 1.49% 
D 17.7291 0.092 0.52% 0.190 1.07% 0.115 0.65% 
E 7.6085 0.036 0.47% 0.060 0.79% 0 0 
F 5.9742 0.241 4.03% 0.009 0.15% 0 0 
a The temperature of the liquid in the pot increased from 100 °C to 101.5 °C during the distillation process.  The 
times for collecting each portion are: Portion A (16 minutes), Portion B (36 minutes), Portion C (53 minutes), 
Portion D (118 minutes), and Portion E (273 minutes).  Portion F was the liquid remaining in the pot. 
55 
Table 3 
The weight and concentration of acetic, propionic and butyric acids in the distillates and the 
leftover in the pot during the distillation of an aqueous solution containing 2% of each acid.a
Acetic Acid Propionic Acid Butyric Acid 
Portion Weight /g 
Weight /g [acid] /% Weight /g [acid] /% Weight /g [acid] /% 
A 1.6168 0 0 0.039 2.41% 0.226 14.0% 
B 1.9673 0 0 0.069 3.51% 0.304 15.5% 
C 1.4156 0 0 0.082 5.79% 0.191 13.5% 
D 5.2372 0 0 0.308 5.88% 0.193 3.69% 
E 12.1139 0.074 0.62% 0.302 2.49% 0.062 0.51% 
F 10.2033 0.092 0.90% 0.254 2.49% 0 0 
G 8.2650 0.106 1.29% 0.067 0.81% 0 0 
H 8.0804 0.630 7.80% 0 0 0 0 
a The temperature of the liquid in the pot increased from 99 °C to 99.5 °C during the distillation process.  The 
times for collecting each portion are: Portion A (73 minutes), Portion B (135 minutes), Portion C (208 
minutes), Portion D (290 minutes), Portion E (375 minutes), Portion F (450 minutes), and Portion G (528 
minutes).  Portion H was the liquid remaining in the pot.  The quantitative 13C NMR Spectra for portion A, E 
and H are included in Appendix C. 
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Table 4 
The weight and concentration of acetic, propionic and butyric acids in the distillates and the 
leftover in the pot during the distillation of an aqueous solution containing 4% of each acid.a
Acetic Acid Propionic Acid Butyric Acid 
Portion Weight /g 
Weight /g [acid] /% Weight /g [acid] /% Weight /g [acid] /% 
A 1.6734 0 0 0.059 3.53% 0.314 18.8% 
B 1.8567 0 0 0.083 4.44% 0.296 15.9% 
C 9.3453 0 0 0.737 7.89% 1.240 13.3% 
D 6.8934 0.017 0.25% 0.624 9.05% 0.358 5.19% 
E 10.0987 0.236 2.34% 0.442 4.37% 0.051 0.51% 
F 8.3830 0.313 3.74% 0.186 2.21% 0 0 
G 8.3626 1.188 14.2% 0.062 0.74% 0 0 
a The temperature of the liquid in the pot increased from 99 °C to 99.5 °C during the distillation process.  The 
times for collecting each portion are: Portion A (113 minutes), Portion B (164 minutes), Portion C (270 
minutes), Portion D (279 minutes), Portion E (346 minutes), and Portion F (443 minutes).  Portion G was the 
liquid remaining in the pot. 
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Appendix A.  Distillation apparatus 
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Appendix B.  Additional distillation data 
 
Table B-1 
The weight and concentration of acetic, propionic and butyric acids in the distillate for the 
distillation of a 50 g anhydrous mixture containing 33.3% of each acid.a
Acetic Acid Propionic Acid Butyric Acid 
Portion Weight /g 
Weight /g [acid] /% Weight /g [acid] /% Weight /g [acid] /% 
A 1.8172 1.570 86.4% 0.247 13.6% 0 0 
a The temperature of the liquid in the pot increased from 135 °C to 137 °C during the distillation process.  The 
time for collecting Portion A is 95 minutes. 
 
 
Table B-2 
The weight and concentration of acetic, propionic and butyric acids in the distillates for the 
distillation of a 50 g aqueous solution containing 25% of each acid.b
Acetic Acid Propionic Acid Butyric Acid 
Portion Weight /g 
Weight /g [acid] /% Weight /g [acid] /% Weight /g [acid] /% 
A 1.6262 0.126 7.72% 0.151 9.26% 0.121 7.43% 
B 11.9705 1.634 13.65% 1.079 9.01% 0.471 3.93% 
b The temperature of the liquid in the pot increased from 105 °C to 118 °C during the distillation process.  The 
times for collecting each portion are: Portion A (115 minutes) and Portion B (215 minutes). 
 
 
Table B-3 
The weight and concentration of propionic and butyric acids in the distillates and the leftover 
in the pot during the distillation of a 50 g aqueous solution containing 1% of each acid.c
Propionic Acid Butyric Acid 
Portion Weight /g 
Weight /g [acid] /% Weight /g [acid] /% 
A 1.4947 0.025 1.68% 0.239 16.0% 
B 1.4942 0.048 3.23% 0.097 6.46% 
C 1.8400 0.050 2.72% 0.033 1.80% 
D 42.2364 0.372 0.88% 0.063 0.15% 
c The temperature of the liquid in the pot was 100 °C during the distillation process.  The times for collecting 
each portion are: Portion A (240 minutes), Portion B (318 minutes), and Portion C (383 minutes).  Portion D 
was the liquid remaining in the pot. 
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Table B-4 
The weight and concentration of acetic acid in the distillates and the leftover in the pot during 
the distillation of a 50 g aqueous solution containing 8% acetic acid.d
Acetic Acid 
Portion Weight /g 
Weight /g [acid] /% 
A 5.0626 0.126 2.50% 
B 5.3780 0.161 3.00% 
C 9.9791 0.460 4.60% 
D 10.3234 0.579 5.61% 
E 10.9208 0.819 7.50% 
F 6.0795 1.520 25.0% 
d The temperature of the liquid in the pot increased from 99.5 °C to 100.5 °C during the distillation process.  
The times for collecting each portion are: Portion A (80 minutes), Portion B (175 minutes), Portion C (255 
minutes), Portion D (335 minutes), and Portion E (420 minutes).  Portion F was the liquid remaining in the pot.  
The amount of acetic acid was determined by titration with NaOH standard solution. 
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Appendix C.  13C NMR Spectra  
 
 
 
Fig. C-1 The 13C NMR spectrum of the distillate Portion A (Table 3) shows ethylene 
glycol (62.45 ppm), butyric acid (35.58, 17.78, 12.62 ppm) and propionic acid 
(27.04, 8.21 ppm).  No signal for acetic acid shows up. 
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Fig. C-2 The 13C NMR spectrum of the distillate Portion E (Table 3) shows ethylene 
glycol (62.45 ppm), butyric acid (35.61, 17.78, 12.58 ppm), propionic acid 
(27.08, 8.21 ppm) and acetic acid (20.28 ppm). 
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Fig. C-3 The 13C NMR spectrum of the distillate Portion H (Table 3) shows ethylene 
glycol (62.45 ppm), and acetic acid (20.26 ppm).  No signal for butyric acid 
and propionic acid shows up. 
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CHAPTER 3.  CHROMATOGRAPHIC EVALUATION OF 
THE POLY (TRANS-1,2-CYCLOHEXANEDIYL-BIS 
ACRYLAMIDE) AS A CHIRAL STATIONARY PHASE FOR 
HPLC 
 
A paper published in Journal of Chromatography A1
 
Qiqing Zhong2,3, Xinxin Han3, Lingfeng He4, Thomas E. Beesley4, Walter S. Trahanovsky3, 
and Daniel W. Armstrong3,5
 
Abstract 
Chiral stationary phases (CSPs) based on polymeric (R,R)- or (S,S)- 1,2-
diaminocyclohexane derivatives are synthesized.  When bonded to 5 μm porous spherical 
silica gel, the poly (trans-1,2-cyclohexanediyl-bis acrylamide) based P-CAP stationary 
phases is proved to be effective chiral stationary phases that could be used in the normal 
phase mode, polar organic mode and with halogenated solvents mobile phases, if desired.  
Since these are entirely synthetic CSPs, the elution order of all enantiomers can be reversed 
between the (R,R) P-CAP and (S,S) P-CAP columns.  Because of the high loading of chiral 
selectors, the columns exhibit very high sample capacities.  Thus, P-CAP columns are useful 
for preparative and semi-preparative enantiomeric separations.  The application of these 
CSPs and optimization of their separations are discussed. 
                                                 
1 Reprinted with permission of Journal of Chromatography A, 2005, 1066, 55-70.  Copyright © 2004 Elsevier 
B.V. All rights reserved. 
2 Graduate student, primary researcher and author. 
3 Department of Chemistry, Iowa State University, Ames, IA 50011 USA 
4 Advanced Separation Technologies Inc, 37 Leslie Court, P. O. Box 297, Whippany, NJ 07981 USA 
5 Author for correspondence. 
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3.1 Introduction 
Enantiomeric separations were thought to be difficult or impossible prior to the early 
1980s with only a few enantiomeric resolutions reported [1-4].  By the late 1990s, advances 
in the field of analytical chiral separations have made the separation of enantiomers practical 
and even routine [1,5].  Over one hundred CSPs were commercialized through the 1980s and 
1990s [6-8].  Based on their structure, chiral selectors can be classified as macrocyclic, 
polymeric, π-π association, ligand exchange, miscellaneous and hybrid CSPs [6].  Generally, 
polymeric CSPs, with the exception of proteins, have a high loading of chiral selector on the 
surface of silica gel, thus they have the potential of high sample loading capacity.  This 
feature makes them suitable for preparative purposes. 
In 1926, Wieland, et al. reported the synthesis of trans-1,2-diaminocyclohexane 
(DACH) for the first time [9].  This diamine has C2 symmetry and its enantiomers can be 
resolved by recrystallization with D- or L-tartaric acid to give enantiomerically pure (1R,2R)- 
or (1S,2S)-DACH [10,11].  In industry, trans-1,2-diaminocyclohexane (DACH) can be 
obtained as a byproduct from purification of 1,6-diaminohexane, which is a starting material 
for the manufacture of Nylon 66.  Thus, enantiomerically pure DACH is commercially 
available at relatively low prices.  Both the pure enantiomers and derivatives of trans-DACH 
can serve as powerful stereogenic ligands in asymmetric synthesis [12-16] or as components 
of chiral stationary phases in chiral chromatographic separations [17-26].   
Polymeric CSPs have been used extensively for enantiomeric HPLC separations.  
Two types of chiral polymers are used as CSPs.  They can be classified by their origin.  One 
group consists of naturally occurring polymers (such as proteins and linear carbohydrates) 
and their derivatives; the other is composed of purely synthetic polymers [27-29].  Unlike 
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small molecule chiral selectors, which are usually bonded onto the surface of silica gel, chiral 
polymers can be bonded or coated on the surface of a silica gel support.  Moreover, chiral 
polymers can also be crosslinked as a monolithic gel.  The ability of chiral recognition by 
small molecular CSPs depends mainly on the structure of the small molecules.  However, the 
mechanism of enantiomeric separation by polymeric CSPs is more complicated than that by 
small molecule CSPs because of the secondary structure of the polymers which may be 
critical for chiral recognition [7].  Generally, it is easier to increase the loading of polymeric 
chiral selectors onto the surface of a silica gel support than it is for small molecule-based 
covalently bonded CSPs.  Therefore, synthetic or semi-synthetic polymeric CSPs may have a 
greater potential for high sample loading capacity. 
The poly (trans-1,2-cyclohexanediyl-bis acrylamide) based stationary phases has 
been commercialized by Advanced Separation Technologies Inc. (Astec, Whippany, NJ, 
USA) with the commercial name of Poly-Cyclic Amine Polymer (P-CAP).  P-CAP can be 
prepared from either (1R,2R)-DACH or (1S,2S)-DACH and thus (R,R) P-CAP or (S,S) P-
CAP, respectively.  These two chiral selectors are enantiomers. Thus, unlike most naturally 
occurring polymeric CSPs such as derivatized linear or branched carbohydrates and proteins, 
it is easy to obtain opposite selectivity using these synthetic polymeric chiral selectors. 
3.2 Experimental 
3.2.1 Materials 
Porous spherical silica gel (diameter: 5 μm; pore size: 200 Å; pore volume: 0.9 ml/g; 
specific surface area: 213 m2/g) was from Akzo Nobel, EKA Chemicals AB, Sweden.  
Acryloyl chloride and 1-methoxy-2-methyl-1-trimethylsyliloxy-1-propene were from 
Lancaster Synthesis, Inc, Pelham, NH.  3-Aminopropyltrimehoxysilane was from SILAR 
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Lab, Scotia, NY.  Anhydrous toluene, methylene chloride and chloroform were from Sigma-
Aldrich.  4,4'-Azo-bis-4-cyanovaleric acid was from Fluka.  Phosphorus pentachloride, (R,R) 
and (S,S) diaminocyclohexane, and diisopropylethylamine were from Alfa Aesar, Ward Hill, 
MA.  Absolute ethanol was obtained from AAPER Alcohol and Chemical Co., Shelbyville, 
KY, USA.  Acetonitrile, 2-propanol, n-heptane, and methylene chloride were HPLC grade 
from Fischer, Fairlawn, NJ.  Triethylamine, trifluoroacetic acid and acetic acid were ACS 
certified grade from Fisher Scientific.  Water was deionized and filtered through activated 
charcoal and a 5 μm filter.  Most analytes used in this study were from Sigma-Aldrich. 
3.2.2 Synthetic procedure  
The (R,R) P-CAP and (S,S) P-CAP columns were prepared as previously reported 
[30].  The stationary phases consisted of the chiral selector were covalently bonded to 5 μm 
porous spherical silica gel.  The dimensions of the columns are 250 × 4.6 mm.  The synthetic 
procedure is summarized below. 
3.2.2.1 Preparation of (1R,2R)-cyclohexanediyl-bis acrylamide (DACH-
ACR) 
(1R,2R)-Diaminocyclohexane (12.1 g, 105.96 mmol) and diisopropylethylamine (36.3 
ml, 210.18 mmol) were dissolved in 160 ml mixed anhydrous solvent (chloroform : toluene = 
3:1 v/v).  Acryloyl chloride (17.3 ml, 210.18 mmol) diluted in the mixed solvent was added 
dropwise into the solution at 0 °C under nitrogen protection with stirring.  The reaction was 
warmed up to room temperature for 2 h.  The product was collected by filtration, washed 
with toluene and hexane, and dried at reduced pressure (0.1 mbar, 25 °C) over night to obtain 
19.08 g white solid (yield: 81.6%). 
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TLC: Merck Kieselgel 60-F254; Eluent: CH2Cl2/MeOH 90/10, Rf = 0.56.  Elemental 
analysis found: C 61.78%; H 8.41%; N 12.81%.  Calculated for C12H18N2O2: C 64.83%; H 
8.16%; N 12.61%.  1H NMR (400 MHz, methanol-d4): δ 8.00 (s, 2H), 6.17-6.15 (m, 4H), 
5.60 (dd, J =6.8 Hz, 5.2 Hz, 2H), 3.80-3.70 (m,2H), 2.00-1.95 (m,2H), 1.80-1.70 (m,2H), 
1.40-1.30 (m,4H).  13C NMR (methanol-d4): δ 166.7, 130.8, 125.3, 52.8, 31.9, 24.5. 
3.2.2.2 Preparation of dichloride of 4,4’-azo-bis-4-cyanovaleric acid 
To a suspension of phosphorous pentachloride (115.1 g, 552.48 mmol) in 576 ml of 
anhydrous methylene chloride is added a suspension of 4,4’-azo-bis-4-cyanovaleric acid 
(28.8 g, 138.24 mol) in 900ml of anhydrous methylene chloride at -5 °C under nitrogen 
protection with continuous stirring.  After 1 hour, the reaction mixture was warmed up to 
room temperature and kept over night, and then filtered.  The precipitate was dried under 
reduced pressure (0.1 mbar, 25 °C) to obtain 24.8 g of the title compound (yield: 73.7%). 
3.2.2.3 Preparation of 3-aminopropyl silica gel (3-APSG-200) 
To anhydrous slurry of 5 μm silica gel (85.7 g) dispersed in 850ml of anhydrous 
toluene is added 3-aminopropyltrimethoxysilane (42 ml, 180.6 mmol) at room temperature.  
The mixture was refluxed for 5 h and filtered afterwards.  The silica gel was dried at 105 °C 
over night to obtain 91.97 g 3-APSG-200 (weight gain: 7.4%).  Elemental analysis found: C 
3.22%, H 0.88%, N 0.88%. 
3.2.2.4 Functionalization of 3-aminopropyl silica gel with the dichloride of 
4,4’-azo-bis-cyanovaleric acid 
To anhydrous slurry of 3-APSG-200 (88.5 g) dispersed in 742 ml anhydrous toluene 
is added a solution of 1-methoxy-2-methyl-1-(trimethylsyliloxy)-1-propene (MMTP) (14.8 
ml, 72.52 mmol) at -5 °C, followed by adding the solution of dichloride of 4,4’-azo-bis-4-
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cyanovaleric acid (9.98 g, 36.24 mmol) in 297 ml anhydrous toluene under nitrogen 
protection with mechanical stirring.  The mixture was warmed up to room temperature (25 
°C) for 5 h.  The modified silica gel was filtered, and dried at reduced pressure (0.1 mbar, 25 
°C) to obtain 95.9 g functionalized silica gel (3-APSG-AZO-200).  The percentage of weight 
gain was 8.4%.  Elemental analysis found: C 7.00%, H 1.10%, N 2.26%. 
3.2.2.5 Preparation of (R,R) P-CAP 
To a solution of (1R,2R)-DACH-ACR (14.0 g) in 1380 ml anhydrous, degassed 
chloroform, is added 3-APSG-AZO-200 (82.4 g) under nitrogen protection.  The mixture was 
heated at 61 °C for 5 h and then heated to reflux for 1 h.  After cooling down to room 
temperature, the reaction mixture was filtered, washed with methanol and acetone, and dried 
under vacuum (0.1 mbar, 60 °C) for 4 h to obtain 91.5 g (R,R) P-CAP bonded silica gel 
(weight gain: 11.1%).  Elemental analysis found: C 12.83%, H 1.98%, N 2.69%. 
3.2.3 Equipment  
Chromatographic separations were carried out using an HP 1050 HPLC system with a 
UV VWD detector, an auto sampler, and computer-controlled HP ChemStation for LC data 
processing software.  The mobile phases were degassed by purging compressed pure helium 
gas for 10 min. UV detection was carried out at 210, 254 or 264 nm for most of the probe 
compounds. All separations were carried out at room temperature (~ 23˚C). 
3.2.4 Column evaluation 
The performance of (R,R) P-CAP and (S,S) P-CAP was evaluated in the normal phase 
mode using n-heptane/ethanol, n-heptane/2-propanol and methylene chloride/methanol 
mobile phases; in polar organic phase mode using acetonitrile/methanol mobile phase.  
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3.2.5 Calculations 
The chiral separation ability of CSPs can be quantitatively evaluated by retention 
factors (k’), selectivity factor (α), and resolution factor (RS).  Those parameters are defined as 
follows: 
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in which, t1 and t2 are the retention times of enantiomers; t0 is the dead time and was 
estimated by using the peak resulting from the change in refractive index from the injection 
solvent on columns; W1 and W2 are the peak widths.  To evaluate the efficiency of separation, 
the number of theoretical plates (N) is also used 
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where tR is the retention time of the peak and W is the peak width. 
3.3 Results and discussion 
3.3.1 The structure of P-CAP chiral selectors 
Gasparrini, et al. used trans-1,2-cyclohexanediamine acrylamide as monomer to 
synthesize Poly-DACH-ACR [19,20,31], which forms a crosslinked structure.  In 
synthesizing the related P-CAP chiral stationary phase, the free radical initiator was 
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immobilized on the surface of silica gel before the free radical polymerization process was 
carried out [30,32].  Therefore, P-CAP is basically a linear brush-type polymer with the 
DACH-ACR units as the branches.  The idealized structure of (R,R) P-CAP CSP is shown in 
Fig. 1.  The structure of (S,S) P-CAP CSP has the opposite configuration of each stereogenic 
center of the cyclohexyl units on (R,R) P-CAP. 
3.3.2 Column performance 
A total of 62 chiral compounds were separated on the P-CAP CSPs in the normal-
phase mode (using two different solvent systems: traditional normal phase and a halogenated 
solvent mobile phase) and the polar organic mode combined.  The majority of compounds 
were separated in the traditional normal-phase mode (heptane/ethanol).  Table 1 shows the 
chromatographic data for 43 racemic compounds separated in the traditional normal-phase 
mode.  Of these compounds, 23 were not separated in the polar organic mode.  Sixteen out of 
43 compounds were baseline separated.   
Table 2 lists the enantioseparation data obtained for the polar organic mobile phase 
mode (34 compounds).  The polar-organic mode is somewhat analogous to the normal-phase 
mode.  The difference of mobile phase composition is the normal phase contains n-heptane 
while the polar-organic phase does not.  Instead, the polar-organic phase has acetonitrile as 
its main solvent.  There are 16 compounds separated in the polar organic mode only, but not 
in the normal-phase modes.  Twelve baseline separations were achieved in polar organic 
phase mode. 
Table 3 shows the enantioseparation data in the normal phase mode with a 
halogenated solvent (methylene chloride) and other mobile phases (10 compounds).  
Methanol was used as a modifier for these separations.  All 10 compounds separated using a 
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methylene chloride-based mobile phase can also be separated in either the normal phase 
mode (8 compounds) or polar organic mode (5 compounds).  Three compounds were 
enantioseparated in all three solvent systems (i.e. the traditional normal-phase mode, polar 
organic mode, and the normal phase mode with halogenated solvent).  One baseline 
enantiomeric resolution of 1,1’-bi-2-naphthol was achieved using a neat acetone mobile 
phase. 
Because of the covalent linkage between the polymeric chiral selector and their solid 
support (5 μm porous silica gel), no degradation in column performance was observed even 
after more than 1000 injections in each mobile phase mode. 
3.3.2.1 Retention behavior 
Typical normal-phase retention (k’) behavior of two analytes, (A) 1,1’-bi-2-naphthol 
and (B) fipronil is shown in Fig. 2.  The diagrams show the first and second eluted 
enantiomers of each analyte plotted as a function of mobile phase composition with different 
ratios of ethanol and n-heptane.  In both cases, the retention and selectivity are greatest when 
using ethanol/heptane 10/90 (v/v) as the mobile phase.  No data were available at 100% n-
heptane because the elution times are extremely long.  As can be seen, retention decreases 
with increasing the concentration of ethanol.  Retention of all analytes tends to be minimal at 
ethanol concentration of ≥ 50% (by volume).  However, it is interesting that even at 100% 
ethanol, the P-CAP column still gives an enantioselectivity (α) of 1.23 and resolution ( SR ) 
of 1.15 for 1,1’-bi-2-naphthol. 
Fig. 3 contains plots for the retention factor  of the first eluted enantiomer, 
selectivity factor α, and resolution of 1,1’-bi-2-naphthol as a function of polar organic 
'
1k
SR
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mode mobile phase composition.  The resolution ( ) curve has a minimum at a mobile 
phase composition of acetonitrile/methanol 30/70 (v/v).  The maximum of retention factor  
of the first eluted enantiomer, selectivity factor α, and resolution  are all at 100% 
acetonitrile.   
SR
'
1k
SR
3.3.2.2 Effects of mobile phase additives 
Additives to the mobile phase can usually improve chromatographic efficiency.  
Trifluoroacetic acid (TFA) is the most effective additive in both the normal-phase mode and 
the polar organic mode.  Ammonium acetate sometimes can also be used in the polar organic 
mode as an additive.  These additives usually shorten the retention time, decrease tailing and 
sharpen the peaks.  Figure 4 shows the enantiomeric separation of (R,R)- and (S,S)-
hydrobenzoin on the (R,R) P-CAP column with different composition of normal-phase 
solvents.  The best separation (Chromatogram A) was achieved when heptane/2-
propanol/TFA 80/20/0.1 was used as the mobile phase.  Without the TFA additive 
(Chromatogram B), only a partial separation can be achieved and the peaks become broader. 
Three probe molecules, including chlorthalidone, sulindac, and (±)-2,3-dibenzoyl-
DL-tartaric acid, were chosen to investigate the influence of acid additives in polar organic 
mode.  The results are summarized in Table 4.  Chlorthalidone (pKa = 9.4) is a weak base.  
The acid additives, acetic acid and TFA, have almost no influence on separation factor α, and 
a minor influence on the resolution (Rs).  Under the same solvent system with the same 
volume ratio of acid additives, TFA increases the Rs more than acetic acid does.  Sulindac 
(pKa = 4.7) has one carboxylic acid group.  It could not be eluted with a mobile phase of 
CH3CN/CH3OH  = 95/5, without acid additives.  The compound (±)-2,3-dibenzoyl-DL-
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tartaric acid has two carboxylic acid groups.  It is the strongest acid among three analytes.  
With the mobile phase of CH3CN/CH3OH  = 95/5, it can only be eluted with the addition of 
0.1% trifluoroacetic acid.  The acid additives protonate acidic analytes as well as any residual 
amine groups on the stationary phase (e.g. from the 3-aminopropylsilanized silica gel). This 
minimizes a source of strong non-enantioselective association between acidic analytes and 
the CSP.  The additives therefore improve the mass transfer and thus improve the efficiency.  
Compared to acetic acid, TFA is a stronger acid and produces better separations. 
3.3.2.3 Normal-phase modifier 
The choice of organic modifier in the normal phase mode (i.e. ethanol, 2-propanol, 
etc. in n-heptane) affects the efficiency, retention, and the resolution of enantiomers.  In Fig. 
4, 2-propanol is used as normal-phase modifier for Chromatogram A.  For Chromatogram C, 
ethanol is used instead of 2-propanol.  A baseline separation was achieved within 15 minutes 
with the mobile phase of heptane/2-propanol/TFA 80/20/0.1.  But for ethanol, with the same 
mobile phase ratio (heptane/ethanol/TFA 80/20/0.1), only a partial separation (Rs 0.8) was 
achieved.  When decreasing the ratio of ethanol to 10% (Chromatogram D in Figure 4. 
Mobile phase: Heptane/ethanol/TFA 90/10/0.1), the retention time is comparable to that of 
Chromatogram A, but the separation still wasn’t baseline even with a longer retention time.  
In both cases, a TFA additive was used.  Separations of some other compounds in the 
normal-phase mode, such as fipronil, produced the same general trend.  For these chiral 
stationary phases, 2-propanol was a better normal mobile phase modifier than ethanol. 
3.3.2.4 Effect of mobile phase flow rate 
The effect of mobile phase flow rate on enantiomeric selectivity and resolution in the 
normal-phase mode also was evaluated.  Table 5 shows the chromatographic data of the 
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normal-phase enantiomeric separations of fipronil on the (R,R) P-CAP column at flow rates 
of 0.5 ml/min, 1.0 ml/min, 1.5 ml/min and 2.0 ml/min.  As can be seen, flow rate has little or 
no effect on enantioselectivity, while resolution is affected.  The resolution is improved from 
1.40 to 1.71 if the flow rate is decreased from 2.0 to 0.5 ml/min.  This is because the mass 
transfer in the stationary phase affects efficiency at higher flow rates [33].  This is a common 
phenomenon for other CSPs.  For high throughput screening, one can use higher flow rates, 
like 2.0ml/min, and still gets reasonable resolution. 
3.3.2.5 Column efficiency in different mobile phase modes 
The normal-phase mode with two different solvent systems (heptane/IPA and 
methylene chloride/methanol) and the polar organic mode can be used on P-CAP columns.  
Table 6 shows the chromatographic data for the enantiomeric separation of 1,1’-bi-2-
naphthol in different mobile phases.  As can be seen in Table 6, the halogenated mobile 
phase gives the highest efficiency (greatest N).  The polar organic mode produces 
intermediate efficiency and the traditional normal-phase separations are the least efficient 
among three mobile phase systems.  However, as noted previously (see Table 1 and 2), far 
more compounds are separated with a heptane/IPA mobile phase than with a methylene 
chloride-based mobile phase. 
3.3.2.6 Sample loading capacity 
P-CAP columns are polymeric CSPs.  The high loading of the chiral selector on the 
silica gel provides the potential of having a high sample loading capacity.  Fig. 5 shows the 
chromatogram of the separation of 1,1’-bi-2-naphthol when 1 μg and 1000 μg racemic 
sample was injected sequentially.  As can be seen, the resolution is still nearly 1.5 even with 
 
75 
a thousand times greater sample load on an analytical column.  Clearly, the P-CAP CSPs are 
suitable for large-scale enantiomeric separations. 
3.3.3 Reversal of elution order 
The totally synthetic chiral selectors of the (R,R) P-CAP column and the (S,S) P-CAP 
column have the opposite absolute configuration.  Therefore, the elution order of all 
separable enantiomers will be inverted on these two columns.  Fig. 6 shows the inversion of 
elution order on (R,R) P-CAP column and the (S,S) P-CAP column under normal phase 
conditions.  The (R,R)- and (S,S)-hydrobenzoin were chosen as example probe molecules.  In 
order to identify the enantiomeric peaks of the probe molecules easily, the analyte sample 
containing (R,R)- and (S,S)-hydrobenzoin was prepared in the mole ratio of 2 to 1 
respectively.  Fig. 6 also shows that (R,R) P-CAP CSP retains (R,R)-hydrobenzoin longer 
than its (S,S)-enantiomer, and of course, the (S,S) P-CAP CSP retains (S,S)-hydrobenzoin to a 
greater extent. 
Interestingly, the (R,R)- and (S,S) P-CAP columns can also separate their mixed 
monomers DACH-ACR very well.  Fig. 7 shows the chromatographic separation of DACH-
ACR on both (R,R)- and (S,S) P-CAP column.  As can be seen from Fig. 8, the (R,R) P-CAP 
column retains (S,S)-DACH-ACR more and the (S,S) P-CAP column favors (R,R)-DACH-
ACR. 
3.3.4 Interactions for chiral recognition 
The P-CAP columns do not contain any aromatic moieties.  Therefore, π-π 
interactions are not important factors with this CSP.  Instead, the P-CAP CSPs have large 
numbers of amide linkages, which provide hydrogen bonding and dipolar interactions 
between these CSPs and chiral analytes.  An examination of the compounds listed in Table 1, 
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2 and 3 reveals a common characteristic for these compounds.  Most of them contain a 
hydroxyl group, carboxylic group, carbonyl, amine, amide, urea, or fluorine group, all of 
which are capable of forming strong hydrogen bonds.  Thus, hydrogen bond interactions are 
believed to be the dominant associative interactions for chiral recognition by P-CAP CSPs 
[19]. 
Some chiral sulfoxides also were resolved on P-CAP columns.  These sulfoxides 
include 4-chlorophenyl methyl sulfoxide and 4-bromophenyl methyl sulfoxide, etc.  These 
chiral sulfoxides are known to possess a strong dipolar element and the amide linkage in the 
P-CAP CSPs also is strongly dipolar.  Therefore dipole-dipole interaction also may be 
important for chiral discrimination on the P-CAP CSPs. 
The cyclohexyl moiety (Fig. 1) is a restricted configurational nonpolar unit of the P-
CAP stationary phase.  It may provide solvophobic-driven attraction or steric repulsive 
effects.  These are possible interactions for enantiomeric selectivity by these CSPs. 
3.4 Conclusions 
The polymeric (R,R) and (S,S) poly (trans-1,2-cyclohexanediyl-bis acrylamide) 
(known as (R,R) P-CAP and (S,S) P-CAP) have been used as liquid chromatographic chiral 
stationary phases.  The branched polymer was bonded covalently to a 5 μm silica gel support 
and evaluated for enantiomeric separations.  P-CAP CSPs can be used in the normal phase 
mode or the polar organic mode to produce enantiomeric separations of a variety of chiral 
compounds.  The retention behavior, selectivity, and resolution were examined for selected 
compounds in each mobile phase mode.  A total of 62 chiral compounds were 
enantioresolved on these two columns.  The traditional normal phase separation mode was 
the most broadly selective, but has the lowest efficiency.  Halogenated mobile phases 
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produced the highest efficiencies but separated the fewest compounds.  The polar organic 
mode was intermediate in terms of both selectivity and efficiency to the two normal phase 
approaches.  The elution order of enantiomers can be reversed between (R,R)- and (S,S) P-
CAP CSPs.  P-CAP columns have great sample loading capacity and are therefore able to do 
large-scale separations.  The P-CAP CSPs were chemically stable under the usual separation 
conditions and not irreversibly damaged or modified when changing the mobile phase modes. 
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Captions to the figures: 
 
Fig. 1 The structure of (R,R) P-CAP chiral stationary phase. 
 
Fig. 2 Normal-phase retention behavior of the first and second eluted enantiomers of (A) 
1,1’-bi-2-naphthol, and (B) fipronil as a function of mobile phase composition.  The mobile 
phases consisted of various ratios of ethanol and heptane.  The column was a 250 × 4.6 mm 
(i.d) (R,R) P-CAP CSP (5 μm silica gel support).  Flow rate: 1.0 ml/min at ambient 
temperature (~23 °C).  Detection: UV at 254nm. 
 
Fig. 3 Polar organic phase retention factor  of the first eluted enantiomer, selectivity factor 
α, and resolution of 1,1’-bi-2-naphthol as a function of mobile phase composition.  The 
mobile phases consisted of various ratios of methanol and acetonitrile.  The column was a 
250 × 4.6 mm (i.d) (S,S) P-CAP CSP (5 μm silica gel support).  Flow rate: 1.0 ml/min at 
ambient temperature (~23 °C).  Detection: UV at 254 nm. 
'
1k
SR
 
Fig. 4 Resolution of (R,R)- and (S,S)-hydrobenzoin on (R,R) P-CAP in the normal phase: (A) 
heptane/2-propanol/trifluoroacetic acid 80/20/0.1 (v/v/v); (B) heptane/2-propanol 80/20 (v/v); 
(C) heptane/EtOH/trifluoroacetic acid 80/20/0.1 (v/v/v). (D) heptane/EtOH/trifluoroacetic 
acid 90/10/0.1 (v/v/v).  Flow rate: 1.0 ml/min; UV detection at 254 nm, T=23 °C. 
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Fig. 5 Sample loading capacity test for the separation of 1,1’-bi-2-naphthol on (R,R) P-CAP 
column.  Sample loading (A) 1000 μg; (B) 1 μg.  (R,R) P-CAP was bonded to 5 μm silica gel 
and the stationary phase was packed in a 250 × 4.6 mm (i.d.) stainless steel column.  Mobile 
phase: EtOH/heptane 50/50; flow rate: 1 ml/min; detection: UV at 254 nm; temperature: ~23 
°C.  This figure is reproduced with permission of Astec, Whippany, NJ, USA. 
(http://www.astecusa.com) 
 
Fig. 6 Reversal of elution order on (A) (R,R) P-CAP and (B) (S,S) P-CAP columns under the 
normal phase.  Peak 1 is (R,R)-hydrobenzoin and Peak 2 is (S,S)- hydrobenzoin with the mole 
ratio of (R,R):(S,S) = 2:1.  Mobile phase: heptane/2-propanol/TFA 80/20/0.1 (v/v/v); flow 
rate: 1 ml/min; UV detection at 254 nm; T=23 °C. 
 
Fig. 7 Reverse elution order on (A) (R,R) P-CAP and (B) (S,S) P-CAP CSPs under polar 
organic phase.  Analytes were the mixture of (R,R) DACH-ACR and (S,S) DACH-ACR.  
Mobile Phase: 85/15/10 mM ACN/MeOH/NH4OAc.  Flow Rate: 0.8 ml/min.  Detection: UV 
at 254 nm.  Temperature: 25 °C. 
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(A) 1,1’-Bi-2-naphthol 
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Table 1 
Chromatographic data for the traditional normal-phase resolution of racemic compounds on (R,R) P-CAP 
column6
No Compounds Structure '1k  '2k  α Rs Mobile Phase7
1 Hydrobenzoin 
OH
OH  
3.43 3.97 1.16 1.91 
Heptane/IPA 
/TFA 
80/20/0.1 
2 Warfarin 
O
OH
O
O
 
11.21 12.65 1.13 1.58 
Heptane/IPA 
/TFA 
90/10/0.1 
3 1,1'-Bi-2-Naphthol OH
HO
 
2.49 3.36 1.35 2.84 
Heptane/EtOH 
/TFA 
50/50/0.1 
4 Di-6,6’-methoxy-bi-2-naphthol 
OH
HO
O
O  
2.69 3.41 1.27 2.7 EtOH/Heptane 50/50 
5 Dioxibrassinin 
N
H
HO
NH
O
S
 
7.67 8.81 1.15 1.4 EtOH/Heptane 30/70 
6 Indapamide 
N
CH3
HN
O
Cl
S
O
O NH2
7.32 7.74 1.06 0.60 
Heptane/EtOH 
/TFA 
60/40/0.1 
7 
3-(α-acetonyl-4-
chlorobenzyl)-4-
hydroxy coumarin 
O O
OH
Cl
O
4.06 4.76 1.17 1.63 Heptane/IPA 80/20 
8 
N-3,5-
dinitrobenzoyl-DL-
leucine OH
HN
O
NO2
NO2
O
 
7.65 8.32 1.09 0.79 
Heptane/EtOH 
/TFA 
90/10/0.1 
2 ml/min 
                                                 
6 (R,R) P-CAP was bonded to 5 μm silica gel and the stationary phase was packed in a 250 × 4.6 mm (i.d.) 
stainless steel column. 
7 All samples were analyzed under the chromatographic condition: a UV detector at 254 nm, flow rate 1 ml/min, 
unless otherwise noted.  All mobile phase ratios were volume to volume.  IPA: 2-propanol.  TFA: 
trifluoroacetic acid. 
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No Compounds Structure '1k  '2k  α Rs Mobile Phase7
9 Bendro-flumethiazide 
F3C
S
N
H
NH
S
O
O
H2N
O O
CH2
14.53 16.34 1.12 0.80 
Heptane/IPA 
/TFA 
50/50/0.1 
10 N,N'-Bis(α-methyl benzyl)sulfamide NH S NH
CH3
O
O
CH3
12.31 13.50 1.10 0.90 
Heptane/IPA 
/TFA 
80/20/0.1 
11 
2,3-O-
Benzylidene-D-
threitol O
O
CH2OH
CH2OH
 
5.49 6.13 1.12 1.21  Heptane/IPA 80/20 
12 
α-carbethoxy- γ-
phenyl-γ- 
butyrolactone 
O
O
O
O
 
2.73 3.06 1.12 1.0  Heptane/IPA 80/20 
13 Chlorthalidone NH
O
HO Cl
S
NH2
O
O
 
10.21 12.57 1.23 1.61  
Heptane/EtOH 
/TFA 
80/20/0.1 
14 
1,5-Dihydroxy-
1,2,3,4-tetrahydro 
naphthalene 
OH
OH
 
6.78 7.22 1.06 0.81  Heptane/IPA 80/20 
15 
DL-3,4-
Dihydroxyphenyl-
α-propylacetamide NH2
OH
OH
O
 
3.84 4.59 1.20 1.64  
Heptane/EtOH 
/TFA 
50/50/0.1 
16 
4-(Diphenyl-
methyl)-2-
oxazolidinone O
H
N O
Ph
Ph
 
8.57 9.31 1.09 0.82  Heptane/IPA 80/20 
17 1,1'-Bi- (2-naphthylamine) 
NH2
NH2
 
5.80 5.95 1.03 0.7  Heptane/IPA 80/20 
18 cis-4,5-Diphenyl -2-oxazolidinone O
H
N
O
 
12.64 13.72 1.09 1.22  
Heptane/IPA 
/TFA 
90/10/0.1 
19 
5-Ethyl-5,6-
dihydro-3,8-
dinitro-6-phenyl-6- 
phenanthridinol 
N
OH
O2N NO2
5.43 5.75 1.06 1.05 
Heptane/EtOH 
/TFA 
80/20/0.1 
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No Compounds Structure '1k  '2k  α Rs Mobile Phase7
20 
5-Fluoro-1-
(tetrahydro-2-
furfuryl)uracil 
N
NHO
O
O
F
 
5.04 5.39 1.07 0.65 
Heptane/EtOH 
/TFA 
90/10/0.1 
2 ml/min 
21 
DL-3-(4-
Hydroxyphenyl)lac
tic acid 
O
H
O
OH
HO  
4.57 5.76 1.26 1.54 
Heptane/IPA 
/TFA 
60/40/0.1 
22 Mandelamide NH2
O
OH
 
9.62 11.53 1.20 1.50 
Heptane/IPA 
/TFA 
80/20/0.1 
23 5-Methyl-5-phenyl hydantoin NH
NH
O
O
CH3  
8.33 9.06 1.09 0.9 Heptane/IPA 80/20 
24 
cis-4-Methyl-5-
phenyl-2-
oxazolidinone O
NH
H3C
O 
10.32 11.37 1.10 1.52 
Heptane/IPA 
/TFA 
80/20/0.1 
25 
N-(α-
Methylbenzyl)-
phthalamic acid 
NH
CH3 O
OHO
 
3.98 4.19 1.05 0.72 
Heptane/EtOH 
/TFA 
80/20/0.1 
26 Methyl mandelate O CH3
OH
O  
1.93 2.47 1.13 1.2 Heptane/IPA 80/20 
27 Benzyl mandelate O
OH
O  
2.07 2.21 1.07 1.0 EtOH/Heptane 10/90 
28 Mandelic acid COOH
OH
 
2.04 2.19 1.07 1.0 EtOH/Heptane 10/90 
29 DL-3-Phenyllactic acid OH
OH
O
 
1.64 2.01 1.23 1.28 
Heptane/EtOH 
/TFA 
60/40/0.1 
30 1-Phenyl-1,2-ethane diol CH2OH
OH
 
4.68 5.25 1.12 1.60 Heptane/IPA 80/20 
31 γ-Phenyl-γ -butyrolactone O O 2.82 3.00 1.06 0.92 
Heptane/IPA 
80/20 
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No Compounds Structure '1k  '2k  α Rs Mobile Phase7
32 Phenylsuccinic anhydride 
O
O
O 
2.68 3.05 1.14 1.45 
Heptane/EtOH 
/TFA 
70/30/0.1 
33 
(3a(R,S)-cis)-
3,3a,8,8a-
Tetrahydro-2H-
indeno[1,2-
d]oxazol- 2-one 
O
NH O
 
7.77 9.36 1.20 1.66 
Heptane/IPA 
/TFA 
80/20/0.1 
34 Fipronil N
Cl
Cl
CF3
N
NH2
NC
S
F3C
O
 
4.11 6.13 1.49 3.73 
Heptane/IPA 
/TFA 
20/80/0.1 
35 
trans-1,2-
cyclohexanediyl-
bis acrylamide 
H
N
N
H
O
O  
0.78 1.02 1.31 2.7 EtOH/Heptane 10/90 
36 
trans-1-(2-Amino-
cyclohexyl)-3-(3,5-
bis-trifluoro-
methylphenyl)-urea 
NH2
NH NH
O
CF3
CF3
1.97 2.11 1.07 0.65 
EtOH/Heptane 
/TFA 
10/90/0.1 
37 
trans-(1,2)-
Diaminocyclohexyl 
di(4-vinyl) 
benzoylamide 
HN
HN
O
O
 
0.30 0.50 1.68 1.25 EtOH/Heptane 50/50 
38 Lorazepam N
H
N
O
OH
Cl
Cl
 
3.48 5.26 1.51 4.2 EtOH/Heptane 50/50 (v/v) 
39 Oxazepam N
H
N
O
OH
Cl
 
3.31 5.03 1.52 4.3 EtOH/Heptane 50/50 
40 4-chlorophenyl methyl sulfoxide S
O
Cl
 
3.81 4.09 1.07 0.78 
Heptane/IPA 
/TFA 
90/10/0.1 
41 
Methyl 4-
trifluoromethylphe
nyl sulfoxide 
S
O
CF3
 
3.30 3.58 1.08 0.92 
Heptane/IPA 
/TFA 
90/10/0.1 
42 4-fluorophenyl methyl sulfoxide S
O
F
 
4.31 4.54 1.05 0.65 
Heptane/IPA 
/TFA 
90/10/0.1 
43 4-bromophenyl methyl sulfoxide S
O
Br
 
3.83 4.13 1.08 0.88 
Heptane/IPA 
/TFA 
90/10/0.1 
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Table 2 
Chromatographic data for the polar organic mode resolution of racemic compounds on (S,S) P-CAP column or 
(R,R) P-CAP column8
No Compounds Structure '1k  '2k α Rs Mobile Phase9
1 
4-Methoxy-2-phenyl-
4,5,6,7-tetrahydrobenzo-
furan-3-carboxylic acid 
O
OMe COOH
Ph
 
1.0 1.17 1.17 1.22 
ACN/MeOH 
/TFA 
99/1/0.1 
2 Sulindac 
S
H3C
O
CH3
COOH
F
4.03 4.62 1.15 1.85 
ACN/MeOH 
/TFA 
99/1/0.1 
3 Benzoin 
OHO
 
0.43 0.56 1.30 1.18 
ACN/MeOH 
/NH4OAc 
99/1/10 mM (v/v/C)
4 DL-β-Phenyllactic acid CO2H
HO  
3.99 4.34 1.09 0.93 
ACN/MeOH 
/TFA 
95/5/0.1 
1.47 1.97 1.34 3.80 
ACN/MeOH/ 
NH4OAc10
95/5/10 mM (v/v/C)5 (±)-1,1’-Bi-2-naphthol OHHO
 1.86 2.54 1.36 3.43 
ACN/MeOH 
/TFA3 
95/5/0.1 
6 Althiazide 
Cl
S
O
O
H2N
N
NH
S
O O
S
H
4.79 5.28 1.10 0.50 
ACN/MeOH 
/NH4OAc 
95/5/10 mM (v/v/C)
7 Benzoin methyl ether 
O OMe
 
0.43 0.61 1.42 1.03 ACN 
8 (±)N,N-Bis-(α-methyl benzyl) sulfamide 
N S
N
CH3
CH3
O
O
H
H
 
0.70 0.93 1.33 1.02 ACN 
9 Bendroflumethiazide 
F3C
S
N
H
NH
S
O
O
H2N
O O
CH2
4.39 4.86 1.11 0.51 
ACN/MeOH 
/NH4OAc 
95/5/10 mM (v/v/C)
10 
3-(4-chlorophenyl)-2-
ethyl-2,3,5,6-tetrahydro- 
imid-azol[2,1-b]-thiazol-
3-ol Cl
N
S
N
Et
OH
 
2.34 2.59 1.11 0.94 
ACN/HOAc 
/TEAA 
100/0.25/0.05 
                                                 
8 (S,S) P-CAP and (R,R) P-CAP were bonded to 5μm silica gel and the stationary phase was packed in a 250 × 
4.6 mm (i.d.) stainless steel column. All data shown were run on (S,S) P-CAP column unless otherwise noted. 
9 All samples were analyzed under the chromatographic condition: a UV detector at 254 nm, flow rate 1 ml/min, 
unless otherwise noted.  All mobile phase ratios were volume to volume, unless otherwise noted.  TEAA: 
triethylammonium acetate.  TFA: trifluoroacetic acid. ACN: acetonitrile. 
10 On (R,R) P-CAP column. 
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No Compounds Structure '1k  '2k α Rs Mobile Phase9
11 Chlorthalidone 
NH
Cl
S
NH2
O
O
HO
O  
5.02 6.92 1.38 2.5 
ACN/MeOH 
/TFA 
90/10/0.1 
12 p-Chloromandelic acid 
Cl
OH
OH
O  
7.06 8.08 1.14 1.65 
ACN/MeOH 
/TFA 
99/1/0.1 
13 7-(2,3-Dihydroxypropyl) theophylline 
N
N
N
N
CH3
O
CH3
O
OH
OH
 
2.23 2.44 1.09 0.72 
ACN/HOAc 
/TEAA 
100/0.25/0.05 
14 (±)-4-(Diphenylmethyl)-2-oxazolidinone 
O
NH
O
Ph
Ph
 
0.61 0.74 1.21 1.06 
ACN/MeOH 
/NH4OAc 
99/1/10 mM (v/v/C)
15 (±)-2,3-Dibenzoyl-DL- tartaric acid 
O
O
OH
O
O
O
OH
O
 
9.26 10.15 1.10 0.94 
ACN/MeOH 
/TFA 
95/5/0.1 
16 DL-p-Hydroxymandelic acid HO
OH
O
OH  
9.40 10.43 1.11 0.95 
ACN/MeOH 
/TFA 
95/5/0.1 
17 DL-3-(4-hydroxyphenyl) lactic acid hydrate HO
O
OH
HO
x H2O  
3.24 3.56 1.10 1.05 
ACN/MeOH 
/TFA 
90/10/0.1 
18 3-[2-Methylphenoxy]-1,2-propanediol 
CH3
O
OH
OH
 
1.48 1.56 1.05 0.50 
ACN/HOAc 
/TEAA 
100/0.25/0.05 
19 DL-Mandelic acid 
OH
OH
O  
5.30 5.90 1.11 1.29 
ACN/MeOH 
/TFA 
99/1/0.1 
20 DL-Mandelamide 
OH
NH2
O  
1.96 2.24 1.14 1.00 
ACN/MeOH 
/TFA 
99/1/0.1 
21 (±)-N-(α-Methylbenzyl) phthalic acid monoamide 
OH
O
N
O
HH3C
 
2.80 3.22 1.15 0.88 
ACN/MeOH 
/TFA 
99/1/0.1 
22 (±)-Phenylsuccinic anhydride 
OO O  
2.42 2.90 1.20 2.62 
ACN/MeOH 
/TFA 
90/10/0.1 
23 
3a,4,5,6-Tetrahydro- 
succinimido [3,4-b] 
acenaphthen-10-one 
NH
O
O
O
 
1.28 1.47 1.15 0.37 
ACN/HOAc 
/TEAA 
100/0.25/0.05 
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No Compounds Structure '1k  '2k α Rs Mobile Phase9
24 DL-Tropic acid 
OH
OH
O
 
4.87 5.71 1.17 1.90 
ACN/MeOH 
/TFA 
99/1/0.1 
25 
(3aR,S-cis)- (±)-3,3a,8,8a-
Tetrahydro- 2H-
indeno[1,2-d]-oxazol-2-
one 
O
N O
H
 
0.64 0.79 1.22 1.03 
ACN/HOAc 
/TEAA 
100/0.25/0.05 
26 (±)-1-Phenyl-1,2- ethanediol 
HO
OH
 
1.35 1.45 1.07 0.56 
ACN/HOAc 
/TEAA 
100/0.25/0.05 
27 (±)-2,2,2-Trifluoro-1- (9-anthryl)ethanol 
CF3HO
 
0.58 0.62 1.07 0.35 
ACN/HOAc 
/TEAA 
100/0.25/0.05 
28 1,1’-Binaphthyl-2,2’-diyl-H phosphate 
O
O
P
O
OH
 
2.00 2.35 1.17 1.4 
ACN/MeOH 
/NH4OAc3 
70/30/20 mM (v/v/C)
29 Diacetyl cysteine S
H
N
COOH
O
O
 
2.61 3.39 1.30 1.5 
ACN/MeOH 
/NH4OAc3 
80/20/0.1 (v/v/w) 
30 
2-Hydroxy-3-(Boc-
amino)-3-phenylpropionic 
acid 
COOH
OH
HN t-Boc
 
2.52 3.63 1.44 2.4 
ACN/MeOH 
/TFA3 
95/5/0.1 (v/v/v) 
1.85 2.54 1.37 3.5 
ACN/MeOH 
/TFA3 
95/5/0.1 (v/v/v) 31 FMOC-phenylalanine 
H
N
COOH
FMOC
 1.17 1.43 1.22 2.1 
ACN/MeOH 
/NH4OAc3
70/30/20 mM (v/v/C)
32 Lorazepam N
H
N
O
OH
Cl
Cl
 
0.86 1.53 1.80 5.8 
ACN/MeOH 
/NH4OAc3 
70/30/20 mM 
33 Oxazepam N
H
N
O
OH
Cl
 
0.85 1.42 1.66 5.4 
ACN/MeOH 
/NH4OAc3 
70/30/20 mM 
34 Diaminocyclohexane acrylamide (DACH-ACR) 
H
N
N
H
O
O  
0.30 0.70 2.34 4.0 ACN/MeOH
3 
70/30 
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Table 3 
Chromatographic data for the normal-phase mode with halogenated solvent and other mobile phases resolution 
of racemic compounds on (R,R) P-CAP column11  
No Compounds Structure '1k  '2k  α Rs Mobile Phase12
0.95 1.65 1.74 3.40 Acetone 
1 1,1’-Bi-2-naphthol OHHO
 
1.47 2.39 1.63 3.85 CH2Cl2/MeOH 95/5 
2 Hydrobenzoin 
OH
OH  
2.94 3.41 1.16 1.48 CH2Cl2/MeOH 99/1 
3 Indapamide 
N
CH3
HN
O
Cl
S
O
O NH2 
4.19 4.33 1.03 0.49 CH2Cl2/MeOH 95/5 
4 
3-(alpha-acetonyl-4-
chlorobenzyl)-4-
hydroxy coumarin 
O O
OH
Cl
O
 
0.77 0.83 1.08 0.68 CH2Cl2/MeOH 95/5 
5 
1,5-Dihydroxy-
1,2,3,4-tetrahydro-
naphthalene 
OH
OH  
7.03 8.17 1.16 1.84 CH2Cl2/MeOH /TFA  98/2/0.1 
6 Mephenesin H3C
O OH
OH
 
3.85 4.15 1.08 0.67 
CH2Cl2/MeOH 
/TFA 
98/2/0.1 
7 Mandelamide NH2
OH
O
 
3.60 4.15 1.15 1.93 CH2Cl2/MeOH 95/5 
8 5-Methyl-5-phenylhydantoin NH
NH
O
O
H3C
 
5.70 5.91 1.04 0.74 CH2Cl2/MeOH 95/5 
                                                 
11 (R,R) P-CAP was bonded to 5 μm silica gel and the stationary phase was packed in a 250 × 4.6 mm (i.d.) 
stainless steel column. 
12 All samples were analyzed under the chromatographic condition: a UV detector at 254 nm, flow rate 1 
ml/min, unless otherwise noted.  All mobile phase ratios were volume to volume.  TEAA: triethylammonium 
acetate. 
 
97 
No Compounds Structure '1k  '2k  α Rs Mobile Phase12
9 
3a,4,5,6-Tetra- 
hydrosuccinimido-
[3,4-b] acenaphthen-
10-one 
NH
O O
O  
5.00 5.27 1.06 0.46 CH2Cl2/MeOH 99/1 
10 
(3a(R,S)-cis)-(±)-
3,3a,8,8a-Tetrahydro-
2H-indeno[1,2-d] 
oxazol-2-one 
O
NH O
 
4.18 4.73 1.13 1.45 CH2Cl2/MeOH 99/1 
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Table 4 
Effect of acid additives on selectivity and resolution for the polar organic mode enantiomeric separations on 
(S,S) P-CAP column13
Name Structure '1k  α Rs Mobile Phase 
5.00 1.38 2.0 CH3CN/CH3OH = 90/10 
5.11 1.37 2.1 CH3CN/CH3OH/HOAc = 90/10/0.1 Chlorthalidone 
NH
Cl
S
NH2
O
O
HO
O  5.02 1.38 2.5 
CH3CN/CH3OH/TFA = 
90/10/0.1 
No elution CH3CN/CH3OH  = 95/5 
2.33 1.11 1.0 CH3CN/CH3OH /HOAc= 95/5/0.1 Sulindac 
S
H3C
O
CH3
COOH
F 2.16 1.12 1.0 CH3CN/CH3OH /TFA = 95/5/0.1
No elution CH3CN/CH3OH  = 95/5 
No elution CH3CN/CH3OH /HOAc = 95/5/0.1 
(±)-2,3- 
Dibenzoyl-DL- 
tartaric acid 
O
O
OH
O
O
O
HO
O
 
9.26 1.10 0.94 CH3CN/CH3OH /TFA = 95/5/0.1
 
 
                                                 
13 The sample was analyzed with a UV detector at 254 nm, flow rate of 1 ml/min, at ambient temperature (~23 
°C). 
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Table 5 
Effect of flow rate on selectivity and resolution for the normal-phase enantiomeric separations of fipronil on 
(R,R) P-CAP column14
Compound Flow rate (ml/min) 
'
1k  '2k  Selectivity (α) 
Resolution 
( ) SR
0.5 2.35 2.87 1.22 1.71 
1.0 2.30 2.80 1.22 1.57 
1.5 2.27 2.76 1.22 1.46 
N
Cl
Cl
CF3
N
NH2
NC
S
F3C
O
 
2.0 2.24 2.73 1.22 1.40 
 
                                                 
14 The mobile used to enantioseparate fipronil consisted of heptane/ethanol/TFA 80/20/0.1.  The sample was 
analyzed with a UV detector at 254 nm. 
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Table 6 
Efficiency comparison of enantioseparation of 1.1’-bi-2-naphthol in the traditional normal-phase mode, polar 
organic mode and the normal phase mode with halogenated solvent system on (R,R) P-CAP column15
Mobile Phase Enantioselectivity(α) 
Enantioresolution
( ) SR
Number of Theoretical 
Plates16
(N)  
The traditonal normal-phase mode  
(heptane/EtOH/TFA 30/70/0.1) 1.32 1.86 1704 
Polar organic mode 
(acetonitrile/MeOH/TFA 95/5/0.1) 1.36 3.43 3552 
The normal-phase with halogenated 
solvent system (methylene 
chloride/MeOH 95/5). 
1.54 4.03 6042 
                                                 
15 The sample was analyzed at the flow rate of 1 ml/min, with a UV detector at 254 nm under room temperature 
(~23 °C). 
16 Theoretical plates (N) are based on the second eluted enantiomer. 
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CHAPTER 4.  DEVELOPMENT OF DINITROPHENYLATED 
CYCLODEXTRIN DERIVATIVES FOR ENHANCED 
ENANTIOMERIC SEPARATIONS BY HIGH 
PERFORMANCE LIQUID CHROMATOGRAPHY 
 
A paper published in Journal of Chromatography A1
 
Qiqing Zhong2,3, Lingfeng He4, Thomas E. Beesley4, Walter S. Trahanovsky3, Ping Sun5, 
Chunlei Wang5, and Daniel W. Armstrong5,6
 
Abstract 
The synthesis and evaluation of new dinitrophenyl (DNP) substituted β-cyclodextrin (β-
CD) chiral stationary phases (CSPs) for the enantioseparation of various classes of chiral 
analytes by HPLC are presented.  The dinitrophenyl substituted β-CD derivatives are 
synthesized and covalently bonded to functionalized 5 μm spherical porous silica gel.  These 
are the first reported derivatized cyclodextrins which contain π-electron deficient substituents 
(i.e., π-acidic moieties).  The column performance in terms of its ability to separate 
enantiomers is evaluated.  A variety of different dinitro-substituted aryl groups are 
investigated and compared.  The pH of the mobile phase buffers, the buffer composition, the 
number and position of the dinitro groups on the phenyl ring substituent, the degree of 
substitution, and the bonding strategy all greatly affect the performance of the CSPs.  A large 
variety of racemic compounds have been separated successfully on these CSPs.  The bonded 
dinitrophenyl-derivatized cyclodextrins are stable in all three mobile phase modes, namely, 
                                                 
1 Reprinted with permission of Journal of Chromatography A, 2006, 1115, 19-45.  Copyright © 2006 Elsevier 
B.V. All rights reserved. 
2 Graduate student, primary researcher and author.   
3 Department of Chemistry, Iowa State University, Ames, IA 50011 USA 
4 Advanced Separation Technologies Inc, 37 Leslie Court, P. O. Box 297, Whippany, NJ 07981 USA 
5 Department of Chemistry and Biochemistry, University of Texas at Arlington, Arlington, TX 76019 USA 
6 Author for correspondence. 
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the reversed-phase, polar organic, and normal phase modes.  No degradation in column 
performance was observed in any mode of operation even after more than 1000 injections.  
The analytical applicability of these types of CSPs for enantiomeric separations is discussed 
in detail. 
4.1 Introduction 
Cyclodextrins were discovered by Villiers et al. over one hundred years ago [1].  These 
enzymatic conversion products of starch are cyclic oligosaccharides consisting of at least six 
D-glucopyranose units bonded through α-1,4 linkages [2].  The application of cyclodextrins 
in separation science was first attempted by Cramer and Dietsche in 1959 as a selective 
precipitation/crystallization agent for enantiomers [3].  The first successful use of 
cyclodextrin in chromatography as a mobile phase additive was in thin layer chromatography 
(TLC) [4-6].  Stable bonded phase cyclodextrin as chiral stationary phases (CSPs) for 
enantiomeric separation by column chromatography followed a short time later [7-13].  
Cyclodextrin bonded stationary phases were the first successfully commercialized reversed-
phase CSPs [14].  Subsequently, the use of cyclodextrin in separation expanded to capillary 
electrophoresis (CE) [15-20], gas chromatography (GC) [21-30], and supercritical fluid 
chromatography (SFC) [31].  Nowadays, cyclodextrins and their derivatives constitute the 
most diverse and successful class of chiral selectors for enantiomeric separation by HPLC, 
GC, CE, and SFC. 
Although native cyclodextrins are able to resolve some enantiomers, this ability can be 
enhanced in many cases by their derivatization.  Each glucose unit that is part of the 
macrocyclic ring of native cyclodextrins has two secondary hydroxyl groups on C-2 and C-3 
position and one primary hydroxyl group on C-6 position.  The hydroxyl groups can readily 
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be derivatized by a wide variety of substituents.  Additional interactions, such as π-π stacking, 
dipole-dipole, ion-paring, electrostatic and steric repulsive effects can be introduced between 
the associated analytes and the appropriately functionalized cyclodextrins.  In this way, the 
solubility and complex-forming capacity of the cyclodextrins can be improved.  Thus, the 
range of enantiomeric compounds that can be separated with cyclodextrins is greatly 
expanded [32-34].  A number of cyclodextrin derivatives have found application in 
chromatography [3,35].  Some of these derivatives have been successfully commercialized 
[3,14,36,37]. 
In order to be separated by π-complex stationary phases, many chiral compounds, such as 
chiral amines, chiral alcohols, and amino acids, etc., are commonly derivatized by 
dinitrobenzoyl groups.  These nitro substituents on the phenyl ring are strong electron 
withdrawing groups through electron resonance as well as inductive effects.  Therefore, the 
dinitrophenyl ring is very π electron deficient and thus is sometimes referred to as π-acidic.  
The dinitrobenzoyl group on the derivatized chiral compounds provides additional sites for 
dipole stacking and much more pronounced steric interactions between the analytes and the 
chiral selector.  The strong π-π interactions may also be introduced if the chiral selector has 
aromatic moieties.  These new interactions help the chiral selector to differentiate the 
enantiomers of the analytes thus allowing a greater variety of chiral separations to be 
achieved. 
Although several π-electron rich derivatized cyclodextrins (i.e., π-basic) have been 
reported in the literature [32,34,38-43], no stable π-acidic substituted cyclodextrins have 
been reported to our knowledge.  So far, the aromatic-derivatized cyclodextrins are the only 
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effective multimodal cyclodextrin-based CSPs, which are useful not only in the reversed-
phase mode, but also in the normal phase and polar organic modes [14,34].  Most of these 
aromatic moieties attached on cyclodextrins, including commercially available 
naphthylethylcarbamate (Cyclobond I RN, SN) and dimethylphenylcarbamate (Cyclobond I 
DMP), are π electron donating (π-basic) in nature, which are effective in separating the 
analytes that have π-electron accepting (π-acidic) groups.  Thus, it is a logical expectation 
that enantiomers with π-electron donating (π-basic) moieties are likely to be separated by the 
CSPs based on cyclodextrins with π-electron accepting (π-acidic) moieties.  However, 
because of the fact that the π-electron-deficient dinitrobenzoates are good leaving groups, the 
dinitrobenzoyl derivatized cyclodextrins and the analogous carbamate, are not stable and thus 
have no practical use in chiral HPLC. 
The goal of this work is to design, synthesize, and evaluate the first stable, new type of 
dinitrophenyl derivatized β-cyclodextrin based CSPs for effective and multimodal chiral 
HPLC separations.  In this work, several dinitrophenyl substituted β-cyclodextrin derivatives 
are synthesized and covalently bonded onto the surface of 5 μm porous spherical silica gel 
particles.  The chromatographic performances of these packed HPLC columns in the 
reversed-phase, polar organic, and normal phase modes were evaluated using a wide variety 
of chiral compounds.  The different mobile phase modes, the effect of substituents, buffer 
effects, flow rate effects, and the retention behavior are discussed in detail. 
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4.2 Experimental 
4.2.1 Chemicals 
Anhydrous N,N’-dimethylformamide (DMF), sodium hydride, diethyl ether, 3-
(triethoxysilyl)propyl isocyanate, and most analytes used in this study were purchased from 
Sigma-Aldrich (Milwaukee, WI, USA).  Acetonitrile, 2-propanol, n-heptane, and methanol 
were HPLC grade, from Fischer (Fairlawn, NJ, USA).  Triethylamine, dibasic potassium 
phosphate, phosphoric acid, trifluoroacetic acid, and acetic acid (ACS certified grade) were 
obtained from Fisher Scientific (St. Louis, MO, USA).  Monobasic Potassium phosphate was 
obtained from EM Science (Gibbstown, NJ, USA).  Distilled water was deionized and 
filtered through activated charcoal and a 5 μm filter.  6-Chloro-2,4-dinitroaniline, 1-chloro-
2,4-dinitrobenzene, 1-chloro-3,4-dinitrobenzene, 2-chloro-3,5-dinitrobenzotrifluoride, and 4-
chloro-3,5-dinitrobenzotrifluoride were obtained from Alfa Aesar (Ward Hill, MA, USA).  
Kromasil silica (5 μm spherical diameter, 100 Å pore diameter, 0.90 ml/g pore volume, 312 
m2/g specific surface area), was purchased from Eka Chemicals, Bohus, Sweden. 
4.2.2 Preparation procedure 
The procedure for the preparation of the nine dinitrophenyl substituted β-cyclodextrin 
(DNP-O-BCD) HPLC columns are similar, so the 2,4-dinitrophenyl derivatized β-
cyclodextrin (2,4-DNP-O-BCD) is used here as an example. 
4.2.2.1 Synthesis of 2,4-DNP-O-BCD 
The dried β-cyclodextrin (2.10 g, 1.85 mmol) was dissolved by 40 ml anhydrous DMF 
with stirring in a 100 ml round flask at room temperature under argon protection.  NaH (0.24 
g, 10.00 mmol) was added into the solution, and the temperature was raised slowly to 70 ˚C 
and kept for 30 min.  Under argon protection, 1-chloro-2,4-dinitrobenzene (2.02 g, 10.00 
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mmol) was added with stirring and the solution was heated to 100 ˚C and kept for 5 hours.  
The salt was removed by filtration and DMF was distilled off by vacuum.  The product was 
washed with 3×100 ml diethyl ether and appeared as yellow/brown solid (3.28 g).  Yield: 
90.2%.  The degree of substitution is in the range from 3 to 5.  The NMR and mass spectra 
are included in the supporting material. 
4.2.2.2 Preparation of bonded sorbents through ether linkage 
The preparation of epoxy functionalized silica was reported elsewhere [44].  The dried 
2,4-DNP-O-BCD (2.70 g, ~1.37 mmol) was dissolved by 35 ml anhydrous DMF in a 100 ml 
round flask with stirring.  Then NaH (0.16 g, 6.67 mmol) was added into the solution at room 
temperature under argon protection and stirred for 12 min.  Unreacted NaH was removed by 
filtration.  The dried epoxy functionalized silica (3.20 g) was added into the solution in a 100 
ml round flask at room temperature.  The mixture was heated to 144 ˚C for 3 hours and 
cooled down to room temperature then filtered.  The CSP was washed by methanol, acetic 
acid in water solution (0.2%, w/w), pure water, and methanol (50 ml for each solvent), and 
dried in oven at 100 ˚C for 2 hours.  The product (3.30 g) was obtained. 
4.2.2.3 Preparation of bonded sorbents through carbamate linkage 
The dried 2,4-DNP-O-BCD (3.50 g, ~1.78 mmol) was dissolved by 55 ml anhydrous 
DMF in a 250 ml 3-neck round flask with mechanical stirring.  Then triethylamine (0.72 ml, 
5.16 mmol) and 3-(triethoxysilyl)propyl isocyanate (0.865 ml, 3.50 mmol) were added into 
the solution at room temperature under argon protection.  The solution was heated to 95 ˚C 
for 5 hours and cooled down to 60 ˚C.  The dried Kromasil silica (3.50 g, 5 μm, 100 Å) was 
added into the solution.  The mixture was heated to 105 ˚C over night and then cooled down 
to room temperature and filtered.  The CSP was washed by methanol, methanol/water (50/50, 
 
107 
v/v), pure water, and methanol (50 ml for each solvent), and dried in oven at 100 ˚C 
overnight.  The product (4.36 g) was obtained. 
4.2.2.4 Preparation of CSP-4 and CSP-8 
CSP-4 and CSP-8 (see Table 1) were made from heptakis[6-O-(tert-butyldimethylsilyl)]-
β-cyclodextrin [45].  The tert-butyldimethylsilyl group was removed [46] before the 
cyclodextrin derivative was bonded to silica gel. 
4.2.2.5 Structures and packing of the HPLC columns 
The structures of nine CSPs made in this study are shown in Table 1.  Some elemental 
analysis data for these CSPs are: for CSP-1, %C 4.41, %H 0.81, %N 0.02; for CSP-2, %C 
8.25, %H 1.21, %N 1.11; for CSP-6, %C 9.12, %H 1.65, %N 0.84; for CSP-7, %C 4.63, %H 
0.97, %N 0.12; for CSP-8, %C 7.38, %H 1.06, %N 0.36; for CSP-9, %C 5.73, %H 0.85, %N 
0.18.  The NMR and mass spectra are included in the supporting material.  The CSPs were 
slurry packed into 250×4.6mm i.d. stainless steel columns except for CSP-5, which was 
packed into a 150×4.6mm i.d. stainless steel column.   
4.2.3 Column evaluation 
HP 1050 HPLC system with a UV VWD detector, an auto sampler, and computer-
controlled HP ChemStation for LC data processing software was used for chromatographic 
evaluation of these HPLC columns in the reversed-phase, polar organic and normal phase 
modes.  The mobile phases were degassed by purging compressed pure helium gas for 10 
minutes.  UV detection was carried out at 234, 244, 254 or 264 nm for most of the probe 
compounds.  All separations were carried out at room temperature (~ 23 ˚C). 
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4.3 Results and Discussion 
4.3.1 Structures of the CSPs 
As can be seen from Table 1, nine different CSPs based on dinitrophenyl ether 
substituted β-cyclodextrins were synthesized.  The degree of substitution of the dinitrophenyl 
group on β-cyclodextrin is in the range from 3 to 5, except for CSP-4, which has the average 
degree of substitution of 10.  Each phenyl ring has two nitro substituents at different 
positions.  There is an additional trifluoromethyl group on the phenyl ring of CSP-6, CSP-8, 
and CSP-9 that makes these CSPs even more π-electron deficient.  CSP-7 has one amino 
substituent in addition to the two nitro groups on the phenyl ring.  Three stationary phases 
(CSP-1, CSP-2, and CSP-6) were attached to the silica gel through a carbamate linkage chain.  
All other CSPs were bonded through an ether linkage (see Experimental).  For CSP-4 and 
CSP-8, the dinitrophenyl substituents were only on C-2 and C-3 positions of the glucose unit.  
For other columns, the dinitrophenyl groups were randomly arranged on the cyclodextrin 
rims. 
4.3.2 Chromatographic evaluation 
It is well-known that native CDs also can be used as CSPs but their capability for the 
enantiomeric separation of some types of compounds is limited.  It has been shown 
conclusively that derivatizing cyclodextrins can change and enhance their chiral recognition 
properties [3,32-34].  Figure 1 gives an example.  This chromatogram shows that racemic 2-
(4-chloro-2-methyl-phenoxy) propionic acid was not separated on the native β-cyclodextrin 
bonded CSP while a baseline separation was achieved on CSP-1, which is based on the 2,4-
DNP-derivative of β-cyclodextrin. 
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The nine columns were tested in three mobile phase modes: the reversed-phase, polar 
organic, and normal phase modes.  In each mode, over 200 racemic aromatic analytes were 
injected on these columns.  These analytes include (A) heterocyclic compounds; (B) chiral 
acids; (C) chiral amines; (D) chiral alcohols; (E) chiral sulfoxides and sulfilimines; (F) amino 
acids derivatives; and (G) other chiral compounds. 
4.3.2.1 Reversed-phase mode 
Usually, the cyclodextrin-based CSPs work well in hydro-organic mobile phases because 
the formation of a cyclodextrin inclusion complex is favored in aqueous solutions.  All of the 
nine different DNP-O-β-cyclodextrin derivatives produced the most separations in the 
reversed-phase mode.  A typical reversed-phase enantiomeric separation is shown in Fig. 2.  
The analyte 5-(3-hydroxyphenyl)-5-phenyl-hydantoin was baseline separated on all six of the 
new DNP derivatized β-cyclodextrin columns in the reversed-phase mode.  The organic 
modifier could either be methanol or acetonitrile.  The best separation seems to be the one 
achieved on CSP-6 (Fig. 2D).  The analyte was separated within 10 minutes and the 
resolution (Rs) was over 4. 
Table 2 lists the chromatographic data for the reversed-phase separations on CSP-1 to 
CSP-9.  Combined, these columns separated 58 heterocyclic compounds, 23 chiral acids, 12 
chiral bases, 25 chiral alcohols, 8 chiral sulfoxides and sulfilimines, 6 amino acid derivatives, 
and 16 other chiral compounds.  So, a total 148 out of around 200 chiral analytes were 
separated. 
CSP-1 to CSP-4 are 2,4-dinitrophenyl ether derivatives of β-cyclodextrin.  CSP-2 has a 
high loading (19.7%, w/w) of chiral selector plus linkage chain on the silica support, 
compared to CSP-1, which has a 7% loading of the chiral selector plus linkage chain.  The 
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higher loading on CSP-2 did not provide any better overall enantioselectivity.  However, the 
retention time for most analytes on CSP-2 was almost doubled that on CSP-1.  Actually, the 
longer retention time does not necessarily produce better selectivity [32].  Results for all 200 
analytes could not be determined on CSP-2 because some analytes were strongly retained in 
the column and hard to elute with the same or even stronger mobile phases.  This results in 
fewer separations on CSP-2 than on CSP-1.  So, for analytical column chromatography, a 
high loading of chiral selectors is not necessarily preferable.  However, a greater amount of 
bonded chiral selector may be useful for preparative separations because of the possibility of 
injecting more analyte per run without overloading the CSP. 
The bonding chemistry does affect the enantioselectivity [47].  CSP-3 was bonded to the 
silica gel through an ether linkage instead of a carbamate linkage (for CSP-1).  This bonding 
strategy brings an additional hydroxyl group on the linkage spacer, which provides an 
additional possible hydrogen bond donor for chiral recognition.  Some analytes, such as 
benzylphthalide (Compound A7 in Table 2), and ethyl 11-cyano-9,10-dihydro-endo-9,10-
ethanoanthracene-11-carboxylate (Compound G9 in Table 2), were only separated on CSP-3, 
but not on CSP-1. 
For CSP-4, the degree of substitution on the β-cyclodextrin is almost doubled compared 
to that of CSP-1.  No enantiomeric separations were observed on CSP-4.  The very high 
degree of substitution actually decreases or even eliminates the enantioselectivity of the 
corresponding derivatives of β-cyclodextrin [48].  A large number of 2,4-dinitrophenyl ether 
groups on the rim of cyclodextrin cavity may actually block the cavity accessibility. 
CSP-5 is a 3,4-dinitrophenyl ether derivative of β-cyclodextrin.  As can be seen from Fig. 
3, either the total number of separations or baseline separations is comparable to that of CSP-
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1.  So, the different position of one nitro group on the phenyl ring did not make much 
difference in column performance. 
Both CSP-6 and CSP-8 are 2,6-dinitro-4-trifluoromethylphenyl ether derivatives of β-
cyclodextrin.  As can be seen from Table 1, there are two differences between these two 
CSPs.  The first difference is the bonding strategy: CSP-6 was bonded to the silica gel 
through a carbamate linkage while CSP-8 was through an ether linkage.  Another difference 
is the distribution of the DNP groups on the cyclodextrin rims because of different synthetic 
routes: for CSP-6, the DNP groups were randomly substituted on the cyclodextrin rims; 
while for CSP-8, the DNP groups can only be on C-2 and C-3 positions of the cyclodextrin.  
These two CSPs separated the most probe analytes and rank as the top two chiral selectors 
among all of the nine different dinitrophenylated β-cyclodextrin based CSPs in this study.  
CSP-7 is the 2-amino-3,5-dinitrophenyl ether derivative of β-cyclodextrin.  Surprisingly, 
only one partial separation was observed on this column in the reversed-phase mode. 
CSP-9 is the 2,4-dinitro-6-trifluoromethylphenyl ether derivative of β-cyclodextrin.  This 
CSP is very similar to CSP-6 and CSP-8.  A total of 61 separations, including 20 baseline 
separations, were obtained on this CSP.  But it seems not to be as broadly selective as CSP-6 
and CSP-8 probably due to the different positions of trifluoromethyl (TFM) and dinitro 
groups on the phenyl ring. 
Fig. 3 gives a comparison of the separation success rate of the nine new dinitrophenyl 
ether derivatized β-cyclodextrin bonded phase columns in the reversed-phase mode.  CSP-6 
and CSP-8 were the most versatile and broadly applicable CSPs among these nine columns.  
For all columns evaluated in the reversed-phase mode, no degradation in column 
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performance was observed even after a thousand injections.  This confirms that the ether 
linkage between DNP groups and cyclodextrin is hydrolytically stable. 
4.3.2.1.1 Retention behavior 
Generally speaking, the retention time of analytes in reversed-phase separations will 
increase when the percentage of organic modifier decreases.  However, for some analytes, 
the plot of mobile phase composition (in terms of percentage of organic modifier) versus 
retention factor k’ may exhibit a so-called U-shaped retention curve behavior (i.e., a 
minimum).  Fig. 4 gives an example which shows the elution behavior of nefopam 
hydrochloride on CSP-6.  The analytes are more strongly retained under high aqueous 
content and high organic content mobile phases.  The retention minimum is analyte-
dependent and usually achieved with the eluting mobile phase of around 50/50 (v/v), 
organic/aqueous.  Similar U-shaped retention behavior can be observed on other stationary 
phases [49-53], especially for the separation of highly water-soluble analytes such as 
hydrophilic proteins, peptides, amino acids, and some organic salts. 
The U-shaped retention behavior provides more choices for method development, 
especially for inverse mobile phase gradients.  High acetonitrile content mobile phases also 
generate lower back pressure than high aqueous content mobile phase at the same flow rate.  
Thus, with a high acetonitrile content mobile phase, higher flow rates can be used without 
exceeding the pressure limit of the instrumentation.  This can be beneficial for high-
throughput separations. 
Fig. 4 also shows that baseline separation for nefopam hydrochloride can be achieved on 
CSP-6 with almost any percentage of acetonitrile (from 90% to 10%).  The resolution (RS) 
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continually increases from 1.54 to 3.85 with decreasing amount of acetonitrile in the mobile 
phase.  From 90% to 50% acetonitrile, the increase in resolution is largely the result of an 
increase of efficiency.  The number of theoretical plates (N) increased from 2600 to 6110.  
From 50% to 10% acetonitrile, the efficiency no longer improves and even decreases 
somewhat.  Therefore, it is the retention factor (k’) and separation factor (α) that contribute 
to the continued increase in resolution. 
4.3.2.1.2 Flow rate 
The effect of mobile phase flow rate on enantiomeric selectivity α, resolution RS, and 
number of theoretic plates N in the reversed-phase mode is shown in Table 3.  The analyte 
nefopam hydrochloride was tested on CSP-6 column at flow rates of 0.5, 1.0, 1.5 and 2.0 
ml/min.  The retention factor (k’) and enantioselectivity (α) do not change, while the 
resolution (RS) and number of theoretic plates (N) are affected.  If the flow rate is decreased 
from 2.0 to 0.5 ml/min, the resolution RS and the number of theoretical plates N are improved 
from 2.38 to 2.70 and from 5780 to over 6240, respectively.  The same phenomenon was also 
observed on most other CSPs including those with macrocyclic chiral selectors [54-57] and 
polymeric chiral selectors [58]. 
4.3.2.1.3 Buffer and pH effects 
All CSPs reported in this work are stable in the pH range of 2.5 to 7.0.  The dissolution of 
the silica support sets the upper pH limit.  The mobile phase pH may affect separations of 
ionizable analytes, thus it must be considered when optimizing the separation conditions.  
The buffer can enhance separation efficiency by masking available silanol groups as well as 
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other strong adsorption sites which cause non-enantioselective retention of analytes.  The 
buffer can also act as displacer for the cavity and/or moderates hydrogen bonding effect. 
Fig. 5 shows the pH effect on the enantiomeric separation of N-(3,5-dinitrobenzoyl)-D,L-
leucine on CSP-6.  With a mobile phase of 15% acetonitrile in buffer (pH 4.1), a baseline 
separation was achieved within 23 minutes (Fig. 5A).  When the pH of the buffer increased 
from 4.1 to 6.4, with the same ratio of acetonitrile, the retention was shortened to 7 minutes 
(Fig. 5B).  However, the resolution decreased slightly.  As usual, when the amount of 
acetonitrile in the mobile phase decreased from 15% to 5%, the analyte’s retention increased, 
and a better baseline separation was achieved (Fig. 5C).  Obviously, the charge and polarity 
of ionizable analytes are affected when the buffer pH changes, which eventually affects the 
interactions between the analytes and CSPs.  In this example, N-(3,5-dinitrobenzoyl)-D,L-
leucine is protonated (neutral form) at pH 4.1 and deprotonated (anion form) at pH 6.4.  
Inclusions in the cyclodextrin cavity usually favors the neutral analyte as opposed to their 
ionized forms [59].  Thus, when pH rises, the analyte is less retained on the CSP.  The 
increased solvation shell of the ionized analyte also may affect chiral recognition. 
The triethylammonium acetate (TEAA) buffer is favored in reversed-phase separations 
when using cyclodextrin-based CSPs because it is non-corrosive and somewhat volatile.  
However, the nature of the buffer does affect enantioselectivity and resolution, thus other 
buffers may also be used in order to achieve better separations.  Fig. 6 shows the comparison 
of TEAA buffer and triethylammonium phosphate (TEAPO4) buffer.  As can be seen, with a 
mobile phase of 25% acetonitrile in TEAA buffer (pH 4.1), a near baseline separation of 
iophenoxic acid on CSP-6 was achieved within 40 minutes (Fig. 6A).  When the buffer pH 
increased to 6.4 while maintaining the same amount of acetonitrile in the mobile phase, the 
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retention was shortened to 17 minutes, but the resolution was almost gone.  After changing to 
TEAPO4 buffer (pH 6.4), a baseline separation was achieved within 25 minutes with a 
mobile phase containing 15% acetonitrile.  The ionic strength of the TEAPO4 buffer is higher 
than that of TEAA buffer.  The buffer with higher ionic strength can compete with the 
analytes in binding with silanol groups thus reducing non-enantioselective association.  
Therefore, the retention decreases but the enantioselectivity is improved. 
4.3.2.2 Polar organic mode  
Armstrong et al. developed a new water-free polar organic mobile phase mode in which 
solvents like acetonitrile and alcohol are the main components of the mobile phase [60,61].  
Although this “polar organic mode” of separation was originally developed for cyclodextrin 
bonded stationary phases, it has expanded in use to many other CSPs and is even used in 
achiral separations today.  Some enantiomeric separations were also observed on all nine of 
these new CSPs in the polar organic mode.  Table 4 lists the chromatographic data for these 
enantiomeric separations.  Due to the low back pressure of the mobile phase, high flow rates, 
≥ 2 ml/min, could be used, which reduces the analysis time dramatically.  Again, CSP-6 and 
CSP-8 are the most broadly applicable CSPs in this separation mode. 
4.3.2.3 Normal phase mode 
In the normal phase and polar organic separation modes, the mobile phase solvent 
occupies the cavity of the cyclodextrin chiral selectors.  Thus the formation of inclusion 
complexes between chiral analytes and cyclodextrin are inhibited [48].  However, some 
aromatic cyclodextrin derivatives, especially (R) and (S)-naphthylethylcarbamoylated β-
cyclodextrin, were developed and successfully used in the normal phase mode [32,34,38].  
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Therefore, it is reasonable to assume that these dinitrophenylated β-cyclodextrins also would 
separate some chiral analytes under normal phase conditions. 
Table 5 shows the chromatographic data for enantiomeric separations achieved on CSP-1 
to CSP-9 in the normal phase mode.  Interestingly, it appears that CSP-8 seems to be much 
more effective than CSP-6 under normal phase conditions.  A total of 22 enantiomeric 
separations were observed on CSP-8 while only 5 separations were achieved on CSP-6. 
4.3.3 Interactions for chiral recognition 
The β-cyclodextrin has 7 primary and 14 secondary hydroxyls which are available for 
derivatization or hooking on to silica support.  However, not all of these 21 hydroxyls can be 
derivatized because of steric hindrance of the substituents.  It has been shown that too high 
degree of substitution can actually hurt enantiomeric separations [32].  Our result on CSP-4 
also confirms this.  The average degree of substitution for all CSPs in this study (except for 
CSP-4) was about 5.  So, hydroxyls remain available at the rims of the cyclodextrin and may 
provide hydrogen bonding interactions for chiral recognition. 
It has been reported that C-2 hydroxyl is more reactive than C-3 hydroxyl group at the 
mouth of the cyclodextrin cavity [62].  If the C-6 hydroxyls are not protected, then the 
dinitrophenyl groups will randomly reside on both sides of the cyclodextrin bucket, with 
more substitution on C-2 and C-6 positions (for CSP-1,2,3,5,6,7, and 9).  If C-6 hydroxyls 
are protected before the nucleophilic aromatic substitution reaction takes place (see 
Experimental), then the DNP groups will only be on C-2 and C-3 positions, and C-2 should 
have more DNPs than C-3 position (for CSP-4 and 8).  On the stereospecific glucopyranose 
units, the restrictedly oriented hydroxyls or the substituents on those sites are thought to 
provide the chiral recognition ability of cyclodextrins [63].  Moreover, the functional sites 
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(such as the carbamoyl group, and the additional hydroxyls created during the reaction of 
cyclodextrins with the epoxy functionalized silica gel, etc.) on the linkage chain, which 
anchors cyclodextrins on the silica support, may also provide hydrogen bonding interactions 
for enantiomeric separation. 
The DNP groups introduced on the cyclodextrin are electron deficient.  With regard to 
chiral recognition, DNP groups may provide π-π association, dipole stacking, as well as 
steric effects.  Such π-π interactions are not available on native cyclodextrins.  The more 
electron-deficient, the stronger π-π interaction is expected between many aromatic analytes 
and this type of CSP.  Three kinds of substituents on the phenyl ring were used in this study: 
nitro, trifluoromethyl, and amino groups.  The electron withdrawing/donating ability of a 
substituent can be estimated by the value of its substituent constant, σ, which is used with the 
Hammett equation [64,65].  The more positive the σ value is, the stronger the substituent 
withdraws electron density from the phenyl ring, thus, the more electron-deficient the phenyl 
ring is.  The σ  (for meta position) and σ  (for para position) in the Hammett equation reflect 
electron withdrawing/donating ability of the substituents on the meta and para position of the 
phenyl ring, respectively.  For the nitro group, σ  = 0.71, σ  = 0.81; for the trifluoromethyl 
group, σ  = 0.46, σ  = 0.53; for the amino group, σ  = -0.09, σ  = -0.30 [64,65].  So, the 
nitro group is the strongest electron withdrawing group among these three substituents.  The 
trifluoromethyl group is also a strong electron withdrawing group.  Both the nitro and the 
trifluoromethyl groups withdraw the electron density away from the phenyl ring through 
resonance effects, field effects, and inductive effects [64].  The amino group is actually a 
electron donating group because of its negative σ values.  Therefore, the dinitro 
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(trifluoromethyl)phenyl groups (TFM-DNP, for CSP-6, 8, and 9) are the most electron 
deficient.  The 2,4-DNP (for CSP-1, 2, 3, and 4) and 3,4-DNP (for CSP-5) are intermediate in 
these terms.  The weakest π-acid may be 2-amino-3,5-DNP (for CSP-7) because of the 
counteracting electron donating effect from the amino group.  The electron deficient aromatic 
ring (π-acid) is thought to be important for this type of CSP.  The enantiomeric separation 
summary in the reversed-phase mode for all columns (see Fig. 3) gives statistical support for 
this assumption.  Generally, the most π-acidic CSPs (CSP-6 and 8) separate the most chiral 
analytes. 
Besides inclusion complex formation, hydrogen bonding, dipole interaction, steric effect, 
and π-π association mentioned above, other forces, such as van der Waals, ionic interaction 
for charged analytes, and various solvent effect may also be involved in chiral recognition 
[66].  Depending on different mobile phase modes, i.e. normal phase, polar organic, and 
reversed-phase modes, the dominant interactions may vary, which results in different chiral 
recognition mechanisms for the three mobile phase modes.  The exact mechanisms for chiral 
separations are dependent on analytes, mobile phases, and the nature of CSPs. 
4.4 Conclusions 
The dinitrophenylated β-cyclodextrin based CSPs are effective for enantiomeric 
separation in three mobile phase modes, including the reversed-phase, polar organic, and 
normal-phase modes.  As with most cyclodextrin based CSPs, the best mobile phase mode 
for these DNP-O-β-cyclodextrin CSPs is the reversed-phase mode.  Some analytes exhibit U-
shaped retention behavior in the reversed-phase mode, which may be useful for inverse 
mobile phase gradients and high flow rate screening. 
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For ionizable analytes, appropriate buffers can shorten the retention times and improve 
the efficiency and selectivity of separations.  The pH and ionic strength of mobile phase 
buffer are important factors for these analytes.  Usually, high pH decreases the retention of 
acidic compounds and low pH has an analogous effect for basic analytes.  The composition 
of the buffer may also affect separations. 
Generally speaking, CSP-6 and CSP-8 are the most versatile CSPs among the nine tested 
columns.  Their similar highly π-electron deficient phenyl substituent is undoubtedly an 
important factor.  Approximately half of the randomly chosen aromatic chiral compounds 
were separated on one single analytical column in the reversed-phase mode.  Some 
enantiomeric separations were also obtained in the normal phase and polar organic modes on 
both CSPs.  CSP-8 exhibits broader enantioselectivity than CSP-6 in the normal phase mode.  
In short, the dinitrophenylated cyclodextrin-based chiral stationary phases are a valuable 
addition to this important versatile class of chiral selectors. 
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Captions to the figures: 
 
Fig. 1 The comparison of column performance on (A) native β-CD and (B) CSP-1 in 
separating 2-(4-chloro-2-methyl-phenoxy) propionic acid.  Mobile phase: methanol/buffer 
40/60 (v/v).  The buffer is composed of 0.1% (v/v) triethylammonium acetate in water, pH 
4.1.  Flow rate: 1 ml/min.  UV detection at 254 nm.  T = 23 ˚C. 
 
Fig. 2 Enantiomeric separations of 5-(3-hydroxyphenyl)-5-phenyl-hydantoin on (A) CSP-1, 
MeOH/buffer 40/60; (B) CSP-3, MeOH/buffer 30/70; (C) CSP-5, MeOH/buffer 35/65; (D) 
CSP-6, ACN/buffer 40/60; (E) CSP-8, ACN/buffer 25/75; (F) CSP-9, ACN/buffer 25/75.  
The buffer is composed of 0.1% (v/v) triethylammonium acetate (TEAA) in water, pH 4.1.  
Flow rate: 1 ml/min.  UV detection at 254 nm.  T = 23 ˚C. 
 
Fig. 3 Enantiomeric separation summary in the reversed-phase mode for all columns.  All 
CSPs were packed as 250 × 4.6 mm HPLC column except for CSP-5, which was packed as a 
150 × 4.6 mm HPLC column.  All separations were at ambient temperature (~23 ˚C).  Flow 
rate: 1 ml/min. 
 
Fig. 4 The reversed-phase retention behavior of nefopam hydrochloride on CSP-6.  The 
retention has a minimum point at 50% acetonitrile.  Starting from 50% acetonitrile, either 
increase or decrease of the percentage of acetonitrile will cause longer retention of the 
analyte.  This analyte can be baseline separated on CSP-6 with almost any ratio of 
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acetonitrile to buffer.  The buffer is composed of 0.1% (v/v) triethylammonium acetate 
(TEAA) in water, pH 4.1.  Flow rate: 1 ml/min.  UV detection at 264 nm.  T = 23 ˚C. 
 
Fig. 5 The pH effect on enantiomeric separations of N-(3,5-dinitrobenzoyl)-D,L-Leucine on 
CSP-6 under (A) ACN/buffer 15/85, pH 4.1; (B) ACN/buffer 15/85, pH 6.4; (C) ACN/buffer 
5/95, pH 6.4.  The buffer is composed of 0.1% TEAA (v/v) in water.  Flow rate: 1 ml/min.  
UV detection at 254 nm for (A); 244 nm for (B) and (C).  T = 23 ˚C. 
 
Fig. 6 Mobile phase buffer effect on enantiomeric separations of iophenoxic acid on CSP-6 
under (A) ACN/TEAA buffer 25/75, pH 4.1; (B) ACN/TEAA buffer 25/75, pH 6.4; (C) 
ACN/TEAPO4 buffer 15/85, pH 6.4.  The TEAA buffer is composed of 0.1% (v/v) 
triethylammonium acetate in water.  The TEAPO4 buffer is composed of 5 mM KH2PO4, 5 
mM K2HPO4, and 0.1% (v/v) triethylammonium phosphate in water.  Flow rate: 1 ml/min.  
UV detection at 244 nm for (A); 264 nm for (B) and (C).  T = 23 ˚C. 
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Fig. 1 
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Fig. 2 
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Fig. 5 
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Fig. 6 
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Table 1. 
The structure of nine different CSPs based on dinitrophenyl ether substituted β-cyclodextrins. 
 
O
OR2
R3O
O
7
OR1
 
CSP R Coupling Chemistry7 
CSP-1 Carbamate linkage (7.2%) 
CSP-2 Carbamate linkage (19.7%) 
CSP-3 
R1=R2=R3=   
NO2
O2N  
or H 
Ether linkage (6.5%) 
CSP-4 R1=H, R2=R3= 
NO2
O2N  
or H Degree of substitution: 10 Ether linkage (6.8%) 
CSP-5 R1=R2=R3= NO2
NO2
 
or H Ether linkage (5.5%) 
CSP-6 R1=R2=R3= 
O2N
O2N
CF3
 
or H Carbamate linkage (24.5%) 
CSP-7 R1=R2=R3= 
NO2
NO2
H2N
 
or H Ether linkage (8.8%) 
CSP-8 R1=H, R2=R3= 
O2N
O2N
CF3
 
or H Ether linkage (9.8%) 
CSP-9 R1=R2=R3= 
O2N
F3C
NO2
 
or H Ether linkage (8.2%) 
 
 
 
                                                 
7 See Experimental section for detail.  The numbers in parenthesis are the loadings of CSPs in percentage. 
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Table 2 
Enantiomeric separations in the reversed-phase mode8
Code Compound Name '1k  α  SR Mobile Phase9 Column
Class A: Heterocyclic compounds 
A1 Althiazide 7.90 1.01 0.52 MeOH/H2O/TEAA 5/95/0.1 pH4.1 CSP-1 
  2.77 1.13 0.95 MeOH/H2O/TEAA 25/75/0.1 pH4.1 CSP-5 
  6.44 1.30 2.20 ACN/H2O/TEAA 10/90/0.1 pH4.1 CSP-9 
A2 3-(α-Acetonyl-4-chlorobenzyl)-4-hydroxycoumarin 5.00 1.29 2.41 MeOH/H2O/TEAA 40/60/0.1 pH4.1 CSP-1 
  2.28 1.22 1.45 MeOH/H2O/TEAA 40/60/0.1 pH4.1 CSP-3 
  9.78 1.03 0.60 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-6 
  16.36 1.09 1.20 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-8 
  9.20 1.16 1.25 ACN/H2O/TEAA 20/80/0.1 pH4.1 CSP-9 
A3 3-(α-Acetonylbenzyl)-4-hydroxycoumarin 5.33 1.27 1.91 MeOH/H2O/TEAA 30/70/0.1 pH4.1 CSP-1 
  1.38 1.25 1.40 MeOH/H2O/TEAA 40/60/0.1 pH4.1 CSP-3 
  3.91 1.04 0.60 MeOH/H2O/TEAA 50/50/0.1 pH4.1 CSP-6 
  9.75 1.07 1.30 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-8 
  2.21 1.43 1.60 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-9 
A4 2,3-O-Benzylidene-DL-threitol 2.37 1.05 0.75 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-6 
  6.47 1.13 1.43 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-8 
  3.00 1.15 1.10 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-9 
A5 4-Benzyl-3-propoinyl-2-oxazolidinone 1.65 1.07 0.85 MeOH/H2O/TEAA 30/70/0.1 pH4.1 CSP-1 
  5.01 1.09 0.92 MeOH/H2O/TEAA 25/75/0.1 pH4.1 CSP-5 
A6 Bendroflumethiazide 2.71 1.22 1.50 ACN/H2O/TEAA 20/80/0.1 pH4.1 CSP-9 
                                                 
8 This table is divided into 7 parts: Class A to Class G.  To reduce the size of the table, all structures of the 
compounds are not shown. 
9 All samples were analyzed under the chromatographic condition: a UV detector at 244, 254 or 264 nm, flow 
rate 1 ml/min, unless otherwise noted.  All mobile phase ratios were volume to volume.  ACN: acetonitrile.  
The TEAA buffer is composed of 0.1% (v/v) triethylammonium acetate in water.  The TEAPO4 buffer is 
composed of 5 mM KH2PO4, 5 mM K2HPO4, and 0.1% (v/v) triethylammonium phosphate in water. 
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αCode Compound Name '1k   SR Mobile Phase9 Column
A7 Benzylphthalide 4.41 1.08 0.72 MeOH/H2O/TEAA 30/70/0.1 pH4.1 CSP-3 
  7.43 1.14 1.02 MeOH/H2O/TEAA 35/65/0.1 pH4.1 CSP-5 
  3.68 1.02 0.60 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-6 
  8.73 1.14 2.18 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-8 
A8 Benzyl-6-oxo-2,3-diphenyl-4-morpholine carboxylate 4.29 1.10 1.05
MeOH/H2O/TEAA 
40/60/0.1 pH4.1 CSP-1 
  5.07 1.06 0.70 MeOH/H2O/TEAA 25/75/0.1 pH4.1 CSP-5 
  12.35 1.16 1.79 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-6 
  4.94 1.03 0.60 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-8 
  2.78 1.14 1.25 ACN/H2O/TEAA 20/80/0.1 pH4.1 CSP-9 
A9 3-(Benzyloxycarbonyl)-4-oxazolidine carboxylic acid 2.69 1.04 0.65
MeOH/H2O/TEAA 
30/70/0.1 pH4.1 CSP-1 
  5.48 1.08 1.00 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-6 
  5.63 1.06 1.00 ACN/H2O/TEAA 40/60/0.1 pH4.1 CSP-8 
  2.30 1.14 0.80 ACN/H2O/TEAA 10/90/0.1 pH4.1 CSP-9 
A10 4-Benzyl-2-oxazolidinone 2.64 1.09 0.86 MeOH/H2O/TEAA 5/95/0.1 pH4.1 CSP-1 
  2.01 1.04 0.60 MeOH/H2O/TEAA 25/75/0.1 pH4.1 CSP-5 
  3.70 1.06 0.95 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-6 
A11 1-(Benzyloxycarbonyl)-2-tert-butyl-3-methyl-4-imidazolidinone 4.03 1.06 0.68
MeOH/H2O/TEAA 
30/70/0.1 pH4.1 CSP-1 
  6.04 1.10 1.15 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-6 
A12 Chlorthalidone 1.10 1.44 1.45 MeOH/H2O/TEAA 30/70/0.1 pH4.1 CSP-1 
  4.89 1.45 2.46 MeOH/H2O/TEAA 15/85/0.1 pH4.1 CSP-5 
  3.29 1.20 1.35 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-6 
  1.66 1.10 1.50 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-8 
  4.68 1.12 0.80 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-9 
A13 5-Chloro-1,3-dihydro-1,3,3-trimethylspiro[2H-indole-2,3'-(3H)naphth[2,1-b](1,4)oxazine] 13.37 1.03 0.58
MeOH/H2O/TEAA 
50/50/0.1 pH4.1 CSP-5 
  3.25 1.14 1.10 ACN/H2O/TEAA 40/60/0.1 pH4.1 CSP-6 
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αCode Compound Name '1k   SR Mobile Phase9 Column
  5.63 1.10 1.75 ACN/H2O/TEAA 40/60/0.1 pH4.1 CSP-8 
  2.89 1.14 1.00 ACN/H2O/TEAA 40/60/0.1 pH4.1 CSP-9 
A14 2-Carbethoxy-γ-phenyl-γ-butyrolactone 3.64 1.08 0.65 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-6 
  7.66 1.10 1.15 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-8 
A15 cis-2,3-Dihydro-7a-methyl-3-phenylpyrrolo[2,1-b]-oxazol-5(7aH)-one 4.60 1.04 0.60
MeOH/H2O/TEAA 
25/75/0.1 pH4.1 CSP-5 
  9.12 1.03 0.60 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-6 
A16 1,3-Dihydro-1,3,3-trimethyl-spiro[2H-indole-2,3'-[3H]-naphth[2,1-b][1,4]oxazine] 2.49 1.20 1.05
ACN/H2O/TEAA 
40/60/0.1 pH4.1 CSP-6 
  1.35 1.10 0.92 ACN/H2O/TEAA 40/60/0.1 pH4.1 CSP-8 
  2.29 1.09 0.60 ACN/H2O/TEAA 40/60/0.1 pH4.1 CSP-9 
A17 cis-4,5-Diphenyl-2-oxazolidinone 3.85 1.18 1.00 MeOH/H2O/TEAA 20/80/0.1 pH4.1 CSP-1 
  1.97 1.35 1.93 MeOH/H2O/TEAA 30/70/0.1 pH4.1 CSP-3 
  1.11 1.47 2.07 MeOH/H2O/TEAA 50/50/0.1 pH4.1 CSP-5 
  5.66 1.12 1.16 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-6 
A18 (4R,5S) and (4S,5R)-1,5-Dimethyl-4-phenyl-2-imidazolidinone 1.45 1.38 3.30
MeOH/H2O/TEAA 
40/60/0.1 pH4.1 CSP-1 
  1.38 1.17 1.42 MeOH/H2O/TEAA 40/60/0.1 pH4.1 CSP-3 
  2.88 1.32 2.31 MeOH/H2O/TEAA 35/65/0.1 pH4.1 CSP-5 
  1.80 1.44 3.82 MeOH/H2O/TEAA 50/50/0.1 pH4.1 CSP-6 
  1.01 1.19 1.94 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-8 
  5.60 1.17 1.60 ACN/H2O/TEAA 10/90/0.1 pH4.1 CSP-9 
A19 4-(Diphenylmethyl)-2-oxazolidinone 4.00 1.06 0.65 MeOH/H2O/TEAA 20/80/0.1 pH4.1 CSP-1 
  2.30 1.12 1.20 MeOH/H2O/TEAA 20/80/0.1 pH4.1 CSP-3 
  4.25 1.11 0.90 MeOH/H2O/TEAA 35/65/0.1 pH4.1 CSP-5 
A20 α,α-Diphenyl-2-pyrolidinemethanol 0.75 1.22 0.83 MeOH/H2O/TEAA 5/95/0.1 pH4.1 CSP-1 
  2.04 1.11 0.75 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-6 
A21 5,5-Dimethyl-4-phenyl-2-oxazolidinone 2.53 1.12 1.05 MeOH/H2O/TEAA 10/90/0.1 pH4.1 CSP-1 
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  1.53 1.11 0.80 MeOH/H2O/TEAA 35/65/0.1 pH4.1 CSP-5 
  1.73 1.18 2.06 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-6 
  1.07 1.27 2.60 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-8 
A22 1,1,4,4-Tetraphenyl-2,3-O-isopropylidene-DL-threitol 4.42 1.15 0.95
MeOH/H2O/TEAA 
35/65/0.1 pH4.1 CSP-5 
A23 Flavanone 7.26 1.14 1.22 MeOH/H2O/TEAA 30/70/0.1 pH4.1 CSP-1 
  4.86 1.10 1.10 MeOH/H2O/TEAA 45/55/0.1 pH4.1 CSP-2 
  9.06 1.08 0.96 MeOH/H2O/TEAA 30/70/0.1 pH4.1 CSP-3 
  13.67 1.08 0.85 MeOH/H2O/TEAA 35/65/0.1 pH4.1 CSP-5 
  10.95 1.10 1.72 ACN/H2O 20/80 CSP-6 
  1.65 1.13 1.76 ACN/H2O/TEAA 40/60/0.1 pH4.1 CSP-8 
  5.76 1.18 1.50 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-9 
A24 Ftorafur 1.39 1.06 0.70 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-6 
  3.13 1.16 1.10 H2O/TEAA 100/0.1 pH4.1 CSP-8 
  0.77 1.16 0.90 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-9 
A25 DL-5-(4-Hydroxyphenyl)-5-phenylhydantoin 5.80 1.21 1.02 MeOH/H2O/TEAA 20/80/0.1 pH4.1 CSP-1 
  6.58 1.09 0.80 MeOH/H2O/TEAA 25/75/0.1 pH4.1 CSP-5 
  0.76 1.47 2.49 ACN/H2O/TEAA 40/60/0.1 pH4.1 CSP-6 
  2.63 1.29 2.70 ACN/H2O/TEAA 20/80/0.1 pH4.1 CSP-8 
  9.33 1.15 1.20 ACN/H2O/TEAA 10/90/0.1 pH4.1 CSP-9 
A26 5-(3-Hydroxyphenyl)-5-phenyl-hydantoin 2.28 1.65 2.87 MeOH/H2O/TEAA 30/70/0.1 pH4.1 CSP-1 
  1.53 1.18 1.45 MeOH/H2O/TEAA 30/70/0.1 pH4.1 CSP-3 
  2.68 1.40 2.58 MeOH/H2O/TEAA 35/65/0.1 pH4.1 CSP-5 
  0.72 2.23 4.37 ACN/H2O/TEAA 40/60/0.1 pH4.1 CSP-6 
  1.21 1.31 2.42 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-8 
  1.14 1.55 1.70 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-9 
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A27 Glycidyl 2-methylphenyl ether 6.31 1.02 0.55 MeOH/H2O/TEAA 2/98/0.1 pH4.1 CSP-1 
  7.21 1.12 1.30 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-8 
A28 5-Methyl-5-phenylhydantoin 3.06 1.09 0.90 MeOH/H2O/TEAA 15/85/0.1 pH4.1 CSP-5 
  2.35 1.07 0.85 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-6 
  3.59 1.14 1.20 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-8 
A29 (±)-Miconazole nitrate salt 10.77 1.10 1.25 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-6 
  16.17 1.06 0.80 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-8 
A30 α-Methyl-α-phenyl-succinimide 5.09 1.13 0.90 MeOH/H2O/TEAA 25/75/0.1 pH4.1 CSP-5 
  4.86 1.08 0.92 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-8 
A31 7,8-Benzo-1,3-diazaspiro[4,5]decane-2,4-dione 2.88 1.10 1.08 MeOH/H2O/TEAA 5/95/0.1 pH4.1 CSP-1 
  2.88 1.10 1.08 MeOH/H2O/TEAA 5/95/0.1 pH4.1 CSP-3 
  4.30 1.05 0.60 MeOH/H2O/TEAA 15/85/0.1 pH4.1 CSP-5 
A32 Naringin 1.61 1.42 2.22 MeOH/H2O/TEAA 50/50/0.1 pH4.1 CSP-6 
  1.30 1.40 2.93 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-8 
  5.53 1.23 1.60 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-9 
A33 (3a(R,S)-cis)-(±)-3,3a,8,8a-Tetrahydro-2H-indeno[1,2-d]oxazol-2-one 3.18 1.07 0.96
ACN/H2O/TEAA 
15/85/0.1 pH4.1 CSP-6 
A34 4',5,7-Trihydroxyflavanone 11.38 1.05 0.60 MeOH/H2O/TEAA 35/65/0.1 pH4.1 CSP-5 
  10.81 1.02 0.60 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-6 
  10.57 1.09 0.80 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-8 
A35 3a,4,5,6-Tetrahydrosuccinimido[3,4-b]acenaphthen-10-one 3.18 1.08 0.95
MeOH/H2O/TEAA 
10/90/0.1 pH4.1 CSP-1 
  4.29 1.08 0.90 MeOH/H2O/TEAA 20/80/0.1 pH4.1 CSP-2 
  7.50 1.17 2.12 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-6 
  1.53 1.14 1.50 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-8 
  6.69 1.13 1.10 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-9 
A36 Promethazine hydrochloride 9.72 1.12 0.90 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-8 
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A37 5-Phenyl-2-(2-propynyl-amino)-2-oxazolin-4-one 3.63 1.07 0.72 MeOH/H2O/TEAA 2/98/0.1 pH4.1 CSP-1 
A38 Thioridazine hydrochloride 13.09 1.28 0.90 MeOH/H2O/TEAA 50/50/0.1 pH4.1 CSP-5 
  1.20 1.08 0.75 ACN/H2O/TEAA 40/60/0.1 pH4.1 CSP-6 
  2.04 1.12 0.98 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-8 
A39 3-Phenylphthalide 4.70 1.05 0.68 MeOH/H2O/TEAA 30/70/0.1 pH4.1 CSP-3 
  9.38 1.12 0.80 MeOH/H2O/TEAA 35/65/0.1 pH4.1 CSP-5 
  4.58 1.04 1.10 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-6 
  1.20 1.14 1.60 ACN/H2O/TEAA 40/60/0.1 pH4.1 CSP-8 
A40 γ-Phenyl-γ-butyrolactone 3.76 1.10 0.70 MeOH/H2O/TEAA 25/75/0.1 pH4.1 CSP-5 
  6.25 1.04 0.60 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-6 
  6.01 1.08 0.70 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-8 
  2.87 1.09 0.60 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-9 
A41 2-Phenylglutaric anhydride 6.12 1.10 1.27 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-6 
  6.43 1.17 1.70 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-9 
A42 N-(1-Phenylethyl)maleimide 4.92 1.59 2.80 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-9 
A43 Phenethylphthalimide 5.98 1.10 1.00 MeOH/H2O/TEAA 45/55/0.1 pH4.1 CSP-2 
  13.06 1.07 0.95 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-6 
  5.94 1.18 1.41 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-8 
  1.68 1.07 0.80 ACN/H2O/TEAA 40/60/0.1 pH4.1 CSP-9 
A44 Methyl trans-3-(4-methoxyphenyl)glycidate 8.63 1.09 1.60 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-9 
A45 Nefopam hydrochloride 4.85 1.13 0.80 MeOH/H2O/TEAA 20/80/0.1 pH4.1 CSP-2 
  1.74 1.17 1.15 ACN/H2O/TEAA 40/60/0.1 pH4.1 CSP-5 
  1.58 1.30 2.49 ACN/H2O/TEAA 40/60/0.1 pH4.1 CSP-6 
  2.41 1.11 0.90 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-7 
  1.40 1.58 2.54 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-8 
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ACN/H2O/TEAA 
40/60/0.1 pH4.1   4.30 1.17 1.70 CSP-9 
A46 Oxazepam 0.82 1.34 1.06 MeOH/H2O/TEAA 50/50/0.1 pH4.1 CSP-5 
  1.82 1.26 2.30 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-6 
  1.39 1.59 5.40 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-8 
A47 1-Methoxy-4-(4-nitro-phenylsulfanyl)-3-phenyl-1H-isochromene 7.68 1.27 2.24
MeOH/H2O/TEAA 
40/60/0.1 pH4.1 CSP-1 
  6.72 1.35 2.83 MeOH/H2O/TEAA 50/50/0.1 pH4.1 CSP-5 
  19.04 1.20 2.27 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-6 
  10.53 1.22 1.52 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-8 
A48 3-(1-Methoxy-3-phenyl-1H-isochromen-4-yl)-acrylic acid ethyl ester 8.74 1.09 0.92
MeOH/H2O/TEAA 
30/70/0.1 pH4.1 CSP-1 
  3.45 1.13 1.25 MeOH/H2O/TEAA 50/50/0.1 pH4.1 CSP-6 
  3.89 1.17 1.74 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-8 
A49 8-Iodo-5-methoxy-7-phenyl-5H-pyrano[4,3-b]pyridine 8.70 1.31 2.73
MeOH/H2O/TEAA 
35/65/0.1 pH4.1 CSP-5 
  3.30 1.24 2.46 MeOH/H2O/TEAA 50/50/0.1 pH4.1 CSP-6 
  2.84 1.21 2.90 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-8 
A50 1-Butoxy-4-iodo-3-phenyl-1H-isochromene 12.22 1.28 2.61 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-6 
  3.46 1.18 3.16 ACN/H2O/TEAA 40/60/0.1 pH4.1 CSP-8 
A51 4-Iodo-1,6,7-trimethoxy-3-phenyl-1H-isochromene 3.99 1.08 0.85 MeOH/H2O/TEAA 40/60/0.1 pH4.1 CSP-1 
A52 (4R,5S) and (4S,5R)-4-Methyl-5-phenyl-2-oxazolidinone 8.11 1.13 1.00
MeOH/H2O/TEAA 
25/75/0.1 pH4.1 CSP-5 
  5.79 1.08 1.50 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-6 
  4.67 1.10 1.00 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-8 
  1.97 1.07 0.80 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-9 
A53 trans-Stilbene oxide 8.10 1.19 2.20 MeOH/H2O/TEAA 45/55/0.1 pH4.1 CSP-2 
  10.12 1.14 2.60 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-6 
  1.79 1.36 3.50 ACN/H2O/TEAA 40/60/0.1 pH4.1 CSP-8 
  2.22 1.16 ACN/H2O/TEAA 40/60/0.1 pH4.1 CSP-9 1.30
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A54 DL-Aminoglutethimide 14.55 1.31 1.30 MeOH/H2O/TEAA 20/80/0.1 pH4.1 CSP-2 
  11.25 1.14 1.20 MeOH/H2O/TEAA 25/75/0.1 pH4.1 CSP-5 
  3.60 1.21 2.25 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-6 
  10.27 1.14 1.56 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-8 
A55 Trögers base 3.54 1.30 2.10 MeOH/H2O/TEAA 45/55/0.1 pH4.1 CSP-2 
  5.67 1.14 1.48 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-6 
  17.41 1.13 1.67 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-8 
  4.82 1.23 1.60 ACN/H2O/TEAA 40/60/0.1 pH4.1 CSP-9 
A56 trans-4-Chlorostilbene oxide 1.63 1.21 1.25 MeOH/H2O/TEAA 65/35/0.1 pH4.1 CSP-2 
  3.14 1.15 2.05 ACN/H2O 35/65 CSP-6 
  1.17 1.40 3.05 ACN/H2O/TEAA 40/60/0.1 pH4.1 CSP-8 
  0.93 1.17 1.10 ACN/H2O/TEAA 50/50/0.1 pH4.1 CSP-9 
A57 2,4'-Dichlorostilbene oxide 13.37 1.19 2.80 MeOH/H2O/TEAA 45/55/0.1 pH4.1 CSP-2 
  4.47 1.14 2.00 ACN/H2O 35/65 CSP-6 
  1.11 1.11 1.00 ACN/H2O/TEAA 50/50/0.1 pH4.1 CSP-9 
A58 Mephenytoin 2.17 1.17 2.30 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-6 
  2.40 1.30 3.50 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-8 
Class B: Chiral acids 
B1 O-Acetyl-mandelic acid 2.10 1.02 0.55 MeOH/H2O/TEAA 2/98/0.1 pH4.1 CSP-1 
  1.33 1.09 0.80 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-6 
  1.15 1.06 0.60 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-9 
B2 DL-Atrolactic acid hemihydrate 1.65 1.05 0.62 MeOH/H2O/TEAA 50/50/0.1 pH4.1 CSP-6 
  5.41 1.02 0.60 ACN/H2O/TEAA 40/60/0.1 pH4.1 CSP-8 
B3 2-(4-Chloro-2-methyl-phenoxy)propionic acid 2.08 1.27 2.40 MeOH/H2O/TEAA 40/60/0.1 pH4.1 CSP-1 
  1.04 0.65 MeOH/H2O/TEAA 40/60/0.1 pH4.1 CSP-3 6.71
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ACN/H2O/TEAA 
25/75/0.1 pH4.1   3.93 1.11 1.08 CSP-6 
B4 p-Chloromandelic acid 2.52 1.09 0.85 MeOH/H2O/TEAA 20/80/0.1 pH4.1 CSP-1 
  2.50 1.06 0.70 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-6 
  6.13 1.07 0.80 ACN/H2O/TEAA 40/60/0.1 pH4.1 CSP-8 
B5 trans-4-Cotinine carboxylic acid 2.16 1.06 0.78 MeOH/H2O/TEAA 2/98/0.1 pH4.1 CSP-1 
  1.18 1.24 1.30 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-6 
  5.03 1.09 1.25 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-8 
B6 α,β-Dibromohydrocinnamic acid 9.29 1.07 0.70 MeOH/H2O/TEAA 30/70/0.1 pH4.1 CSP-1 
B7 2,3-Dibenzoyl-DL-tartaric acid 13.48 1.19 2.63 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-6 
B8 2-(4-Hydroxyphenoxy)-propionic acid 1.95 1.28 2.31 MeOH/H2O/TEAA 10/90/0.1 pH4.1 CSP-1 
  2.15 1.02 0.55 MeOH/H2O/TEAA 30/70/0.1 pH4.1 CSP-3 
  1.53 1.08 0.80 MeOH/H2O/TEAA 15/85/0.1 pH4.1 CSP-5 
  5.95 1.13 1.40 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-6 
  1.85 1.08 0.60 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-9 
B9 DL-3-(4-Hydroxyphenyl) lactic acid 2.86 1.09 1.06 MeOH/H2O/TEAA 5/95/0.1 pH4.1 CSP-1 
  2.71 1.10 1.00 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-6 
  5.04 1.07 0.92 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-8 
B10 Iophenoxic acid 4.85 1.29 2.08 ACN/H2O/TEAPO4 15/85/0.1 pH6.1 CSP-6 
  15.18 1.15 2.38 ACN/H2O/TEAPO4 15/85/0.1 pH6.15 CSP-8 
  6.32 1.14 1.25 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-9 
B11 α-Methoxyphenylacetic acid 5.24 1.03 0.70 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-8 
B12 Ibuprofen 2.59 1.08 0.71 ACN/H2O/TEAPO4 40/60/0.1 pH6.1 CSP-6 
  3.71 1.04 0.65 ACN/H2O/TEAA 40/60/0.1 pH4.1 CSP-8 
B13 2-Phenoxypropionic acid 2.00 1.23 1.40 MeOH/H2O/TEAA 10/90/0.1 pH4.1 CSP-1 
  3.03 1.31 1.50 MeOH/H2O/TEAA 20/80/0.1 pH4.1 CSP-2 
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  1.97 1.09 0.80 MeOH/H2O/TEAA 15/85/0.1 pH4.1 CSP-5 
  2.67 1.10 0.95 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-6 
  1.59 1.10 0.50 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-9 
B14 2-Phenylpropionic acid 3.63 1.03 0.55 MeOH/H2O/TEAA 5/95/0.1 pH4.1 CSP-1 
  12.08 1.08 1.50 MeOH/H2O/TEAA 45/55/0.1 pH4.1 CSP-2 
  8.33 1.11 1.08 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-6 
B15 3-Oxo-1-indancarboxylic acid 2.33 1.03 0.68 MeOH/H2O/TEAA 10/90/0.1 pH4.1 CSP-1 
  3.45 1.05 0.70 MeOH/H2O/TEAA 20/80/0.1 pH4.1 CSP-2 
  5.43 1.06 1.10 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-6 
  6.62 1.07 0.95 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-8 
  2.24 1.09 0.90 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-9 
B16 DL-β-Phenyllactic acid 2.90 1.06 0.68 MeOH/H2O/TEAA 5/95/0.1 pH4.1 CSP-1 
  4.30 1.07 0.70 MeOH/H2O/TEAA 20/80/0.1 pH4.1 CSP-2 
  3.72 1.06 0.75 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-6 
  4.80 1.09 0.78 ACN/H2O/TEAA 40/60/0.1 pH4.1 CSP-8 
B17 2-Phenylbutyric acid 3.64 1.15 1.72 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-6 
  5.08 1.08 0.80 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-8 
  1.56 1.14 1.00 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-9 
B18 2-(4-Nitrophenyl)propionic acid 4.37 1.08 0.90 MeOH/H2O/TEAA 35/65/0.1 pH4.1 CSP-2 
  4.09 1.04 0.62 ACN/H2O/TEAA 5/95/0.1 pH6.35 CSP-6 
  7.70 1.08 0.80 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-9 
B19 (R,S)-(±)-N-(α-Methylbenzyl)phthalamic acid 8.76 1.07 0.90 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-8 
B20 Ketoprofen 5.14 1.10 1.18 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-6 
  12.47 1.25 1.90 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-9 
B21 Indoprofen 13.55 0.80 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-6 1.06
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  5.06 1.10 1.04 ACN/H2O/TEAA 40/60/0.1 pH4.1 CSP-8 
B22 Flurbiprofen 2.70 1.04 0.60 MeOH/H2O/TEAA 65/35/0.1 pH4.1 CSP-2 
  1.23 1.06 0.62 ACN/H2O/TEAPO4 40/60/0.1 pH7.0 CSP-8 
B23 1,2,3,4-Tetrahydro-2-naphthoic acid 5.66 1.14 0.80 ACN/H2O/TEAA 40/60/0.1 pH4.1 CSP-8 
Class C: Chiral bases 
C1 2-Amino-1,2-diphenyl-ethanol 1.41 1.20 ACN/H2O/TEAA 5/95/0.1 pH4.1 1.30 CSP-6 
C2 2,2'-Diamino-1,1'-binaphthalene 9.12 1.08 0.70 MeOH/H2O/TEAA 20/80/0.1 pH4.1 CSP-1 
  6.03 1.07 0.65 MeOH/H2O/TEAA 20/80/0.1 pH4.1 CSP-3 
  6.44 1.11 0.85 MeOH/H2O/TEAA 35/65/0.1 pH4.1 CSP-5 
  2.50 1.33 2.44 MeOH/H2O/TEAA 50/50/0.1 pH4.1 CSP-6 
  3.11 1.26 2.13 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-8 
  3.30 1.52 2.10 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-9 
C3 (±)-Verapamil hydrochloride 0.86 1.11 0.70 MeOH/H2O/TEAA 65/35/0.1 pH4.1 CSP-2 
  6.78 1.13 0.82 MeOH/H2O/TEAA 35/65/0.1 pH4.1 CSP-5 
C4 1-Naphthalen-2-yl-ethylamine 11.84 1.05 0.58 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-6 
  4.16 1.08 0.65 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-8 
  8.13 1.06 0.60 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-9 
C5 Propyl (±)-1-(1-phenylethyl)-imidazole-5-carboxylate hydrochloride 5.75 1.07 0.75
MeOH/H2O/TEAA 
5/95/0.1 pH4.1 CSP-1 
  5.71 1.08 0.77 MeOH/H2O/TEAA 35/65/0.1 pH4.1 CSP-5 
  3.89 1.18 2.19 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-6 
  6.67 1.20 1.73 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-8 
  7.57 1.24 2.70 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-9 
C6 1-(2-Amino-cyclohexyl)-3-(3,5-bis-trifluoromethyl-phenyl)-urea 2.02 1.04 0.60
MeOH/H2O/TEAA 
5/95/0.1 pH4.1 CSP-1 
  1.99 1.29 1.45 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-8 
C7 trans-N-(2-Amino-cyclohexyl)-3,5-dinitro-benzamide 5.67 1.16 1.20
MeOH/H2O/TEAA 
15/85/0.1 pH4.1 CSP-5 
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C8 1-(1-Naphthyl)ethylamine 1.62 1.07 0.70 MeOH/H2O/TEAA 40/60/0.1 pH4.1 CSP-2 
C9 Fluoxetine hydrochloride 5.79 1.10 0.94 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-6 
  5.34 1.23 1.05 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-8 
C10 Proglumide sodium salt 6.51 1.10 0.80 MeOH/H2O/TEAA 20/80/0.1 pH4.1 CSP-2 
C11 Indapamide 2.99 1.15 1.10 MeOH/H2O/TEAA 25/75/0.1 pH4.1 CSP-5 
  3.96 1.10 1.35 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-6 
  3.30 1.22 2.90 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-8 
  1.55 1.18 1.25 ACN/H2O/TEAA 40/60/0.1 pH4.1 CSP-9 
C12 trans-1,2-diphenylethylenediamine 3.40 1.04 0.60 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-6 
  2.75 1.32 1.72 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-8 
Class D: Chiral alcohols 
D1 Ancymidol 2.13 1.34 1.52 MeOH/H2O/TEAA 30/70/0.1 pH4.1 CSP-1 
  1.81 1.13 1.28 MeOH/H2O/TEAA 30/70/0.1 pH4.1 CSP-3 
  4.44 1.22 1.40 MeOH/H2O/TEAA 35/65/0.1 pH4.1 CSP-5 
  4.24 1.20 2.14 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-6 
  3.44 1.04 0.70 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-8 
D2 trans-2-Bromo-1-indanol 2.06 1.12 1.05 MeOH/H2O/TEAA 20/80/0.1 pH4.1 CSP-1 
  11.23 1.12 1.50 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-6 
  2.52 1.12 1.52 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-8 
  5.45 1.17 1.50 ACN/H2O/TEAA 10/90/0.1 pH4.1 CSP-9 
D3 Baytan 2.38 1.05 0.72 MeOH/H2O/TEAA 30/70/0.1 pH4.1 CSP-1 
  4.75 1.14 1.10 MeOH/H2O/TEAA 35/65/0.1 pH4.1 CSP-5 
  2.46 1.11 1.45 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-6 
  1.22 1.27 2.06 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-8 
  2.68 1.20 1.50 ACN/H2O/TEAA 20/80/0.1 pH4.1 CSP-9 
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D4 6-(4-Chlorophenyl)-4,5-dihydro-2-(2-hydroxybutyl)-3(2H)-pyridazinone 5.00 1.06 0.70
MeOH/H2O/TEAA 
35/65/0.1 pH4.1 CSP-5 
D5 2-Cyclopropylbenzyl alcohol 1.84 1.09 0.86 MeOH/H2O/TEAA 10/90/0.1 pH4.1 CSP-1 
  2.11 1.09 0.75 MeOH/H2O/TEAA 25/75/0.1 pH4.1 CSP-5 
  5.30 1.13 1.56 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-6 
  5.85 1.19 1.59 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-8 
  5.31 1.14 1.00 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-9 
D6 1,5-Dihydroxy-1,2,3,4-tetrahydronaphthalene 2.94 1.22 1.31 MeOH/H2O/TEAA 2/98/0.1 pH4.1 CSP-1 
  3.25 1.15 1.15 MeOH/H2O/TEAA 15/85/0.1 pH4.1 CSP-5 
  3.28 1.17 2.06 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-6 
  3.74 1.19 1.82 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-8 
  2.24 1.17 1.25 ACN/H2O/TEAA 10/90/0.1 pH4.1 CSP-9 
D7 N,N'-Dibenzyl-DL-tartramide 4.37 1.04 0.58 MeOH/H2O/TEAA 5/95/0.1 pH4.1 CSP-1 
  6.72 1.08 0.98 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-6 
D8 Furoin 1.77 1.09 1.05 MeOH/H2O/TEAA 5/95/0.1 pH4.1 CSP-1 
  4.36 1.10 1.23 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-6 
  2.13 1.16 2.19 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-8 
  0.99 1.07 0.70 ACN/H2O/TEAA 10/90/0.1 pH4.1 CSP-9 
D9 Midodrine hydrochloride 0.84 1.30 1.30 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-8 
D10 DL-Mandelamide 1.66 1.13 1.42 H2O/TEAA 100/0.1 pH4.1 CSP-6 
  1.58 1.16 1.25 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-8 
  0.74 1.20 0.90 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-9 
D11 α-Methyl-2-naphthalenemethanol 3.62 1.03 0.60 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-6 
  8.94 1.10 2.01 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-8 
D12 1-Indanol 3.84 1.12 1.02 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-8 
  4.16 1.10 0.80 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-9 
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D13 O-Methoxy-α-methylbenzyl alcohol 3.43 1.13 0.96 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-8 
D14 Hydrobenzoin 1.94 1.29 1.45 MeOH/H2O/TEAA 5/95/0.1 pH4.1 CSP-1 
  2.23 1.22 1.20 MeOH/H2O/TEAA 20/80/0.1 pH4.1 CSP-2 
  0.77 1.07 0.70 MeOH/H2O/TEAA 30/70/0.1 pH4.1 CSP-3 
  3.56 1.28 1.40 MeOH/H2O/TEAA 15/85/0.1 pH4.1 CSP-5 
  1.45 1.26 2.31 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-6 
  0.91 1.28 2.78 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-8 
  0.83 1.20 1.00 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-9 
D15 (±)-1,2,3,4-Tetrahydro-1-naphthol 6.00 1.07 0.80 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-6 
  6.56 1.13 0.95 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-8 
  7.16 1.09 0.70 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-9 
D16 (R,S)-(+,-)-1-(9-Anthryl)-2,2,2-trifluoroethanol 5.68 1.08 0.88 MeOH/H2O/TEAA 30/70/0.1 pH4.1 CSP-1 
  7.67 1.07 1.10 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-6 
D17 Oxyphencyclimine hydrochloride 2.59 1.12 0.80 MeOH/H2O/TEAA 40/60/0.1 pH4.1 CSP-1 
  4.62 1.20 1.51 ACN/H2O/TEAA 40/60/0.1 pH4.1 CSP-6 
  1.08 1.34 1.50 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-8 
D18 (±)-trans-2-Phenyl-1-cyclohexanol 5.82 1.09 1.00 MeOH/H2O/TEAA 20/80/0.1 pH4.1 CSP-2 
  6.78 1.08 1.75 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-6 
  6.19 1.13 1.50 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-8 
  7.02 1.10 0.80 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-9 
D19 1-Phenyl-1-butanol 6.26 1.08 0.60 MeOH/H2O/TEAA 15/85/0.1 pH4.1 CSP-5 
  5.86 1.09 1.10 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-6 
  2.18 1.09 0.80 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-8 
  2.60 1.08 0.60 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-9 
D20 α-(Methylaminomethyl)benzyl alcohol 4.92 1.94 1.20 MeOH/H2O/TEAA 20/80/0.1 pH4.1 CSP-2 
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D21 trans-2-(1-Methyl-1-phenylethyl)cyclohexanol 2.97 1.30 1.50 ACN/H2O/TEAA 40/60/0.1 pH4.1 CSP-6 
  4.70 1.15 0.90 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-8 
  7.31 1.20 1.50 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-9 
D22 Labetalol hydrochloride 8.54 1.05 0.50 MeOH/H2O/TEAA 20/80/0.1 pH4.1 CSP-2 
  5.34 1.03 0.50 MeOH/H2O/TEAA 25/75/0.1 pH4.1 CSP-5 
D23 Benzoin 6.67 1.11 1.25 MeOH/H2O/TEAA 20/80/0.1 pH4.1 CSP-2 
  6.56 1.09 1.10 MeOH/H2O/TEAA 25/75/0.1 pH4.1 CSP-5 
  2.20 1.11 1.28 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-6 
D24 α-DL-Oxyphene 5.21 1.16 0.90 MeOH/H2O/TEAA 25/75/0.1 pH4.1 CSP-5 
  3.06 1.11 0.90 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-6 
  2.24 1.23 1.15 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-8 
  4.96 1.08 0.90 ACN/H2O/TEAA 40/60/0.1 pH4.1 CSP-9 
D25 Tropicamide 1.23 1.11 0.80 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-6 
  0.86 1.19 0.70 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-8 
Class E: Chiral sulfoxides and sulfilimines 
E1 N,S-Dimethyl-S-phenyl-sulfoximine 5.53 1.08 0.90 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-6 
  3.87 1.16 1.50 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-8 
  2.42 1.09 0.70 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-9 
E2 Phenyl vinyl sulfoxide 4.31 1.06 0.72 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-8 
E3 1-Chloro-4-methanesulfinyl-benzene 9.05 1.08 1.10 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-8 
E4 1-Bromo-4-methanesulfinyl-benzene 4.50 1.02 0.70 MeOH/H2O/TEAA 10/90/0.1 pH4.1 CSP-1 
  4.10 1.06 1.00 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-8 
E5 1-Bromo-2-methanesulfinyl-benzene 9.99 1.09 1.50 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-6 
  3.18 1.15 1.74 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-8 
E6 4-Methyl-benzenesulfinic acid isobutyl ester 7.40 1.05 0.75 MeOH/H2O/TEAA 20/80/0.1 pH4.1 CSP-1 
 
147 
α  Code Compound Name '1k  SR Mobile Phase9 Column
E7 N-[(4-methylphenyl)sulfonyl]-S-phenyl-S-benzyl sulfilimine 4.74 1.05 0.70
MeOH/H2O/TEAA 
30/70/0.1 pH4.1 CSP-1 
  7.82 1.11 1.40 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-8 
E8 N-[(4-methylphenyl)sulfonyl]-S-phenyl-S-(2-phenylethyl) sulfilimine 8.54 1.07 0.72
MeOH/H2O/TEAA 
35/65/0.1 pH4.1 CSP-5 
  7.37 1.12 1.92 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-8 
Class F: Amino acid derivatives 
F1 N-(3,5-Dinitrobenzoyl)-D,L-phenylglycine 2.77 1.11 0.95 MeOH/H2O/TEAA 30/70/0.1 pH4.1 CSP-1 
  2.24 1.17 1.00 ACN/H2O/TEAA 5/95/0.1 pH6.35 CSP-6 
F2 N-(3,5-Dinitrobenzoyl)-D,L-Leucine 2.65 1.18 1.07 MeOH/H2O/TEAA 20/80/0.1 pH4.1 CSP-1 
  4.53 1.19 1.84 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-6 
F3 N-Benzoyl-DL-valine 2.41 1.08 0.85 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-6 
F4 Z-DL-phenylalanine 6.45 1.22 1.80 MeOH/H2O/TEAA 45/55/0.1 pH4.1 CSP-2 
  5.07 1.07 0.60 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-6 
F5 Dansyl-DL-norleucine cyclohexylammonium salt 5.69 1.06 0.75 MeOH/H2O/TEAA 25/75/0.1 pH4.1 CSP-5 
  3.55 0.96 0.68 ACN/H2O/TEAA 15/85/0.1 pH6.48 CSP-6 
  7.61 1.08 1.50 ACN/H2O/TEAPO4 15/85/0.1 pH6.15 CSP-8 
  2.52 1.12 0.70 ACN/H2O/TEAA 40/60/0.1 pH4.1 CSP-9 
F6 Dansyl-DL-phenylalanine cyclohexylammonium salt 8.30 1.04 0.60
MeOH/H2O/TEAA 
45/55/0.1 pH4.1 CSP-2 
  4.51 1.05 0.96 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-3 
  8.88 1.11 0.95 MeOH/H2O/TEAA 25/75/0.1 pH4.1 CSP-5 
  9.09 1.10 1.40 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-6 
  2.69 1.18 2.19 ACN/H2O/TEAPO4 25/75/0.1 pH6.15 CSP-8 
  1.96 1.08 0.80 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-9 
Class G: Other chiral compounds 
G1 Benzoin methyl ether 8.45 1.05 0.72 MeOH/H2O/TEAA 10/90/0.1 pH4.1 CSP-1 
  2.85 1.08 0.68 MeOH/H2O/TEAA 30/70/0.1 pH4.1 CSP-3 
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  4.95 1.12 1.05 MeOH/H2O/TEAA 35/65/0.1 pH4.1 CSP-5 
  12.93 1.05 0.78 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-6 
  4.30 1.12 1.20 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-8 
G2 (R,R) and (S,S)-N,N'-Bis(2-methylbenzyl) sulfamide 1.09 1.30 1.52
MeOH/H2O/TEAA 
40/60/0.1 pH4.1 CSP-1 
  2.92 1.05 0.72 MeOH/H2O/TEAA 35/65/0.1 pH4.1 CSP-5 
  2.71 1.03 0.55 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-6 
  1.45 1.09 0.70 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-9 
G3 Benzoin ethyl ether 1.65 1.07 0.81 MeOH/H2O/TEAA 30/70/0.1 pH4.1 CSP-3 
  4.69 1.13 1.15 MeOH/H2O/TEAA 35/65/0.1 pH4.1 CSP-5 
  4.43 1.24 3.45 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-8 
G4 1-Benzocylcobutene-carbonitrile 7.80 1.07 1.05 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-8 
G5 2-(3-Chlorophenoxy) propionamide 1.99 1.13 1.10 MeOH/H2O/TEAA 20/80/0.1 pH4.1 CSP-1 
  6.04 1.08 1.16 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-6 
G6 1-(2-Chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane 10.01 1.06 0.62
MeOH/H2O/TEAA 
30/70/0.1 pH4.1 CSP-1 
  17.20 1.12 1.18 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-6 
  3.46 1.05 0.98 ACN/H2O/TEAA 40/60/0.1 pH4.1 CSP-8 
G7 (±)Camphor p-tosyl hydrazon 14.37 1.08 0.84 MeOH/H2O/TEAA 35/65/0.1 pH4.1 CSP-5 
  21.56 1.06 0.95 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-6 
  3.80 1.07 1.02 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-8 
G8 3,4-Dihydroxyphenyl-2-propylacetamide 3.42 1.20 1.16 MeOH/H2O/TEAA 10/90/0.1 pH4.1 CSP-1 
  4.26 1.15 1.00 MeOH/H2O/TEAA 15/85/0.1 pH4.1 CSP-5 
  4.55 1.26 3.16 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-6 
  6.50 1.11 1.05 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-8 
  4.32 1.09 1.00 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-9 
G9 Ethyl 11-cyano-9,10-dihydro-endo-9,10-ethanoanthracene-11-carboxylate 2.53 1.12 1.38
MeOH/H2O/TEAA 
30/70/0.1 pH4.1 CSP-3 
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  1.49 1.17 1.05 MeOH/H2O/TEAA 50/50/0.1 pH4.1 CSP-6 
  6.70 1.09 1.54 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-8 
G10 1,1'-Bi-2-naphthol 5.80 1.11 1.01 MeOH/H2O/TEAA 20/80/0.1 pH4.1 CSP-1 
  5.02 1.05 0.70 MeOH/H2O/TEAA 35/65/0.1 pH4.1 CSP-2 
  5.17 1.05 0.55 MeOH/H2O/TEAA 20/80/0.1 pH4.1 CSP-3 
  12.20 1.15 1.75 ACN/H2O/TEAA 15/85/0.1 pH4.1 CSP-6 
  3.86 1.13 2.01 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-8 
  2.93 1.24 1.70 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-9 
G11 Ibuprofen sulfomethyl ester 5.99 1.11 0.81 MeOH/H2O/TEAA 40/60/0.1 pH4.1 CSP-1 
G12 2-Phenylbutyrophenone 8.51 1.03 0.58 MeOH/H2O/TEAA 30/70/0.1 pH4.1 CSP-3 
  14.67 1.08 1.00 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-6 
  6.97 1.09 0.85 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-8 
G13 1,1'-Bi-2-naphthyl-2,2'-diyl hydrogen phosphate 3.89 1.12 1.06 MeOH/H2O/TEAA 40/60/0.1 pH4.1 CSP-1 
  8.21 1.08 0.80 MeOH/H2O/TEAA 45/55/0.1 pH4.1 CSP-2 
  13.26 1.09 0.75 MeOH/H2O/TEAA 35/65/0.1 pH4.1 CSP-5 
  5.29 1.36 1.97 ACN/H2O/TEAA 15/85/0.1 pH6.48 CSP-6 
  16.99 1.19 3.09 ACN/H2O/TEAPO4 15/85/0.1 pH6.15 CSP-8 
G14 1,1'-Bi-2-naphthol bis(trifluoromethanesulfonate) 14.72 1.13 0.82 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-6 
  2.62 1.14 1.46 ACN/H2O/TEAA 40/60/0.1 pH4.1 CSP-8 
G15 trans-N-{2-[3-(3,5-Bis-trifluoromethyl-phenyl)-ureido]-cyclohexyl}-acrylamide 4.49 1.17 1.78
ACN/H2O/TEAA 
25/75/0.1 pH4.1 CSP-6 
  2.14 1.17 1.50 ACN/H2O/TEAA 25/75/0.1 pH4.1 CSP-8 
G16 trans-1,2-Cyclohexanediyl-bis acrylamide 2.53 1.10 0.90 ACN/H2O/TEAA 5/95/0.1 pH4.1 CSP-8 
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Table 3 
Effect of flow rate on selectivity, resolution, and efficiency for the reversed-phase 
enantiomeric separations of nefopam hydrochloride on CSP-6 stationary phase10
Flow rate  
(ml/min) 
Retention factor 
( ) '1k
Selectivity  
(α ) 
Resolution  
( ) SR
Number of theoretical plates11
( ) N
0.5 5.66 1.18 2.70 6240 
1.0 5.67 1.17 2.66 6180 
1.5 5.67 1.17 2.51 5800 
2.0 5.64 1.17 2.38 5780 
 
 
                                                 
10 Chromatographic conditions: CSP-6 250mm × 4.6mm column with UV detection at 264 nm.  Mobile phases 
are 80% acetonitrile in TEAA buffer, pH 4.1. 
11 The numbers of theoretical plates are based on the first eluted enantiomer. 
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Table 4 
Enantiomeric separations in the polar organic mode12
Compound Name '1k  α  SR Mobile Phase13 Column
N-[(4-Methylphenyl)sulfonyl]-S-methyl-S-phenyl sulfilimine 0.54 1.15 0.60 ACN 100  CSP-6 
(±) cis-1-Amino-2-indanol 0.84 1.13 0.93 ACN/MeOH 95/5  CSP-8 
Ancymidol 0.89 1.05 0.50 ACN/MeOH 95/5 2ml/min CSP-1 
 1.33 1.08 0.70 ACN/MeOH 95/5  CSP-6 
 1.46 1.11 0.94 ACN 100  CSP-8 
2,6-Bis(4-isopropyl-2-oxazolin-2-yl)pyridine 1.05 1.06 0.70 ACN 100  CSP-8 
2-(3-Chlorophenoxy)propionamide 1.04 1.05 0.60 ACN 100  CSP-6 
N,N'-Dibenzyl-DL-tartramide 5.49 1.12 0.95 ACN/MeOH 95/5  CSP-6 
(4R,5S) and (4S,5R)-1,5-Dimethyl-4-phenyl-2-imidazolidinone 1.39 1.09 0.95 ACN/MeOH 95/5 2ml/min CSP-1 
 2.32 1.37 3.76 ACN/MeOH 95/5  CSP-6 
 2.32 1.04 0.78 ACN 100  CSP-8 
 2.08 1.05 0.80 ACN/MeOH 99/1  CSP-9 
3,4-Dihydroxyphenyl-2-propylacetamide 8.36 1.11 0.75 ACN 100  CSP-6 
DL-5-(4-Hydroxyphenyl)-5-phenylhydantoin 0.51 1.14 0.58 ACN/MeOH 95/5 2ml/min CSP-1 
 4.16 1.16 0.75 ACN 100  CSP-6 
 1.45 1.17 0.94 ACN 100  CSP-8 
5-(3-Hydroxyphenyl)-5-phenyl-hydantoin 4.15 1.18 0.80 ACN 100  CSP-6 
 1.56 1.13 0.82 ACN 100  CSP-8 
trans-2,3-O-Isopropylidene-2,3-dihydroxy-1,4-
bis(diphenylphosphino)butane 3.89 1.08 0.70 
ACN/MeOH 
95/5  CSP-8 
DL-Mandelamide 1.35 1.06 0.71 ACN 100  CSP-8 
 1.02 1.06 0.70 ACN/MeOH 99/1  CSP-9 
(3a(R,S)-cis)-(±)-3,3a,8,8a-Tetrahydro-2H-indeno[1,2-d]oxazol-
2-one 1.00 1.04 0.55 
ACN 
100  CSP-6 
                                                 
12 To reduce the size of this table, all structures of the compounds are not shown. 
13 All samples were analyzed under the chromatographic condition: a UV detector at 244, 254 or 264 nm, flow 
rate 1 ml/min, unless otherwise noted.  All mobile phase ratios were volume to volume.  ACN: acetonitrile. 
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αCompound Name '1k   SR Mobile Phase13 Column
2-Phenoxypropionic acid 4.17 1.18 0.60 ACN/MeOH 70/30  CSP-2 
2-Phenylcyclohexanone 0.11 1.24 0.68 ACN 100  CSP-8 
Phenylsuccinic anhydride 3.33 1.27 1.50 ACN/MeOH 80/20  CSP-3 
(±)-Ketamine hydrochloride 4.80 1.50 0.60 ACN/MeOH 90/10  CSP-9 
Thioridazine hydrochloride 5.15 1.45 0.60 ACN/MeOH 50/50  CSP-2 
Norphenylephrine hydrochloride 1.01 1.22 0.70 ACN/MeOH 80/20  CSP-3 
trans-N-{2-[3-(3,5-Bis-trifluoromethyl-phenyl)-ureido]-
cyclohexyl}-acrylamide 3.84 1.27 1.93 
ACN 
100  CSP-6 
Oxazepam 1.76 1.38 1.42 ACN 100  CSP-6 
 0.80 1.18 0.95 ACN 100  CSP-8 
trans-1,2-Cyclohexanediyl-bis 4-vinyl-benzamide 1.22 1.06 0.72 ACN 100  CSP-8 
trans-3-(1,2-Cyclohexanediyl)-bis 1-(3,5-bis-trifluoromethyl-
phenyl) urea 0.51 1.26 0.80 
ACN/MeOH 
99/1  CSP-3 
trans-N-(2-Amino-cyclohexyl)-3,5-dinitro-benzamide 0.82 1.17 0.92 ACN 100  CSP-8 
1-Bromo-4-methanesulfinyl-benzene 1.91 1.03 0.58 ACN 100  CSP-6 
1-Bromo-2-methanesulfinyl-benzene 0.85 1.10 0.92 ACN 100  CSP-8 
trans-1,2-Cyclohexanediyl-bis Acrylamide 1.19 1.16 1.05 ACN/MeOH 95/5  CSP-5 
Fluoxetine hydrochloride 1.68 1.09 0.70 ACN/MeOH 50/50  CSP-2 
Dansyl-DL-phenylalanine cyclohexylammonium salt 3.27 1.09 0.50 ACN/MeOH 70/30  CSP-2 
trans-1,2-diphenylethylenediamine 1.03 1.16 0.70 ACN/MeOH 99/1  CSP-3 
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Table 5 
Enantiomeric separations in the normal phase mode14
Name '1k  α  SR Mobile Phase15 Column
Ancymidol 3.49 1.03 0.60 Heptane/IPA 80/20 CSP-1 
 6.11 1.03 0.60 Heptane/IPA/TFA 15/85/0.1 CSP-8 
3-(α-Acetonyl-4-chlorobenzyl)-4-hydroxycoumarin 1.07 1.34 1.45 Heptane/IPA 75/25 CSP-6 
Warfarin 1.02 1.23 1.42 Heptane/IPA 75/25 CSP-6 
 4.42 1.08 0.92 Heptane/IPA/TFA 15/85/0.1 CSP-8 
(R,R) and (S,S)-N,N'-Bis(2-methylbenzyl)sulfamide 0.49 1.08 0.55 Heptane/IPA/TFA 50/50/0.1 CSP-1 
Bendroflumethiazide 13.27 1.07 0.80 Heptane/IPA 65/35 CSP-8 
Benzylphthalide 1.13 1.04 0.70 Heptane/IPA 65/35 CSP-8 
Benzyl-6-oxo-2,3-diphenyl-4-morpholine carboxylate 7.77 1.16 2.21 Heptane/IPA/TFA 95/5/0.1 CSP-8 
3-(Benzyloxycarbonyl)-4-oxazolidine carboxylic acid 0.45 1.11 0.57 Heptane/IPA/TFA 60/40/0.1 CSP-1 
Chlorthalidone 2.76 1.13 0.84 Heptane/IPA/TFA 50/50/0.1 CSP-1 
N,N'-Dibenzyl-DL-tartramide 8.94 1.09 0.92 Heptane/IPA/TFA 85/15/0.1 CSP-8 
(4R,5S) or (4S,5R)-1,5-Dimethyl-4-phenyl-2-imidazolidinone 1.29 1.05 0.65 Heptane/IPA/TFA 60/40/0.1 CSP-1 
 3.88 1.07 0.94 Heptane/IPA/TFA 85/15/0.1 CSP-8 
N,S-dimethyl-S-phenyl-sulfoximine 3.18 1.03 0.58 Heptane/IPA 65/35 CSP-8 
DL-5-(4-Hydroxyphenyl)-5-phenylhydantoin 5.15 1.15 0.65 Heptane/IPA 50/50 CSP-6 
 13.03 1.03 0.72 Heptane/IPA/TFA 85/15/0.1 CSP-8 
5-(3-Hydroxyphenyl)-5-phenyl-hydantoin 4.63 1.17 0.70 Heptane/IPA 50/50 CSP-6 
 4.04 1.20 0.96 Heptane/IPA 65/35 CSP-8 
(R,S)-(±)-1-(9-Anthryl)-2,2,2-trifluoroethanol 2.24 1.06 0.70 Heptane/IPA 90/10 CSP-9 
1,1'-Bi-2-naphthol 0.44 1.35 1.29 Heptane/IPA/TFA 60/40/0.1 CSP-1 
                                                 
14 To reduce the size of this table, all structures of the compounds are not shown. 
15 All samples were analyzed under the chromatographic condition: a UV detector at 244, 254 or 264 nm, flow 
rate 1 ml/min, unless otherwise noted.  All mobile phase ratios were volume to volume.  IPA: 2-propanol.  
TFA: trifluoroacetic acid. 
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αName '1k   SR Mobile Phase15 Column
(3a(R,S)-cis)-(±)-3,3a,8,8a-Tetrahydro-2H-indeno[1,2-
d]oxazol-2-one 5.85 1.02 0.63
Heptane/IPA/TFA 
85/15/0.1 CSP-8 
1,2,3,4-Tetrahydro-1-naphthylamine 7.03 1.04 0.62 Heptane/IPA/TFA 85/15/0.1 CSP-8 
DL-Norephedrine hydrochloride 2.86 1.29 1.52 Heptane/IPA/TFA 60/40/0.1 CSP-1 
3-Phenylphthalide 4.49 1.10 0.88 Heptane/IPA/TFA 95/5/0.1 CSP-8 
γ-Phenyl-γ-butyrolactone 4.45 1.03 0.70 Heptane/IPA 15/85 CSP-6 
4-Phenyl-1,3-dioxane 0.63 1.28 1.38 Heptane/IPA/TFA 60/40/0.1 CSP-1 
(1-Phenethyl)phthalimide 1.82 1.05 0.61 Heptane/IPA/TFA 98/2/0.1 CSP-8 
(R,S)-(±)-N-(α-Methylbenzyl)phthalamic acid 0.65 1.13 0.90 Heptane/IPA 90/10 CSP-9 
Methyl trans-3-(4-methoxyphenyl)glycidate 9.14 1.05 0.60 Heptane/IPA 90/10 CSP-9 
Oxazepam 9.79 1.12 1.22 Heptane/IPA/TFA 85/15/0.1 CSP-8 
3-(1-Methoxy-3-phenyl-1H-isochromen-4-yl)-acrylic acid 
ethyl ester 2.43 1.05 0.96
Heptane/IPA/TFA 
98/2/0.1 CSP-8 
1-Bromo-2-methanesulfinyl-benzene 5.37 1.04 0.60 Heptane/IPA/TFA 95/5/0.1 CSP-8 
N-[(4-Methylphenyl)sulfonyl]-S-benzyl-S-phenyl sulfilimine 7.02 1.08 1.12 Heptane/IPA/TFA 75/25/0.1 CSP-8 
N-[(4-Methylphenyl)sulfonyl]-S-phenyl-S-(2-phenylethyl) 
sulfilimine 4.92 1.18 2.36
Heptane/IPA 
65/35 CSP-8 
[3a(R,S)-[2(3'aR*,8'aS*),3'a(α,β),8'a(α,β)]]-(±)-2,2'-
Methylenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole] 5.23 1.12 0.75
Heptane/IPA 
65/35 CSP-8 
Indapamide 7.47 1.04 0.72 Heptane/IPA/TFA 75/25/0.1 CSP-8 
Trogers base 10.56 1.03 0.62 Heptane/IPA/TFA 95/5/0.1 CSP-8 
1,2,3,4-Tetrahydro-2-naphthoic acid 1.37 1.34 0.60 Heptane/IPA 90/10 CSP-9 
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Appendix A.  Supporting Materials 
1. 1H NMR (in DMSO-d6) and mass spectrum of 2,4-DNP-O-BCD for CSP-1, CSP-2 
and CSP-3. 
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2. Mass spectrum of 3,4-DNP-O-BCD for CSP-5. 
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3. 1H NMR (in DMSO-d6) and mass spectrum of 4-CF3-2,6-DNP-O-BCD for CSP-6. 
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4. 1H NMR (in Acetone-d6) and mass spectrum of 4-CF3-2,6-DNP-O-heptakis[6-O-
(tert-butyldimethylsilyl)]-β-cyclodextrin for CSP-8. 
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CHAPTER 5.  OPTIMIZATION OF THE SYNTHESIS OF 2,6-
DINITRO-4-TRIFLUOROMETHYLPHENYL ETHER 
SUBSTITUTED CYCLODEXTRIN BONDED CHIRAL 
STATIONARY PHASES 
 
A paper published in Chromatographia1
 
Q. Zhong2,3, L. He4, T. E. Beesley4, W. S. Trahanovsky3, P. Sun5, C. Wang5,  
and D. W. Armstrong5,6
 
Abstract 
The comparisons of five different chiral stationary phases (CSPs) based on 2,6-
dinitro-4-trifluoromethylphenyl (DNP-TFM) ether substituted β-cyclodextrin are presented.  
The five CSPs differ from each other in the linkage/spacer chemistry, or on the position of 
the substituents on β-cyclodextrin, or in the sequence of the synthetic procedure.  The results 
show that there are two optimum combinations: (1) DNP-TFM randomly substituted on the 
β-cyclodextrin as the chiral selector along with a carbamate linkage chain bonding it to the 
silica support; and (2) β-cyclodextrin derivatized by DNP-TFM substituents only on the C-2 
and C-3 positions of the cyclodextrin with an ether linkage chain anchoring it to the silica gel.  
These two combinations show complementary separations for some enantiomers.  The spacer 
chain effect is much more pronounced for the CSP based on the β-cyclodextrin derivatives 
with DNP-TFM substituents only on C-2 and C-3 positions than its randomly substituted 
                                                 
1 Reprinted with permission of Chromatographia, 2006, 64, 147-155.  Copyright © 2006 Friedr. Vieweg & 
Sohn/GWV Fachverlage GmbH.  All rights reserved. 
2 Graduate student, primary researcher and author. 
3 Department of Chemistry, Iowa State University, Ames, IA 50011 USA 
4 Advanced Separation Technologies Inc, 37 Leslie Court, P. O. Box 297, Whippany, NJ 07981 USA 
5 Department of Chemistry and Biochemistry, University of Texas at Arlington, Arlington, TX 76019 USA 
6 Author for correspondence. 
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counterpart.  The sequence of derivatizing the cyclodextrin and attaching it to silica gel also 
affects its selectivity and efficiency.  The β-cyclodextrin should be derivatized before it is 
linked to the silica gel. 
5.1 Introduction 
The possibility of different enantiomers having different physiological effects makes 
chiral separations desirable in many areas, such as pharmaceutical, medicinal, food and 
beverage, and environmental sciences and their associated industries [1].  For over two 
decades, cyclodextrin (CD)-based chiral selectors have been important in industrial and 
academic areas involving liquid chromatography (LC), gas chromatography (GC), and 
capillary electrophoresis (CE) for enantiomeric separations [1-10].  Although a series of 
cyclodextrins, from α- (6-membered) to θ-CD (13-membered) have been discovered [11], 
only the first three major cyclodextrins (α-, β-, and γ-CD) have been shown to have practical 
uses in separation science [12].  Moreover, because of their suitable size of cavity and 
geometry, the chiral stationary phases (CSPs) based on β-cyclodextrin and its derivatives 
appear to be more broadly applicable than α- and γ-cyclodextrins for many liquid-based 
separations [1,4,13,14].  Indeed, the first stable and commercially successful reversed-phase 
chiral stationary phase was based on β-cyclodextrin [1,15,16]. 
The formation of an inclusion complex plays an important role in the chiral 
recognition mechanism by cyclodextrins in the reversed-phase mode [15,17-20].  While in 
the polar organic and normal-phase modes, in which hydrophobic inclusion complexation 
between analytes and the cyclodextrin cavity does not occur, chiral recognition on the 
exterior surface of the cyclodextrin, especially near the secondary hydroxyl groups at the 
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mouth of the cavity is dominant [12,21-24].  Besides the chiral selector itself, the spacer 
chain, which attaches the chiral selector to the solid support or links two chiral units together 
in a dimeric chiral selector [25], may also affect chiral recognition [25-30].  Both the length 
and the nature of the spacer can have an influence on enantiomeric separations.  Depending 
on the nature of the chiral selector, some CSPs favor short spacers [30] while others may 
favor longer linkage chains [29].  Therefore, whenever optimizing a CSP for best 
performance, the effect of the linkage chain on the enantiomeric separations should be 
considered. 
Recently, we reported the first derivatized cyclodextrins containing π-electron 
deficient substituents (i.e. π-acidic moieties), especially two related 2,6-dinitro-4-trifluoro-
methylphenyl ether substituted β-cyclodextrin (DNP-TFM-BCD) bonded stationary phases, 
which showed broad enantioselectivity in three LC separation modes, namely, the reversed-
phase, polar organic, and normal-phase modes [31].  In this study, we devoted our efforts to 
the optimization of the chiral recognition ability of this kind of chiral selector.  The effect of 
the linkage chain, the position of the substituents on β-cyclodextrin, and sequence of the 
synthetic procedure are discussed. 
5.2 Experimental 
5.2.1 Chemicals 
Kromasil silica (5 μm spherical diameter, 100 Å pore diameter, 0.90 mL g-1 pore 
volume, 312 m2 g-1 specific surface area), was purchased from Eka Chemicals, Bohus, 
Sweden.  Anhydrous N,N'-dimethylformamide (DMF), sodium hydride (95%), 3-(triethoxy-
silyl)propyl isocyanate, and most analytes used in this study were purchased from Sigma-
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Aldrich (Milwaukee, WI, USA).  Acetonitrile, 2-propanol, and methanol were HPLC grade, 
from Fischer (Fairlawn, NJ, USA).  Triethylamine and acetic acid (ACS certified grade) were 
obtained from Fisher Scientific (St. Louis, MO, USA).  Distilled water was deionized and 
filtered through activated charcoal and a 5 µm filter.  The 4-chloro-3,5-dinitrobenzotri-
fluoride (98%) were obtained from Alfa Aesar (Ward Hill, MA, USA).   
5.2.2 Preparation procedure 
The structures of five CSPs (from DT-BCD-1 to DT-BCD-5, where DT-BCD refers 
to dinitrotrifluoromethylphenyl substituted β-cyclodextrin) are shown in Table 1.  The 
procedure for the preparation of DT-BCD-1 and DT-BCD-2 was described in a previous 
report [31] as CSP-6 and CSP-8, respectively.  DT-BCD-3 and DT-BCD-4 were prepared in 
a similar way.  For these four CSPs, the β-cyclodextrins were derivatized before they were 
attached to the solid support.  The carbamate linkage chain for DT-BCD-1 and DT-BCD-4 is 
achieved by using 3-(triethoxysilyl)propyl isocyanate as the spacer reagent, and the ether 
linkage chain for DT-BCD-2, DT-BCD-3 and DT-BCD-5 is obtained by using (3-glycidyl-
oxypropyl)trimethoxysilane as the spacer reagent.  As described below, the preparation of 
DT-BCD-5 is different from the other four CSPs in that the β-cyclodextrin was derivatized 
after it was attached to the silica gel through an ether linkage. 
The Cyclobond I 2000 sorbent [14] was dried before use.  To a slurry of Cyclobond I 
2000 sorbent (3.5 g) in 40 mL anhydrous DMF was added NaH (0.10 g, 3.9 mmol) at room 
temperature under argon protection with stirring.  After 30 minutes, 4-chloro-3,5-dinitro-
benzotrifluoride (0.27 g, 1 mmol) was added.  The mixture was heated to 100 ˚C for 5 h and 
cooled down to room temperature then filtered.  The CSP was washed with methanol, acetic 
acid in water solution (0.2%, w/w), pure water, and methanol (50 ml for each solvent), and 
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dried in oven at 110 ˚C over night.  The product (3.61 g) appeared as light yellow/brown 
powder. 
DT-BCD-1 and DT-BCD-3 were using the same chiral selector (randomly substituted 
DNP-TFM-BCD) but with different linkage chain.  DT-BCD-2 and DT-BCD-4 were also 
using the same chiral selector (the DNP-TFM groups were only on C-2 and C-3 positions) 
but differed in spacers.  The characterization data (1H-NMR and ESI-MS) of these two chiral 
selectors, as well as the elemental analysis data for DT-BCD-1 and DT-BCD-2, are available 
in the previous report [31].  The elemental analysis data for the other three CSPs are: for DT-
BCD-3, %C 6.71, %H 1.04, %N 0.40; for DT-BCD-4, %C 5.28,%H 1.98,%N 0.91; for DT-
BCD-5, %C 6.34, %H 1.06, %N 0.20.  All CSPs were slurry packed into 250 × 4.6 mm i.d. 
stainless steel columns. 
5.2.3 Column evaluation 
The chromatographic experiments were done on either a HP 1050 or Agilent 1100 
HPLC system with a UV variable wavelength detector (VWD), an auto sampler, and 
computer-controlled HP ChemStation for LC data processing software.  Since this type of 
CSPs works well in the reversed-phase mode [31], all chromatographic comparisons in this 
study were carried out under reversed-phase conditions at room temperature (~ 23 ˚C).  The 
mobile phases were degassed by purging compressed pure helium gas for 10 minutes.  UV 
detection was accomplished using a VWD at 230, 244, 254 or 264 nm for most of the 
analytes. 
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5.3 Results and Discussion 
5.3.1 Structures of the CSPs 
The structures of five different CSPs based on 2,6-dinitro-4-trifluoromethylphenyl 
(DNP-TFM) ether substituted β-cyclodextrin are listed in Table 1.  The average degree of 
substitution of DNP-TFM groups on each β-cyclodextrin is 5 [31].  The distribution of the 
DNP-TFM groups on the cyclodextrin rim can be random or mainly on the C-2 or C-3 
positions by protecting the hydroxyl groups of the C-6 position.  Two different bonding 
strategies were used.  These two differently substituted DNP-TFM cyclodextrin derivatives 
were linked to porous spherical silica gel via either (3-glycidyloxypropyl)trimethoxysilane or 
3-(triethoxysilyl)propyl isocyanate.  Therefore, four different DNP-TFM-BCD based CSPs 
(DT-BCD-1, 2, 3, 4) can be obtained.  Furthermore, just like some other derivatives of the 
Cyclobond I 2000 family [14], DNP-TFM-BCD CSPs can also be made directly from pre-
bonded Cyclobond I 2000 sorbent (for DT-BCD-5, see Experimental).   
5.3.2 Chromatographic results 
A set of 14 pairs of enantiomers were used as probe molecules for chromatographic 
comparison of the enantioselectivity of all five DNP-TFM-BCD CSPs under reversed-phase 
conditions.  The chromatographic data are summarized in Table 2.  For convenient 
comparisons, this Table also contains some data for DT-BCD-1 and DT-BCD-2, part of 
which was presented in a previous report [31].  The success rate for enantiomeric separation 
of the 14 selected probe enantiomers on all five columns is summarized in Fig. 1. 
5.3.2.1 DNP-TFM randomly substituted β-cyclodextrins 
Three columns (DT-BCD-1, 3 and 5) were made without protection/deprotection of 
the C-6 position of glucopyranose units on β-cyclodextrins.  So, the DNP-TFM groups were 
 
178 
randomly distributed on the cyclodextrin.  Because DT-BCD-5 CSP was made directly from 
a previously synthesized Cyclobond I 2000 sorbent, which differed from DT-BCD-1 and DT-
BCD-3 CSPs, we will first focus on the DT-BCD-1 to DT-BCD-4 CSPs, and leave the DT-
BCD-5 CSP for later discussion.  Although both DT-BCD-1 and DT-BCD-3 CSPs were 
randomly substituted β-cyclodextrins, they were bonded to silica gel through different 
spacers: i.e., a carbamate linkage for the DT-BCD-1 CSP and an ether linkage for the DT-
BCD-3 CSP (see Experimental). 
Both DT-BCD-1 and DT-BCD-3 CSPs separated all 14 pairs of probe enantiomers.  
DT-BCD-1 CSP produced 9 baseline separations while 6 baseline separations were found for 
DT-BCD-3 CSP (Fig. 1).  Both columns are comparable and DT-BCD-1 CSP is slightly 
better than DT-BCD-3 CSP in terms of enantioselectivity (α-values) for these probe analytes 
(see Table 2).  The linkage chain did not make a profound difference on the column 
performance for these two CSPs. 
5.3.2.2 DNP-TFM only on C-2 and C-3 positions of β-cyclodextrins 
Both DT-BCD-2 and DT-BCD-4 CSPs were made from heptakis[6-O-(tert-
butyldimethylsilyl)]-β-cyclodextrin and the tert-butyldimethylsilyl group was subsequently 
deprotected before the cyclodextrin derivative was bonded to silica gel [31-33].  Therefore, 
the DNP-TFM groups can only reside on the C-2 and C-3 positions of the β-cyclodextrins.  
The bonding chemistry seems to affect the enantioselectivity of these two CSPs greatly.  
Figure 2 gives three examples.  The analyte chlorthalidone, 1,1’-binaphthol, and 
hydrobenzoin can be baseline separated on DT-BCD-2 CSP with a mobile phase of 
ACN/TEAA buffer 15/85, 25/75 and 25/75, respectively.  However, with the same mobile 
phase, almost no separation was observed on DT-BCD-4 CSP.  From Fig. 1, we also see that 
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DT-BCD-2 CSP separated all 14 analytes with 13 baseline separations but only 10 analytes 
were separated on the DT-BCD-4 CSP and only 1 baseline separation was achieved.   
It’s very interesting that an achiral linkage chain can have such a great influence on 
enantiomeric separations.  Clearly, this is predominantly a selectivity effect and not one 
related to efficiency.  In every case, the enantiomeric resolution is enhanced because of the 
increase in the selectivity factor (α) on DT-BCD-2 CSP (Table 2).  As we know, the DNP-
TFM groups are present only on the secondary hydroxyls because the primary hydroxyl 
groups were protected.  The subsequently deprotected primary 6-hydroxyl groups are more 
reactive than the remaining secondary hydroxyls.  In addition, the DNP-TFM groups at the 
mouth of the cyclodextrin cavity further limits the reactivity of the secondary hydroxyls.  So, 
it is reasonable to assume that the linkage reactions (to the silica gel) mostly occur with the 
primary hydroxyl groups.  In this case, the spacer is the only “derivatizing group” at the 
smaller opening of the cyclodextrin cavity.  When deprotected DNP-TFM-BCD was bonded 
to the silica gel through an ether linkage (which makes DT-BCD-2 CSP), it opened the epoxy 
ring on the functionalized silica gel and generated an additional hydroxyl group on the spacer 
chain.  This additional hydroxyl makes the ether linkage different from the carbamate linkage 
(DT-BCD-4 CSP).  Therefore, it is not hard to understand why different spacers, which are 
the only groups attached at the smaller opening of the cyclodextrin cavity, may affect the 
analyte-cyclodextrin complex. 
A question arises as to why the spacer effect is not so obvious in the DNP-TFM 
randomly substituted cyclodextrins (for DT-BCD-1 and DT-BCD-3 CSPs).  Because of 
random substitution, the DNP-TFM groups are on both sides of cyclodextrin molecule.  
When the DNP-TFM groups are attached to the same side of the cyclodextrin as the linkage 
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chain, there may be some additional steric effects for analytes that form inclusion complexes.  
Also, the spacer/linkage chain can attach to either end of the cyclodextrin cavity. 
5.3.2.3 Sequence of manufacturing procedure 
To make a DNP-TFM-BCD CSP, one can derivatize β-cyclodextrin with the DNP-
TFM group, and then bond this derivative to silica gel (as was discussed in previous sections); 
or, one can first attach native β-cyclodextrin to the silica gel, and then do the derivatization 
reaction.  The first method was used to prepare all the CSPs in this study except DT-BCD-5 
CSP, which is prepared by the second method.  The Cyclobond I 2000 sorbent, which 
contains native β-cyclodextrin attached via an ether linkage [14], was used as the starting 
material to make DT-BCD-5 CSP (see Experimental).  So, both DT-BCD-3 and DT-BCD-5 
CSPs were DNP-TFM randomly substituted β-cyclodextrins with an ether linkage spacer.  
However, they had a different sequence in their synthesis procedure. 
Figure 3 shows a column performance comparison of DT-BCD-3, DT-BCD-5 and 
Cyclobond I 2000 in separating trans-stilbene oxide with the same mobile phase of 25/75 
ACN/TEAA buffer.  A partial separation was achieved on DT-BCD-5 CSP while no 
separation was observed on Cyclobond I 2000.  This shows the DNP-TFM group improves 
the chiral recognition ability for DT-BCD-5 CSP.  However, a baseline separation was 
obtained on DT-BCD-3 CSP.  As can be seen in Fig. 1, the DT-BCD-5 CSP could not 
separate 2 of the 14 probe enantiomers while the DT-BCD-3 CSP separated all of them.  So, 
DT-BCD-3 CSP has a somewhat better column performance than DT-BCD-5 CSP.  It should 
be noted that the derivatization reaction of the cyclodextrin in DT-BCD-5 is a heterogeneous 
solid-liquid reaction.  It is more difficult to control than homogenous reactions, and likely 
produces a somewhat different distribution of the DNP-TFM substituent groups.  
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Derivatizing cyclodextrin in homogenous solution then attaching it onto the silica gel appears 
to produce the most effective CSP for this particular derivative. 
5.3.2.4 The best DNP-TFM-BCD CSP 
Thus far, based on the results and discussion above, we know that for randomly 
substituted DNP-TFM-BCD CSP, the carbamate linkage between the silica gel and chiral 
selector is slightly better (DT-BCD-1) than the ether linkage (DT-BCD-3).  When the DNP-
TFM-BCD CSP has the DNP-TFM groups mainly on C-2 and C-3 positions, the spacer with 
the ether linkage (DT-BCD-2) is much better than the spacer with the carbamate linkage 
(DT-BCD-4).  It might be interesting to compare the column performance of these two 
columns (DT-BCD-1 and DT-BCD-2) and see how the differences affect the column 
performance. 
Figure 4 shows three analytes which were baseline separated on DT-BCD-1 CSP 
while only a partial separation could be achieved on DT-BCD-2 CSP with the same or 
similar mobile phases.  Figure 5 gives three completely opposite examples which show that 
baseline separation on the DT-BCD-2 CSP while only partial or no separation at all occurred 
on DT-BCD-1 CSP with the same or similar mobile phases.  Therefore, in terms of column 
performance in the reverse-phase mode, DT-BCD-1 and DT-BCD-2 CSPs appear to be 
complementary to one another for enantiomeric separations. 
Another interesting point in Fig. 5 is the comparison of separations of benzyl-
phthalide and 3-phenylphthalide.  The only difference between these two analytes is the 
distance of the phenyl ring to the stereogenic center.  On the DT-BCD-1 CSP, benzyl-
phthalide could not be separated; but 3-phenylphthalide was partially separated with the same 
mobile phase of ACN/buffer 25/75.  On the DT-BCD-2 CSP, both analytes were baseline 
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separated, however, the retention time for the baseline separation of 3-phenylphthalide is 
much shorter than that of benzylphthalide.  That means the shorter the distance of a 
functional group (here the phenyl ring) to the stereogenic center, the easier it is to achieve the 
enantiomeric separation.  This is generally true for the separation of closely related chiral 
compounds [34]. 
5.4 Conclusions 
The 2,6-dinitro-4-trifluoromethylphenyl ether substituted β-cyclodextrin based CSPs 
are effective in the separation of 14 pairs of selected probe racemates in the reversed-phase 
mode.  The linkage attaching the chiral selector to the silica gel can have a significant effect 
on the enantioselectivity.  For DNP-TFM randomly substituted β-cyclodextrin, the carbamate 
linkage (DT-BCD-1) works slightly better than its ether-linkage counterpart (DT-BCD-3).  
However, for DNP-TFM-BCD CSPs with DNP-TFM substituents only on the C-2 and C-3 
positions, the ether linkage chain (DT-BCD-2) is much better than the carbamate linkage 
chain (DT-BCD-4).  The effect of an achiral spacer on enantiomeric separations often is 
dependent on the chiral selector itself.  Better CSPs are produced when β-cyclodextrin is first 
derivatized with DNP-TFM groups in homogeneous solution, and then immobilized on the 
silica gel.  The DT-BCD-1 and DT-BCD-2 proved to be the best CSPs among the five tested 
in terms of versatility and enantioselectivity for enantiomeric separations.  These two CSPs 
show complementary selectivities for many enantiomers. 
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Captions to the figures: 
 
Fig. 1 The success rate for enantiomeric separation of 14 selected probe compounds on five 
related CSPs.  All CSPs were packed as 250 × 4.6 mm HPLC column.  All separations were 
achieved at ambient temperature (~23 ˚C).  Flow rate: 1 mL min-1. 
 
Fig. 2 Comparison of the column performance of DT-BCD-2 and DT-BCD-4 CSPs in 
separating (A) chlorthalidone, mobile phase: 15/85 ACN/TEAA buffer; (B) 1,1’-binaphthol, 
mobile phase: 25/75 ACN/TEAA buffer; (C) hydrobenzoin, mobile phase: 25/75 
ACN/TEAA buffer.  ACN: acetonitrile.  The TEAA buffer is composed of 0.1% (v/v) 
triethylammonium acetate in water, pH 4.1.  Flow rate: 1.0 mL min-1; UV detection at 230 
nm.  T = 23 ˚C. 
 
Fig. 3 Comparison of column performance of DT-BCD-3, DT-BCD-5 CSP and Cyclobond I 
2000 in separating trans-stilbene oxide with the same mobile phase of 25/75 ACN/TEAA 
buffer. ACN: acetonitrile.  The TEAA buffer is composed of 0.1% (v/v) triethylammonium 
acetate in water, pH 4.1.  Flow rate: 1.0 mL min-1; UV detection at 230 nm.  T = 23 ˚C. 
 
Fig. 4 Enantiomeric separation comparison between DT-BCD-1 and DT-BCD-2 CSPs in the 
separations of (A) ancymidol, with the same mobile phase of ACN/buffer 25/75; (B) DL-5-
(4-hydroxyphenyl)-5-phenylhydantoin, with the mobile phase of ACN/buffer 40/60 for DT-
BCD-1, and ACN/buffer 15/85 for DT-BCD-2.  (C) 2-phenylbutyric acid, with the same 
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mobile phase of ACN/buffer 25/75.  The buffer is composed of 0.1% TEAA (v/v) in water, 
pH 4.1.  Flow rate: 1 mL min-1.  UV detection at 254 nm.  T = 23 ˚C.  These examples show 
baseline separations on DT-BCD-1 but only partial separations on DT-BCD-2 under the 
same or similar mobile phase conditions. 
 
Fig. 5 Enantiomeric separation comparison between DT-BCD-1 and DT-BCD-2 CSPs in the 
separations of (A) benzoin ethyl ether, with the same mobile phase of ACN/buffer 25/75; (B) 
benzylphthalide, with the same mobile phase of ACN/buffer 25/75; (C) 3-phenylphthalide, 
with the mobile phase of ACN/buffer 25/75 for DT-BCD-1, and ACN/buffer 40/60 for DT-
BCD-2.  The buffer is composed of 0.1% TEAA (v/v) in water, pH 4.1.  Flow rate: 1 mL 
min-1.  UV detection at 254 nm.  T = 23 ˚C.  These examples show baseline separations on 
the DT-BCD-2 CSP but only a partial separation or no separation on the DT-BCD-1 CSP 
under the same or similar mobile phase conditions.   
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Table 1 
The structure of five different CSPs based on 2,6-dinitro-4-trifluoromethylphenyl ether 
substituted β-cyclodextrins (abbreviated as DT-BCDs). 
 
O
OR2
R3O
O
7
OR1
 
R1/R2/R3 =
O2N
O2N
CF3 (DNP-TFM) or H 
 
CSP R Coupling Chemistry7 
DT-BCD-1 R1=R2=R3= DNP-TFM or H Carbamate linkage 
DT-BCD-2 R1=H, R2=R3= DNP-TFM or H Ether linkage 
DT-BCD-3 R1=R2=R3= DNP-TFM or H Ether linkage 
DT-BCD-4 R1=H, R2=R3= DNP-TFM or H Carbamate linkage 
DT-BCD-5 R1=R2=R3= DNP-TFM or H 
The native β-CD was bonded onto silica 
through ether linkage, then derivatized 
with 2,6-dinitro-4-trifluoromethylphenyl 
group. 
 
 
 
                                                 
7 See Experimental section for details. 
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Table 2 
Comparison of chiral separations on DNP-TFM-BCD CSPs in the reversed-phase mode.8
 
No. Compound k1’ α Rs Mobile phase9 Column 
1 12.20 1.15 1.75 D DT-BCD-1 
 5.69 1.16 2.04 B DT-BCD-2 
 4.42 1.03 0.70 B DT-BCD-3 
 2.31 1.00 0.00 B DT-BCD-4 
 
1,1’-Binaphthol 
OH
OH
 1.68 1.00 0.00 B DT-BCD-5 
2 4.58 1.04 1.10 B DT-BCD-1 
 2.11 1.29 1.96 A DT-BCD-2 
 6.27 1.06 1.30 B DT-BCD-3 
 3.17 1.09 1.00 C DT-BCD-4 
 
3-Phenylphthalide 
O
O
Ph
 
3.73 1.03 0.70 B DT-BCD-5 
3 2.31 1.25 2.60 B DT-BCD-1 
 2.63 1.29 2.70 C DT-BCD-2 
 2.31 1.10 1.30 B DT-BCD-3 
 0.72 1.00 0.00 B DT-BCD-4 
 
5-(4-Hydroxyphenyl)-5-phenyl hydantoin 
 
H
N
O
N
HO
Ph
HO
 1.22 1.10 1.20 B DT-BCD-5 
4 1.73 1.18 2.06 B DT-BCD-1 
 1.62 1.28 3.56 B DT-BCD-2 
 1.44 1.11 1.40 B DT-BCD-3 
 0.54 1.04 0.50 B DT-BCD-4 
 
5,5-Dimethyl-4-phenyl-2-oxazolidone 
 
O
N
HPh
O
 0.93 1.13 1.30 B DT-BCD-5 
5 9.24 1.22 2.50 D DT-BCD-1 
 10.27 1.14 1.56 D DT-BCD-2 
 5.75 1.05 0.80 B DT-BCD-3 
 2.95 1.11 1.10 E DT-BCD-4 
 
Aminoglutethimide 
HN
O
O
NH2
 
11.93 1.00 0.00 B DT-BCD-5 
6 3.29 1.20 1.35 D DT-BCD-1 
 1.66 1.10 1.50 D DT-BCD-2 
 3.19 1.10 1.30 D DT-BCD-3 
 1.42 1.00 0.00 D DT-BCD-4 
 
Chlorthalidone 
NH
O
HO
Cl
S NH2
O
O
 1.38 1.16 1.30 D DT-BCD-5 
7 6.72 1.07 1.40 B DT-BCD-1 
 3.64 1.17 2.74 A DT-BCD-2 
 8.95 1.11 1.90 B DT-BCD-3 
 2.28 1.09 1.20 B DT-BCD-4 
 
Flavanone 
O Ph
O
 
3.85 1.10 1.40 B DT-BCD-5 
                                                 
8 All samples were analyzed under the chromatographic condition: a UV detector at 230, 244, 254 or 264 nm, 
flow rate 1 mL min-1, unless otherwise noted. 
9 All mobile phases were made by ACN/TEAA buffer (v/v):  A: 40/60; B: 25/75; C: 20/80; D: 15/85; E: 10/90.  
ACN: acetonitrile.  The TEAA buffer is composed of 0.1% (v/v) triethylammonium acetate in water, pH 4.1. 
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No. Compound k1’ α Rs Mobile phase9 Column 
8 1.45 1.26 2.31 B DT-BCD-1 
 0.88 1.28 2.70 B DT-BCD-2 
 1.32 1.12 1.50 B DT-BCD-3 
 0.55 1.04 0.50 B DT-BCD-4 
 
Hydrobenzoin 
 
OH
OH  0.73 1.21 1.60 B DT-BCD-5 
9 5.20 1.09 1.30 D DT-BCD-1 
 3.30 1.22 2.90 D DT-BCD-2 
 5.89 1.11 1.40 D DT-BCD-3 
 2.27 1.02 0.50 D DT-BCD-4 
 
Indapamide 
N
O
NH
S O
O NH2
Cl
 2.24 1.16 1.80 D DT-BCD-5 
10 2.17 1.17 2.30 D DT-BCD-1 
 2.40 1.30 3.50 D DT-BCD-2 
 2.88 1.23 3.00 D DT-BCD-3 
 0.97 1.11 1.20 D DT-BCD-4 
 
Mephenytoin 
NH
O
N
O
 
2.03 1.41 4.40 D DT-BCD-5 
11 1.28 1.35 2.60 D DT-BCD-1 
 0.81 1.65 2.90 D DT-BCD-2 
 3.52 1.37 2.50 B DT-BCD-3 
 1.05 1.10 1.20 D DT-BCD-4 
 
Nefopam 
N
O
Ph
CH3
HCl
 1.97 1.30 2.30 B DT-BCD-5 
12 1.81 1.88 6.36 B DT-BCD-1 
 1.39 1.59 5.40 B DT-BCD-2 
 2.20 1.42 4.30 B DT-BCD-3 
 1.00 1.11 0.80 B DT-BCD-4 
 
Oxazepam 
N
H
N
Ph
Cl
OH
O
 0.99 1.68 5.20 B DT-BCD-5 
13 10.12 1.14 2.60 B DT-BCD-1 
 1.79 1.36 3.50 A DT-BCD-2 
 12.34 1.12 1.90 B DT-BCD-3 
 6.07 1.18 1.80 B DT-BCD-4 
 
trans-Stilbene oxide 
O
 
5.38 1.05 1.00 B DT-BCD-5 
14 1.23 1.11 0.80 D DT-BCD-1 
 0.86 1.19 0.70 D DT-BCD-2 
 2.17 1.17 0.90 D DT-BCD-3 
 0.50 1.00 0.00 D DT-BCD-4 
 
Tropicamide 
HO
O
N
N
Ph
 
0.89 1.24 1.00 D DT-BCD-5 
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CHAPTER 6.  GENERAL CONCLUSIONS 
 
Distillation and chiral high performance liquid chromatography are two widespread 
chemical separation methods in both research and process industries.  Being one of the oldest 
separation methods for chemicals, distillation has a relatively simple process flowsheet.  On 
the contrary, chiral high performance liquid chromatography is a relatively new and 
sophisticated separation method, which has undergone explosive development during last 
three decades.  The work in this dissertation described new applications and developments of 
these two distinct separation technologies. 
The azeotropic distillation has successfully been applied in the separation of three 
volatile fatty acids – acetic, propionic, and butyric acids in dilute water solution.  The 
sequence of these three acids to distill out is butyric, propionic and acetic acids, opposite to 
the sequence of their boiling points (from low to high).  Quantitative 13C NMR protocols 
have been developed for detection.  The key point in quantitative carbon-13 NMR analysis is 
to make sure that all the carbons have relaxed back to the Boltzmann equilibrium before next 
radiofrequency pulse is applied.  So, generally speaking, there are two ways for quantitative 
analysis of the three acids by carbon-13 NMR.  The first method is to extend the delay (D1) 
between successive scans to 30 seconds.  This method may suffer from long acquisition 
times.  The second method consists of adding 10 μmol/mL of disodium (diethylenetriamine-
pentaacetato)iron(III) (Na2[Fe(DTPA)]) as a paramagnetic relaxation reagent and setting a 
delay D1 of 3 seconds.  High concentrations of paramagnetic relaxation reagents may 
severely worsen the signal-to-noise ratio (S/N), which turns out to be unfavorable for dilute 
samples.   
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The poly-cyclic amine polymer (P-CAP) CSPs are based on free radical initiated 
polymerization of (1R,2R)- or (1S,2S)-diaminocyclohexane (DACH).  An essential aspect in 
the synthesis of these CSPs is that the free radical initiator 4,4’-azo-bis-4-cyanovaleric acid is 
immobilized on the silica gel before the free radical initiated polymerization takes place.  
Therefore, the CSPs are covalently bonded onto the surface of porous silica gel.  The elution 
order of analytes on these two columns can easily be inverted because the monomers are pure 
(1R,2R)- or (1S,2S)-enantiomers.  These CSPs produced the most separations in the 
traditional normal phase mode, although the efficiency is the best when halogenated solvents 
and polar organic phase modes are used.  Although the highest efficiency was obtained with 
the halogenated mobile phases, the fewest compounds were separated.  The polar organic 
mode is in between these two normal phase approaches in terms of versatility and efficiency.  
Due to the high coverage of chiral selectors, the P-CAP columns have great sample loading 
capacity, thus are useful for preparative and semi-preparative chiral separations. 
A series of dinitrophenylated (DNP) β-cyclodextrin (β-CD) derivatives were 
synthesized, bonded to 5 μm spherical porous silica gel, and tested as chiral stationary phases 
in HPLC.  All three mobile phase modes, namely, the reversed-phase, polar organic, and 
normal phase modes, are applicable for these CSPs.  The reversed-phase mode yields the 
highest success rate of the separation of enantiomers, as with most cyclodextrin-based CSPs.  
Compared to other types of cyclodextrin-based CSPs, the DNP substituted β-CD CSPs 
produces unique separations for some chiral compounds, such as 1,1’-bi-2-naphthol.  For 
ionizable analytes, the appropriate pH and ionic strength of the buffer can shorten the 
retention time and improve separations.  The nature of the buffer may also affect separations.  
Among the five tested dinitrophenyl substituents, 2,6-dinitro-4-trifluoromethylphenyl (DNP-
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TFM) derivatized β-cyclodextrin CSP gives the broadest enantioselectivity.  Approximately 
half of the randomly chosen aromatic racemic compounds were separated on a single DNP-
TFM substituted β-CD analytical HPLC column in the reversed-phase mode.  The very π-
electron deficient phenyl ring, caused by the strong π-electron withdrawing dinitro and 
trifluoromethyl groups, is thought to be involved in enantioseparations.  Other interactions, 
such as inclusion complexation, hydrogen bonding, and steric repulsion, may also contribute 
to chiral recognition.
Five different CSPs based on 2,6-dinitro-4-trifluoromethylphenyl substituted β-
cyclodextrin were prepared and their column performance was compared under the reversed-
phase conditions, in order to study the spacer effect, the effect of DNP-TFM substituents on 
β-CD ring, and the effect of the sequence of manufacturing procedure.  The β-CD derivatized 
by DNP-TFM substituents only on its secondary hydroxyl groups, and with an ether linkage 
chain, has the best chromatographic performance overall.  The DNP-TFM randomly 
substituted β-CD with the carbamate linkage chain also exhibits broad enantioselectivity.  
The results also show that β-CDs should be derivatized by DNP-TFM groups first and then 
bonded on the silica support.  The DNP-TFM substituted β-cyclodextrin-based CSPs are 
proved to be a valuable addition to the versatile cyclodextrin-based chiral selectors.   
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